About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
1413 genotypes with 1939 annotations displayed of selected term and subterms
Searched Term: abnormal immune tolerance
Allelic Composition
(Genetic Background)		 Annotated Term Reference
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(NOD.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/Jdk) 		decreased susceptibility to autoimmune diabetes J:137009
AA467197em1Nyam/AA467197em1Nyam
(C.B6-AA467197em1Nyam) 		increased susceptibility to autoimmune disorder J:347271
Abattm1c(EUCOMM)Hmgu/Abattm1c(EUCOMM)Hmgu
Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * DBA/2) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:333883
Acantm2Afos/Acantm2Afos
(involves: C57BL/6) 		decreased susceptibility to induced arthritis J:122102
Ackr4tm1.1Rjbn/Ackr4tm1.1Rjbn
(B6.129S6-Ackr4tm1.1Rjbn) 		increased susceptibility to experimental autoimmune encephalomyelitis J:166490
Acla1BXSB/Slc/Acla1BXSB/Slc
(involves: BXSB/Slc * NZW/Slc) 		increased autoantibody level J:49899
Acla1NZW/Slc/Acla1BXSB/Slc
(involves: BXSB/Slc * NZW/Slc) 		increased autoantibody level J:49899
Acla2BXSB/Slc/Acla2BXSB/Slc
(involves: BXSB/Slc * NZW/Slc) 		increased autoantibody level J:49899
Acla2NZW/Slc/Acla2BXSB/Slc
(involves: BXSB/Slc * NZW/Slc) 		increased autoantibody level J:49899
Actbtm4(cre/ERT2)Npa/Actb+
Sgpl1tm1.1Npa/Sgpl1tm1.1Npa
(involves: BALB/cJ * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:199525
Adam8tm1.1Mdz/Adam8tm1.1Mdz
(DBA/1LacJ-Adam8tm1.1Mdz) 		decreased susceptibility to induced arthritis J:155243
Adamts5tm1.1Eam/Adamts5+
(involves: 129S5/SvEvBrd) 		decreased susceptibility to induced arthritis J:97590
Adamts5tm1.1Eam/Adamts5tm1.1Eam
(involves: 129S5/SvEvBrd) 		decreased susceptibility to induced arthritis J:97590
Adamts5tm2.2Lex/Adamts5tm2.2Lex
(B6.129S5-Adamts5tm2.2Lex) 		decreased susceptibility to induced arthritis J:175366
Adaz1NZM2328/J/Adaz1NZM2328/J
(involves: C57L/J * NZM2328/J) 		increased anti-double stranded DNA antibody level J:71397
Adgrd1tm1b(EUCOMM)Wtsi/Adgrd1tm1b(EUCOMM)Wtsi
(C57BL/6N-Adgrd1tm1b(EUCOMM)Wtsi/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
Adgre1tm1Stst/Adgre1tm1Stst
(B6.129S1-Emr1tm1Stst) 		abnormal immune tolerance J:99213
Ads1NZB/Ads1NZB
(involves: NZB * NZW) 		increased anti-double stranded DNA antibody level J:7239, J:7111
increased susceptibility to autoimmune disorder J:7111
Ads1NZB/Ads1NZW
(involves: NZB * NZW) 		increased anti-double stranded DNA antibody level J:7111
increased susceptibility to autoimmune disorder J:7111
Ads2NZB/Ads2NZB
(involves: NZB * NZW) 		increased anti-double stranded DNA antibody level J:7111
increased susceptibility to autoimmune disorder J:7111
Ads2NZB/Ads2NZW
(involves: NZB * NZW) 		increased anti-double stranded DNA antibody level J:7111
increased susceptibility to autoimmune disorder J:7111
Ads3NZB/Ads3NZW
(involves: NZB * NZW) 		increased susceptibility to autoimmune disorder J:7111
Ads3NZW/Ads3NZW
(involves: NZB * NZW) 		increased anti-double stranded DNA antibody level J:7239
increased susceptibility to autoimmune disorder J:7111
Ads4NZB/Ads4NZB
(involves: NZB * NZW) 		decreased anti-double stranded DNA antibody level J:11074
Ads4NZB/Ads4NZW
(involves: NZB * NZW) 		increased susceptibility to autoimmune disorder J:7111
Ads4NZW/Ads4NZW
(involves: NZB * NZW) 		increased susceptibility to autoimmune disorder J:7111
Aec1NOD/Uf/Aec1NOD/Uf
Aec2NOD/Uf/Aec2NOD/Uf
(B6.NOD-Aec2NOD/Uf Aec1NOD/Uf) 		increased anti-nuclear antigen antibody level J:129282
increased susceptibility to autoimmune disorder J:128900
Aem1C57BL/6/Aem1NZB
(involves: C57BL/6 * NZB) 		decreased autoantibody level J:7191
Aem2C57BL/6/Aem2C57BL/6
(involves: C57BL/6 * NZB) 		decreased autoantibody level J:59427
Aem2C57BL/6/Aem2NZB
(involves: C57BL/6 * NZB) 		decreased autoantibody level J:59427
Aem2C57BL/6/Aem2NZB
Aem3C57BL/6/Aem3NZB
(involves: C57BL/6 * NZB) 		decreased autoantibody level J:59427
Agnm1MRL/MpJ/Agnm1MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr) 		increased susceptibility to systemic lupus erythematosus J:97786
Agnm2C3H/HeJ/Agnm2MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr) 		increased susceptibility to systemic lupus erythematosus J:97786
Agnm2MRL/MpJ/Agnm2MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr) 		increased susceptibility to systemic lupus erythematosus J:97786
Agnm3C3H/HeJ/Agnm3MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr) 		increased susceptibility to systemic lupus erythematosus J:97786
Agnm3MRL/MpJ/Agnm3MRL/MpJ
(involves: C3H/HeJ-Faslpr * MRL/MpJ-Faslpr) 		increased susceptibility to systemic lupus erythematosus J:97786
Aia1NZB/Omr/Aia1NZB/Omr
(involves: NZB/Omr * NZC/Omr) 		increased susceptibility to autoimmune hemolytic anemia J:6517
Aia1NZB/Omr/Aia1NZC/Omr
(involves: NZB/Omr * NZC/Omr) 		increased susceptibility to autoimmune hemolytic anemia J:6517
Aif1tm1Nsib/Aif1tm1Nsib
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to induced arthritis J:204462
Aim2tm1.2Arte/Aim2tm1.2Arte
Dnase2atm1Osa/Dnase2atm1Osa
Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129 * BALB/c * C57BL/6 * C57BL/6J) 		increased autoantibody level J:238323
rheumatoid arthritis J:238323
Airetm1.1Doi/Airetm1.1Doi
(involves: 129S2/SvPas * C57BL/6) 		increased autoantibody level J:119475
increased susceptibility to autoimmune disorder J:83422
Airetm1.1Doi/Airetm1.1Doi
(B6.129S2-Airetm1.1Doi/Doi) 		increased autoantibody level J:107432
Airetm1.1Doi/Airetm1.1Doi
(NOD.129S2(B6)-Airetm1.1Doi/Doi) 		increased autoantibody level J:107432
Airetm1.1Doi/Airetm1.1Doi
(C.129S2-Airetm1.1Doi/Doi) 		increased autoantibody level J:107432
Airetm1.1Doi/Airetm1.1Doi
(SJL.129S2-Airetm1.1Doi/Doi) 		increased autoantibody level J:107432
Airetm1Mand/Aire+
(NOD.129P2-Airetm1Mand) 		increased autoantibody level J:188686
increased susceptibility to autoimmune diabetes J:135154, J:188686
Airetm1Mmat/Airetm1Mmat
(involves: C57BL/6 * CBA) 		autoimmune response J:96580
Airetm1Mmat/Airetm1Mmat
(C.Cg-Airetm1Mmat) 		increased autoantibody level J:96580
Airetm1Mmat/Airetm1Mmat
(B6.Cg-Airetm1Mmat) 		autoimmune response J:96580
Airetm1Mmat/Airetm2Mmat
(involves: C57BL/6 * CBA) 		autoimmune response J:141379
Airetm1Pltn/Airetm1Pltn
(involves: 129S4/SvJae * C57BL/6) 		increased autoantibody level J:77873
Airetm1Ptsn/Airetm1Ptsn
(C57BL/6-Airetm1Ptsn) 		increased autoantibody level J:145910
Airetm1Ptsn/Airetm1Ptsn
(C.B6-Airetm1Ptsn) 		increased susceptibility to autoimmune disorder J:174653
Airetm2Mmat/Airetm2Mmat
(involves: C57BL/6 * CBA) 		autoimmune response J:141379
Alox5tm1Fun/Alox5tm1Fun
(B6.129S2-Alox5tm1Fun/J) 		decreased susceptibility to experimental autoimmune uveoretinitis J:108446
Alox5aptm1Jdm/Alox5ap+
(DBA/1LacJ-Alox5aptm1Jdm) 		decreased susceptibility to induced arthritis J:100736
Alox5aptm1Jdm/Alox5aptm1Jdm
(DBA/1LacJ-Alox5aptm1Jdm) 		decreased susceptibility to induced arthritis J:100736
anan/anan
(involves: C57BL/6 * C57BL/10Sg * C57BR/c) 		increased anti-nuclear antigen antibody level J:169366
anan/anan+
(involves: C57BL/6 * C57BL/10Sg * C57BR/c) 		increased anti-nuclear antigen antibody level J:169366
anaya/anaya
(involves: C57BL/6 * C57BL/10Sg * C57BR/c) 		increased anti-nuclear antigen antibody level J:169366
andra/andra
(involves: C57BL/6 * C57BL/10Sg * C57BR/c) 		increased anti-nuclear antigen antibody level J:169366
Anta/Anta+
(involves: C57BL/6 * C57BL/10 * C57BR/cd) 		increased anti-nuclear antigen antibody level J:169366
Apcstm1Mpe/Apcs+
(B6.Cg-Apcstm1Mpe) 		increased autoantibody level J:90502
Apcstm1Mpe/Apcstm1Mpe
(B6.Cg-Apcstm1Mpe) 		increased autoantibody level J:90502
Apcstm1Smae/Apcstm1Smae
(involves: 129S/SvEv * C57BL/6) 		increased autoantibody level J:71194
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J) 		increased anti-double stranded DNA antibody level J:133606
increased anti-nuclear antigen antibody level J:133606
increased autoantibody level J:133606
increased susceptibility to systemic lupus erythematosus J:133606
Apoetm1Unc/Apoetm1Unc
(B6.Cg-Apoetm1Unc Faslpr) 		increased anti-double stranded DNA antibody level J:133606
increased anti-nuclear antigen antibody level J:133606
increased susceptibility to systemic lupus erythematosus J:133606
Apoetm1Unc/Apoetm1Unc
Faslpr/Faslpr
(MRL.Cg-Apoetm1Unc Faslpr) 		increased anti-double stranded DNA antibody level J:133606
increased anti-nuclear antigen antibody level J:133606
increased autoantibody level J:133606
increased susceptibility to systemic lupus erythematosus J:133606
Apoetm1Unc/Apoetm1Unc
Faslpr/Faslpr
(B6.Cg-Apoetm1Unc Faslpr) 		decreased autoantibody level J:121671
increased anti-double stranded DNA antibody level J:121671
increased autoantibody level J:121671
Apoetm1Unc/Apoetm1Unc
Faslgld/Faslgld
(B6.Cg-Faslgld Apoetm1Unc) 		increased anti-nuclear antigen antibody level J:200141, J:91058
increased autoantibody level J:91058
Arid5atm1Rnis/Arid5atm1Rnis
(B6.Cg-Arid5atm1Rnis) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:197418
Arigg1NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ) 		increased anti-erythrocyte antigen antibody level J:93737
Arigg2NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ) 		increased anti-erythrocyte antigen antibody level J:93737
Arigg3NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ) 		increased anti-erythrocyte antigen antibody level J:93737
Arigg4NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ) 		increased anti-erythrocyte antigen antibody level J:93737
Arigg5NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ) 		increased anti-erythrocyte antigen antibody level J:93737
Arigg6NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ) 		increased anti-erythrocyte antigen antibody level J:93737
Arigg7NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ) 		increased anti-erythrocyte antigen antibody level J:93737
Arigg8BALB/cByJ/?
(involves: BALB/cByJ * NZB/BlNJ) 		increased anti-erythrocyte antigen antibody level J:93737
Arigg9NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ) 		increased anti-erythrocyte antigen antibody level J:93737
Arigg10BALB/cByJ/?
(involves: BALB/cByJ * NZB/BlNJ) 		increased anti-erythrocyte antigen antibody level J:93737
Art2atm1Fkn/Art2atm1Fkn
Art2btm1Fkn/Art2btm1Fkn
Cd38tm1Lnd/Cd38tm1Lnd
(NOD.129(B6)-Cd38tm1Lnd Art2atm1Fkn Art2btm1Fkn/Lt) 		decreased susceptibility to autoimmune diabetes J:108097
asa/asa
(either: A/J or BALB/c or DBA/2J) 		increased autoantibody level J:2843
Asbb1BALB/c/Asbb1BALB/c
(involves: BALB/c * C57BL/6J) 		increased susceptibility to systemic lupus erythematosus J:76486
Asbb2BALB/c/Asbb2C57BL/6J
(involves: BALB/c * C57BL/6J) 		increased susceptibility to systemic lupus erythematosus J:76486
Asbb2C57BL/6J/Asbb2C57BL/6J
(involves: BALB/c * C57BL/6J) 		increased susceptibility to systemic lupus erythematosus J:76486
Asbb3C57BL/6J/Asbb3C57BL/6J
(involves: BALB/c * C57BL/6J) 		increased susceptibility to systemic lupus erythematosus J:76486
Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu
(B6.FVB-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu) 		increased autoantibody level J:208213
increased susceptibility to autoimmune disorder J:208213
increased susceptibility to induced arthritis J:208213
Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu
Il6tm1Kopf/Il6tm1Kopf
(B6.Cg-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu Il6tm1Kopf) 		increased susceptibility to induced arthritis J:208213
Atg5tm1Myok/Atg5tm1Myok
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S/SvEv) 		increased anti-double stranded DNA antibody level J:235399
increased anti-nuclear antigen antibody level J:235399
increased autoantibody level J:235399
increased susceptibility to systemic lupus erythematosus J:235399
Atg7tm1Tchi/Atg7tm1Tchi
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj) 		increased anti-double stranded DNA antibody level J:235399
increased anti-nuclear antigen antibody level J:235399
increased autoantibody level J:235399
increased susceptibility to systemic lupus erythematosus J:235399
Atxn3tm1a(KOMP)Wtsi/Atxn3tm1a(KOMP)Wtsi
(C57BL/6N-Atxn3tm1a(KOMP)Wtsi/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
Aviltm2(cre)Fawa/Aviltm2(cre)Fawa
(B6J.129P2-Aviltm2(cre)Fawa) 		increased susceptibility to experimental autoimmune encephalomyelitis J:265529
Axltm1Grl/Axltm1Grl
Mertktm1Grl/Mertktm1Grl
(involves: C57BL/6J) 		increased anti-double stranded DNA antibody level J:70420
Axltm1Grl/Axltm1Grl
Mertktm1Grl/Mertktm1Grl
Tyro3tm1Grl/Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal susceptibility to autoimmune disorder J:70420
increased anti-double stranded DNA antibody level J:70420
increased autoantibody level J:70420
Axltm1Grl/Axltm1Grl
Tyro3tm1Grl/Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased anti-double stranded DNA antibody level J:70420
B2mtm1Unc/B2mtm1Unc
(NOD.129P2-B2mtm1Unc) 		decreased susceptibility to autoimmune diabetes J:121685, J:17000
B2mtm1Unc/B2mtm1Unc
(B6.129P2-B2mtm1Unc/DcrJ) 		decreased susceptibility to autoimmune diabetes J:135214
B2mtm1Unc/B2mtm1Unc
Ciitatm1Ccum/Ciitatm1Ccum
(NOD.Cg-B2mtm1Unc Ciitatm1Ccum) 		decreased susceptibility to autoimmune diabetes J:107051
B2mtm1Unc/B2mtm1Unc
Emv30b/Emv30b
Prkdcscid/Prkdcscid
Tg(B2M)55Hpl/?
Mcph1Tg(HLA-A2.1)1Enge/?
(NOD.Cg-B2mtm1Unc Mcph1Tg(HLA-A2.1)1Enge Emv30b Prkdcscid Tg(B2M)55Hpl/Dvs) 		decreased susceptibility to autoimmune diabetes J:109851
B2mtm1Unc/B2mtm1Unc
Tg(B2M)55Hpl/0
(NOD.Cg-B2mtm1Unc Tg(B2M)55Hpl/Dvs) 		decreased susceptibility to autoimmune diabetes J:71837
B2mtm1Unc/B2mtm1Unc
Tg(B2M)55Hpl/Tg(B2M)55Hpl
Mcph1Tg(HLA-A2.1)1Enge/Mcph1Tg(HLA-A2.1)1Enge
(NOD.Cg-B2mtm1Unc Mcph1Tg(HLA-A2.1)1Enge Tg(B2M)55Hpl) 		increased susceptibility to autoimmune diabetes J:109851
B2mtm1Unc/B2mtm1Unc
Tg(GFAP-B2m)9Mdos/?
(involves: 129P2/OlaHsd * C57BL/6 * NOD/ShiLtJ) 		decreased susceptibility to autoimmune diabetes J:135214
B2mtm1Unc/B2mtm1Unc
Tg(GFAP-B2m)#Mdos/?
(involves: 129P2/OlaHsd * C57BL/6 * NOD/ShiLtJ) 		decreased susceptibility to autoimmune diabetes J:135214
B2mtm1Unc/B2mtm1Unc
Tg(HLA-A/H2-D/B2M)1Dvs/0
(NOD.Cg-B2mtm1Unc Tg(HLA-A/H2-D/B2M)1Dvs) 		increased susceptibility to autoimmune diabetes J:121685
B2mtm1Unc/B2mtm1Unc
Tg(TcraAI4)1Dvs/0
Tg(TcrbAI4)1Dvs/0
(NOD.Cg-B2mtm1Unc Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs) 		decreased susceptibility to autoimmune diabetes J:93553
B2mtm1Unc/B2mtm1Unc
X/Yaa
(BXSB.129P2(B6)-B2mtm1Unc/Dcr) 		increased anti-nuclear antigen antibody level J:179430
increased susceptibility to systemic lupus erythematosus J:179430
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:123547
increased anti-double stranded DNA antibody level J:123547
increased anti-nuclear antigen antibody level J:123547
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:169839
B9d2/Tgfb1tm1Flv/B9d2+
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:169839
Bak1tm1Thsn/Bak1tm1Thsn
Baxtm1Sjk/Baxtm2Sjk
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		increased anti-double stranded DNA antibody level J:100463
increased susceptibility to autoimmune disorder J:100463
Batftm1.1Kmm/Batftm1.1Kmm
(129S6/SvEvTac-Batftm1.1Kmm) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:150643
Bcl2l1tm1Cant/Bcl2l1tm1Cant
(involves: 129S6/SvEvTac) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:77507
Bcl2l11tm1.1Ast/Bcl2l11+
(involves: 129S1/Sv * C57BL/6) 		increased susceptibility to autoimmune disorder J:58641
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(involves: 129S1/Sv * C57BL/6) 		increased anti-double stranded DNA antibody level J:132217
increased anti-histone antibody level J:132217
increased anti-nuclear antigen antibody level J:132217
increased anti-single stranded DNA antibody level J:132217
increased autoantibody level J:132217
increased susceptibility to autoimmune disorder J:58641
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
Faslpr/Faslpr
(B6.Cg-Bcl2l11tm1.1Ast Faslpr) 		increased anti-double stranded DNA antibody level J:132217
increased anti-histone antibody level J:132217
increased anti-nuclear antigen antibody level J:132217
increased anti-single stranded DNA antibody level J:132217
increased autoantibody level J:132217
increased susceptibility to autoimmune disorder J:132217
Becn1tm1.1Bflu/Becn1tm1.1Bflu
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * C57BL/6 * DBA/2) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:203090
Becn1tm1Ebr/Becn1tm1Ebr
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd) 		increased anti-double stranded DNA antibody level J:235399
increased anti-nuclear antigen antibody level J:235399
increased autoantibody level J:235399
increased susceptibility to systemic lupus erythematosus J:235399
Bhlhe40tm1Tan/Bhlhe40tm1Tan
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		abnormal susceptibility to autoimmune disorder J:72651
increased anti-nuclear antigen antibody level J:72651
Blnktm1Dkit/Blnktm1Dkit
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:94297
Bmxtm1Ali/Bmxtm1Ali
(involves: 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to induced arthritis J:173099
Bsgtm1Tmu/Bsgtm1Tmu
(involves: 129S2/SvPas) 		increased susceptibility to systemic lupus erythematosus J:287636
Btkxid/?
Ptpn6me/Ptpn6me
(involves: C57BL/6J * CBA/N * NFS) 		increased autoantibody level J:30994
Btkxid/Btkxid
(CBA/CaHN-Btkxid/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:92639
Btkxid/Btkxid
(CBA/HN-Btkxid) 		autoimmune response J:125114
Btlatm1Dgra/Btlatm1Dgra
(involves: C57BL/6) 		abnormal peripheral T cell anergy J:147751
Btlatm1Dgra/Btlatm1Dgra
Tg(TcraTcrb)425Cbn/?
(involves: C57BL/6) 		abnormal peripheral T cell anergy J:147751
Btlatm1Dgra/Btlatm1Dgra
Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6) 		abnormal peripheral T cell anergy J:147751
Btlatm1Kmm/Btlatm1Kmm
(involves: 129S/SvEv) 		increased susceptibility to experimental autoimmune encephalomyelitis J:84084
Btn2a2tm1.2Wrth/Btn2a2tm1.2Wrth
(C57BL/6-Btn2a2tm1.2Wrth) 		increased anti-nuclear antigen antibody level J:232636
increased susceptibility to experimental autoimmune encephalomyelitis J:232636
Bxs6BXSB/MpJ/Bxs6BXSB/MpJ
(involves: BXSB/MpJ * C57BL/10ScSnOlaHsd) 		autoimmune response J:145903
increased autoantibody level J:145903
Bxs6BXSB/MpJ/Bxs6BXSB/MpJ
(B10.BXSB-(D13Mit3-D13Mit78)) 		autoimmune response J:145049
increased anti-double stranded DNA antibody level J:145049
increased anti-single stranded DNA antibody level J:145049
increased autoantibody level J:145049
Bxs6BXSB/MpJ/Bxs6BXSB/MpJ
Gpab1C57BL/6J/?
(involves: BXSB/MpJ * C57BL/10ScSnOlaHsd) 		autoimmune response J:145903
increased autoantibody level J:145903
Bxs6BXSB/MpJ/Bxs6BXSB/MpJ
X/Yaa
(B10.BXSB-(D13Mit3-D13Mit78) Yaa) 		autoimmune response J:145049
increased anti-double stranded DNA antibody level J:145049
increased anti-single stranded DNA antibody level J:145049
increased autoantibody level J:145049
C1qatm1Mjw/C1qatm1Mjw
(involves: 129P2/Ola * 129S/SvEv * C57BL/6) 		increased anti-histone antibody level J:47315
increased anti-nuclear antigen antibody level J:47315
C1qatm1Mjw/C1qatm1Mjw
Sle16129S6/SvEvTac/Sle16129S6/SvEvTac
(involves: 129S/SvEv * 129X1/Sv * C57BL/6) 		increased anti-chromatin antibody level J:118645
increased anti-double stranded DNA antibody level J:118645
increased anti-nuclear antigen antibody level J:118645
increased anti-single stranded DNA antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
C1qatm1Mjw/C1qatm1Mjw
Sle16129S6/SvEvTac/Sle16C57BL/6
(involves: 129S/SvEv * 129X1/Sv * C57BL/6) 		increased anti-chromatin antibody level J:118645
increased anti-double stranded DNA antibody level J:118645
increased anti-nuclear antigen antibody level J:118645
increased anti-single stranded DNA antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
C1qatm1Mjw/C1qatm1Mjw
Sle18C57BL/6/Sle18C57BL/6
(involves: 129S/SvEv * 129X1/Sv * C57BL/6) 		increased anti-nuclear antigen antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
C1qatm1Mjw/C1qatm1Mjw
Sle18C57BL/6/Sle18C57BL/6
(involves: 129P2/Ola * 129S/SvEv * C57BL/6) 		increased anti-nuclear antigen antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
C1qatm1Mjw/C1qatm1Mjw
Sle19C57BL/6/?
(involves: 129S/SvEv * 129X1/Sv * C57BL/6) 		increased anti-nuclear antigen antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
C1qatm1Mjw/C1qatm1Mjw
Sle19C57BL/6/?
(involves: 129P2/Ola * 129S/SvEv * C57BL/6) 		increased anti-nuclear antigen antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
C1qatm1Mjw/C1qatm1Mjw
Sle21129P2/Ola/?
Sle18C57BL/6/Sle18C57BL/6
(involves: 129P2/Ola * 129S/SvEv * C57BL/6) 		increased anti-nuclear antigen antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
C1qatm1Mjw/C1qatm1Mjw
Sle21129P2/Ola/Sle21129P2/Ola
(involves: 129P2/Ola * 129S/SvEv * C57BL/6) 		increased anti-chromatin antibody level J:118645
increased anti-double stranded DNA antibody level J:118645
increased anti-nuclear antigen antibody level J:118645
increased anti-single stranded DNA antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
C1qatm1Mjw/C1qatm1Mjw
Sle21129P2/Ola/Sle21C57BL/6
(involves: 129P2/Ola * 129S/SvEv * C57BL/6) 		increased anti-chromatin antibody level J:118645
increased anti-double stranded DNA antibody level J:118645
increased anti-nuclear antigen antibody level J:118645
increased anti-single stranded DNA antibody level J:118645
increased susceptibility to systemic lupus erythematosus J:118645
C1qtnf3tm1Yiw/C1qtnf3tm1Yiw
(involves: C57BL/6NSlc) 		increased susceptibility to induced arthritis J:211893
C1qtnf6tm1Yiw/C1qtnf6tm1Yiw
(involves: 129P2/OlaHsd * C57BL/6J) 		increased anti-nuclear antigen antibody level J:227217
increased autoantibody level J:227217
C1qtnf6tm1Yiw/C1qtnf6tm1Yiw
(B6.129P2-C1qtnf6tm1Yiw) 		increased susceptibility to experimental autoimmune encephalomyelitis J:227217
increased susceptibility to induced arthritis J:227217
C3tm1Crr/C3tm1Crr
(B6.129S4-C3tm1Crr) 		decreased susceptibility to autoimmune hemolytic anemia J:145432
C3tm1Crr/C3tm1Crr
C4btm1Crr/C4btm1Crr
Faslpr/Faslpr
(involves: 129S4/SvJae * C57BL/6 * MRL) 		increased anti-double stranded DNA antibody level J:127292
increased anti-nuclear antigen antibody level J:127292
C3tm1Crr/C3tm1Crr
Faslpr/Faslpr
(involves: 129S4/SvJae * C57BL/6 * MRL) 		decreased susceptibility to autoimmune disorder J:127292
C3tm1Crr/C3tm1Crr
Fcer1gtm1Rav/Fcer1gtm1Rav
Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		decreased susceptibility to autoimmune diabetes J:122114
C3tm1Crr/C3tm1Crr
Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to autoimmune diabetes J:122114
C3tm1Pkna/C3tm1Pkna
(D1.129P2-C3tm1Pkna) 		decreased susceptibility to induced arthritis J:88872
C3ar1tm1Raw/C3ar1tm1Raw
(B6.129X1(B6)-C3ar1tm1Raw) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:93791
C4btm1Crr/C4btm1Crr
(involves: 129S4/SvJae * C57BL/6J) 		increased anti-double stranded DNA antibody level J:111811
increased anti-nuclear antigen antibody level J:111811
increased anti-single stranded DNA antibody level J:111811
C4btm1Crr/C4btm1Crr
Faslpr/Faslpr
(involves: 129S4/SvJae * C57BL/6 * MRL) 		increased anti-double stranded DNA antibody level J:127292
increased anti-nuclear antigen antibody level J:127292
C9orf72em1Eggn/C9orf72em1Eggn
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:240357
C9orf72tm1.1Eggn/C9orf72+
(involves: C57BL/6 * C57BL/6N) 		increased autoantibody level J:240357
C9orf72tm1.1Eggn/C9orf72tm1.1Eggn
(involves: C57BL/6 * C57BL/6N) 		increased anti-double stranded DNA antibody level J:240357
increased autoantibody level J:240357
increased susceptibility to autoimmune disorder J:240357
C9orf72tm1Eggn/C9orf72tm1Eggn
(involves: C57BL/6 * C57BL/6N) 		increased anti-double stranded DNA antibody level J:240357
increased susceptibility to autoimmune disorder J:240357
Card19tm1Rwen/Card19tm1Rwen
(involves: 129P2/OlaHsd * C57BL/6) 		decreased autoantibody level J:336763
Casp1tm1Flv/Casp1tm1Flv
Casp4del/Casp4del
(involves: 129S2/SvPas * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:57101
Cblbtm1Hua/Cblbtm1Hua
(B6.129P2-Cblbtm1Hua) 		increased susceptibility to experimental autoimmune encephalomyelitis J:94685
Cblbtm1Hua/Cblbtm1Hua
Ubash3btm1Jni/Ubash3btm1Jni
Ubash3atm1Jni/Ubash3atm1Jni
(Not Specified) 		increased susceptibility to experimental autoimmune encephalomyelitis J:89761
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:68145
Ccl2tm1Rol/Ccl2tm1Rol
(SJL.129S4-Ccl2tm1Rol) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:68145
Ccl4em1Narl/Ccl4em1Narl
(C57BL/6JNarl-Ccl4em1Narl) 		decreased susceptibility to autoimmune diabetes J:346348
Ccnt1Gt(RRR115)Byg/Ccnt1Gt(RRR115)Byg
(involves: 129P2/OlaHsd) 		autoimmune response J:130071
Ccr1tm1Cge/Ccr1tm1Cge
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:63952
Ccr2tm1Ifc/Ccr2tm1Ifc
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:75838
Ccr2tm2.1Ifc/Ccr2tm2.1Ifc
Cx3cr1tm1Litt/Cx3cr1+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:166664
Ccr2tm2.1Ifc/Ccr2tm2.1Ifc
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:166664
Ccr6tm1Lira/Ccr6tm1Lira
(involves: 129 * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:148286
Ccr7tm1Rfor/Ccr7tm1Rfor
(B6.129P2-Ccr7tm1Rfor) 		increased susceptibility to autoimmune disorder J:110910
Ccr8tm1Lira/Ccr8tm1Lira
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:118417
Cd1d1tm1Crw/Cd1d1tm1Crw
(B6.129S4-Cd1d1tm1Crw) 		decreased susceptibility to induced arthritis J:99107
Cd1d1tm1Luc/Cd1d1tm1Luc
(B6.129S6-Cd1d1tm1Luc) 		autoimmune response J:122245
Cd1d1tm1Luc/Cd1d1tm1Luc
(C.129S6-Cd1d1tm1Luc) 		increased anti-double stranded DNA antibody level J:121187
increased anti-nuclear antigen antibody level J:121187
Cd1d1tm1Luc/Cd1d1tm1Luc
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(B6.129-Cd1d1tm1Luc Cx3cr1tm1Litt) 		increased susceptibility to experimental autoimmune encephalomyelitis J:129712
Cd4tm1(cre/ERT2)Thbu/Cd4+
Gfm1tm1c(EUCOMM)Wtsi/Gfm1tm1c(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N * SJL) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:302272
Cd4tm1Knw/Cd4tm1Knw
(NOD.Cg-Cd4tm1Knw) 		decreased susceptibility to autoimmune diabetes J:93553
Cd4tm1Knw/Cd4tm1Knw
Tg(TcraAI4)1Dvs/0
Tg(TcrbAI4)1Dvs/0
(NOD.Cg-Cd4tm1Knw Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs) 		increased susceptibility to autoimmune diabetes J:93553
Cd4tm1Mak/Cd4tm1Mak
Igh-Jtm2(3H9-VDJ*)Mwg/Igh-J+
(B6.Cg-Cd4tm1Mak Igh-Jtm2(3H9-VDJ*)Mwg) 		increased anti-double stranded DNA antibody level J:142389
Cd5tm1.1Chra/Cd5tm1.1Chra
(involves: C57BL/6 * FVB/N) 		abnormal T cell anergy J:189919
decreased susceptibility to experimental autoimmune encephalomyelitis J:189919
Cd5tm1Cgn/Cd5tm1Cgn
(B6.129P2-Cd5tm1Cgn) 		abnormal T cell anergy J:189919
decreased susceptibility to experimental autoimmune encephalomyelitis J:189919
Cd8atm1Mak/Cd8atm1Mak
Il15tm1Imx/Il15tm1Imx
X/Yaa
(BXSB.Cg-Cd8atm1Mak Il15tm1Imx/Dcr) 		increased anti-nuclear antigen antibody level J:179430
increased susceptibility to systemic lupus erythematosus J:179430
Cd8atm1Mak/Cd8atm1Mak
X/Yaa
(BXSB.129S2(B6)-Cd8atm1Mak/4Dcr) 		increased susceptibility to systemic lupus erythematosus J:179430
Cd19tm1(cre)Cgn/Cd19+
Ep300tm2Reck/Ep300+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		increased anti-double stranded DNA antibody level J:147840
increased susceptibility to systemic lupus erythematosus J:147840
Cd19tm1(cre)Cgn/Cd19+
Ep300tm2Reck/Ep300+
(involves: 129/Sv * 129P2/OlaHsd * FVB/N) 		increased susceptibility to systemic lupus erythematosus J:147840
Cd19tm1(cre)Cgn/Cd19+
Fastm1Ach/Fastm1Ach
(involves: 129P2/OlaHsd * BALB/c) 		increased anti-nuclear antigen antibody level J:123556
Cd19tm1(cre)Cgn/Cd19+
Fastm1Cgn/Fastm1Cgn
(B6.Cg-Cd19tm1(cre)Cgn Fastm1Cgn) 		increased anti-single stranded DNA antibody level J:114948
Cd19tm1(cre)Cgn/Cd19+
Gt(ROSA)26Sortm2(Cd74/MOG)Awai/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:140751
Cd19tm1(cre)Cgn/Cd19+
Gt(ROSA)26Sortm2(Cd74/MOG)Awai/Gt(ROSA)26Sor+
Il10tm1Roer/Il10tm1Roer
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:140751
Cd19tm1(cre)Cgn/Cd19+
Ptentm1Hwu/Ptentm1Hwu
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		abnormal peripheral B cell anergy J:155314
Cd19tm1(cre)Cgn/Cd19+
Ptpn6tm1Rsky/Ptpn6tm1Rsky
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to systemic lupus erythematosus J:123568
Cd19tm1(cre)Cgn/Cd19+
Tnfaip3tm1.1Awai/Tnfaip3tm1.1Awai
(involves: 129P2/OlaHsd) 		increased anti-nuclear antigen antibody level J:175422
Cd19tm1(cre)Cgn/Cd19+
Tnfaip3tm2Ama/Tnfaip3+
(involves: 129P2/OlaHsd * C57BL/6) 		increased autoantibody level J:163917
increased susceptibility to autoimmune disorder J:163917
Cd19tm1Tft/Cd19tm1Tft
(B6.Cg-Cd19tm1Tft) 		decreased anti-double stranded DNA antibody level J:136210
decreased anti-nuclear antigen antibody level J:136210
increased susceptibility to experimental autoimmune encephalomyelitis J:106487
Cd19tm1Tft/Cd19tm1Tft
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased anti-double stranded DNA antibody level J:71174
decreased susceptibility to systemic lupus erythematosus J:71174
Cd22tm1Msn/Cd22tm1Msn
(either: (involves: 129S/SvEv * BALB/c) or (involves: 129S/SvEv * C57BL/6J)) 		increased anti-double stranded DNA antibody level J:76974, J:76975
Cd22tm2Lnit/Cd22tm2Lnit
(involves: 129P2/OlaHsd * C57BL/6) 		autoimmune response J:198790
Cd22tm2Tft/Cd22tm2Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal peripheral B cell anergy J:208364
Cd22tm3Lnit/Cd22tm3Lnit
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		autoimmune response J:198790
Cd28tm1Jmg/Cd28tm1Jmg
(B6.129X1-Cd28tm1Jmg) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:149888
Cd28tm1Ltu/Cd28tm1Ltu
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to autoimmune disorder J:194503
increased susceptibility to experimental autoimmune encephalomyelitis J:194503
Cd28tm1Mak/Cd28+
Cd5tm1Cgn/Cd5tm1Cgn
(either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP)) 		abnormal T cell clonal deletion J:110925
Cd28tm1Mak/Cd28tm1Mak
(NOD.129S2-Cd28tm1Mak) 		increased susceptibility to autoimmune diabetes J:93421
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas * NOD) 		increased susceptibility to autoimmune diabetes J:35353
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:149888
Cd28tm1Mak/Cd28tm1Mak
(B6.129S2-Cd28tm1Mak/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:57613
Cd28tm1Mak/Cd28tm1Mak
Cd5tm1Cgn/Cd5+
(either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP)) 		abnormal T cell clonal deletion J:110925
Cd28tm1Mak/Cd28tm1Mak
Cd5tm1Cgn/Cd5tm1Cgn
(either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP)) 		abnormal T cell clonal deletion J:110925
Cd28tm1Mak/Cd28tm1Mak
Cd40lgtm1Flv/Cd40lgtm1Flv
(NOD.Cg-Cd40lgtm1Flv Cd28tm1Mak) 		increased susceptibility to autoimmune diabetes J:93421
Cd28tm1Mak/Cd28tm1Mak
Tg(TcrLCMV)327Sdz/0
(involves: 129S2/SvPas * C57BL/6 * DBA/2) 		abnormal T cell anergy J:123989
Cd28tm1Shr/Cd28tm1Shr
Ctla4tm1Shr/Ctla4+
(C.129S4-Cd28tm1Shr Ctla4tm1Shr) 		increased susceptibility to autoimmune disorder J:125259
Cd38tm1Lnd/Cd38tm1Lnd
(NOD.129P2(B6)-Cd38tm1Lnd/LtJ) 		increased susceptibility to autoimmune diabetes J:108097
Cd40tm1Kik/Cd40tm1Kik
Tg(Tnfsf13b)1Fma/?
(B6.Cg-Cd40tm1Kik Tg(Tnfsf13b)1Fma) 		increased anti-double stranded DNA antibody level J:113556
Cd40lgtm1Flv/Y
Faslpr/Faslpr
(involves: 129P2/OlaHsd * 129S2/SvPas * MRL) 		decreased autoantibody level J:38492
Cd40lgtm1Flv/Y
Faslpr/Faslpr
Tcratm1Mjo/Tcratm1Mjo
(involves: 129P2/OlaHsd * 129S2/SvPas * MRL) 		decreased autoantibody level J:38492
increased anti-double stranded DNA antibody level J:38492
Cd40lgtm1Flv/Cd40lgtm1Flv
(NOD.129S2-Cd40lgtm1Flv) 		decreased susceptibility to autoimmune diabetes J:93421
Cd40lgtm1Flv/Cd40lgtm1Flv
Faslpr/Faslpr
(involves: 129P2/OlaHsd * 129S2/SvPas * MRL) 		decreased autoantibody level J:38492
Cd40lgtm1Flv/Cd40lgtm1Flv
Faslpr/Faslpr
Tcratm1Mjo/Tcratm1Mjo
(involves: 129P2/OlaHsd * 129S2/SvPas * MRL) 		decreased autoantibody level J:38492
increased anti-double stranded DNA antibody level J:38492
Cd40lgtm1Imx/Cd40lgtm1Imx
(involves: 129S2/SvPas * C57BL/6J * BALB/c) 		abnormal T cell clonal deletion J:110925
Cd44tm1.1Ugu/Cd44tm1.1Ugu
(B6.129(Cg)-Cd44tm1.1Ugu) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:199279
Cd44tm1.1Ugu/Cd44tm1.1Ugu
(SJL.129(Cg)-Cd44tm1.1Ugu) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:199279
Cd44tm1Mak/Cd44tm1Mak
(D1.129P2-Cd44tm1Mak) 		increased susceptibility to induced arthritis J:95275
Cd44tm2.1Ugu/Cd44tm2.1Ugu
(B6.129-Cd44tm2.1Ugu) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:199279
Cd44tm2Kmz/Cd44tm2Kmz
(DBA/1LacJ-Cd44tm2Kmz) 		decreased susceptibility to induced arthritis J:74268
Cd55tm1Mme/Cd55tm1Mme
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to experimental autoimmune myasthenia gravis J:80116
Cd55tm1Song/Cd55tm1Song
(B6.129S6-Cd55tm1Song) 		increased susceptibility to experimental autoimmune myasthenia gravis J:113567
Cd55tm1Song/Cd55tm1Song
Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd55tm1Song Cd59atm1Bpm) 		increased susceptibility to experimental autoimmune myasthenia gravis J:113567
Cd59atm1Bpm/Cd59atm1Bpm
(involves: 129 * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:89014
Cd59atm1Bpm/Cd59atm1Bpm
(involves: 129) 		increased susceptibility to induced arthritis J:146711
Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd59atm1Bpm) 		increased susceptibility to experimental autoimmune myasthenia gravis J:113567
Cd69tm1Naka/Cd69tm1Naka
(C.129P2-Cd69tm1Naka) 		decreased susceptibility to induced arthritis J:84940
Cd72b/Cd72b
Faslpr/Faslpr
(involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp) 		autoimmune response J:204782
decreased anti-double stranded DNA antibody level J:204782
decreased anti-nuclear antigen antibody level J:204782
decreased susceptibility to autoimmune disorder J:204782
Cd72c/Cd72c
Faslpr/Faslpr
(involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp) 		autoimmune response J:204782
increased anti-chromatin antibody level J:204782
increased anti-double stranded DNA antibody level J:204782
increased anti-single stranded DNA antibody level J:204782
increased susceptibility to systemic lupus erythematosus J:204782
Cd72tm1Tsub/Cd72tm1Tsub
(involves: C57BL/6J) 		increased anti-chromatin antibody level J:204782
increased anti-double stranded DNA antibody level J:204782
increased anti-single stranded DNA antibody level J:204782
Cd72tm1Tsub/Cd72tm1Tsub
Faslpr/Faslpr
(involves: C57BL/6J * C57BL/6JJmsSlc * MRL/Mp) 		autoimmune response J:204782
increased anti-chromatin antibody level J:204782
increased anti-double stranded DNA antibody level J:204782
increased anti-single stranded DNA antibody level J:204782
Cd74tm1Liz/Cd74tm1Liz
(involves: 129S/SvEv * C57BL/6J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:72243
Cd74tm1Liz/Cd74tm1Liz
(B6.129S-Cd74tm1Liz) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:125654
Cd74tm2Liz/Cd74tm2Liz
(involves: 129S/SvEv * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:72243
Cd74tm3Liz/Cd74tm3Liz
(involves: 129S/SvEv * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:72243
Cd79atm1(cre)Reth/Cd79a+
Inpp5dtm1Rav/Inpp5dtm1Rav
(involves: 129 * BALB/c * C57BL/6) 		increased anti-chromatin antibody level J:178833
increased anti-double stranded DNA antibody level J:178833
increased anti-nuclear antigen antibody level J:178833
increased anti-single stranded DNA antibody level J:178833
increased autoantibody level J:178833
increased susceptibility to systemic lupus erythematosus J:178833
Cd79atm1(cre)Reth/Cd79a+
Wastm1.1Ldn/Y
(involves: BALB/c * C57BL/6) 		increased anti-chromatin antibody level J:182528
increased anti-double stranded DNA antibody level J:182528
increased anti-single stranded DNA antibody level J:182528
increased autoantibody level J:182528
Cd79atm1(cre)Reth/Cd79a+
Wastm1.1Ldn/Wastm1.1Ldn
(involves: BALB/c * C57BL/6) 		increased anti-chromatin antibody level J:182528
increased anti-double stranded DNA antibody level J:182528
increased anti-single stranded DNA antibody level J:182528
increased autoantibody level J:182528
Cd79atm1.1Rsky/Cd79atm1.1Rsky
(involves: C57BL/6) 		increased anti-single stranded DNA antibody level J:179254
Cd80tm1Shr/Cd80tm1Shr
Cd86tm1Shr/Cd86tm1Shr
(B6.129S4-Cd80tm1Shr Cd86tm1Shr) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:57613
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr
(involves: 129S4/SvJae) 		increased susceptibility to autoimmune diabetes J:113109
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr
(involves: 129S4/SvJae * NOD) 		increased susceptibility to autoimmune diabetes J:61905
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr
(129.SJL-Cd86tm2Shr) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:78992
increased susceptibility to experimental autoimmune encephalomyelitis J:78992
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr
(involves: 129S4/SvJae * C57BL/6J * SJL) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:78992
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr
Tg(Ighm-Ctla4Ig/Cd80)1Jbs/0
(involves: 129S4/SvJae * FVB/N * NOD) 		decreased susceptibility to autoimmune diabetes J:113109
Cd86tm1Shr/Cd86tm1Shr
(NOD.129S4-Cd86tm1Shr) 		decreased susceptibility to autoimmune diabetes J:71352
increased autoantibody level J:142046
increased susceptibility to autoimmune diabetes J:93421
Cd180tm1Kmiy/Cd180tm1Kmiy
Faslpr/Faslpr
(MRL.Cg-Cd180tm1Kmiy Faslpr) 		increased anti-nuclear antigen antibody level J:137066
increased autoantibody level J:137066
Cd200tm1Jods/Cd200tm1Jods
(C57BL/6-Cd200tm1Jods) 		increased susceptibility to experimental autoimmune encephalomyelitis J:65982
increased susceptibility to experimental autoimmune uveoretinitis J:79906
increased susceptibility to induced arthritis J:65982
Cd247tm2.1Lov/Cd247tm2.1Lov
(B6.Cg-Cd247tm2.1Lov) 		increased susceptibility to experimental autoimmune encephalomyelitis J:192915
Cd274tm1.1Lex/Cd274tm1.1Lex
(involves: 129S5/SvEvBrd) 		increased susceptibility to experimental autoimmune encephalomyelitis J:126829
Cd274tm1Lpc/Cd274tm1Lpc
(B6.129S-Cd274tm1Lpc) 		increased susceptibility to autoimmune disorder J:89781
Cd274tm1Lpc/Cd274tm1Lpc
(involves: 129S/SvEv * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:142815
Cd274tm1Lpc/Cd274tm1Lpc
(C.129S-Cd274tm1Lpc) 		increased susceptibility to induced arthritis J:165841
Cd274tm1Shr/Cd274tm1Shr
(C.B6-Cd274tm1Shr) 		increased susceptibility to autoimmune diabetes J:123785
Cd274tm1Shr/Cd274tm1Shr
Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6) 		increased susceptibility to autoimmune diabetes J:153040
Cd276tm1Lpc/Cd276tm1Lpc
(B6.129-Cd276tm1Lpc) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:237700
Cd276tm1Lpc/Cd276tm1Lpc
(D1J.129-Cd276tm1Lpc) 		decreased susceptibility to induced arthritis J:237700
Cd276tm1Mak/Cd276tm1Mak
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-single stranded DNA antibody level J:84973
increased susceptibility to experimental autoimmune encephalomyelitis J:84973
Cd300lftm1Gne/Cd300lftm1Gne
(involves: C57BL/6N) 		increased susceptibility to experimental autoimmune encephalomyelitis J:156819
Cdk2tm2Sgo/Cdk2tm2Sgo
Cdk4tm2.1Bbd/Cdk4tm2.1Bbd
Polr2atm1(cre/ERT2)Bbd/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased susceptibility to autoimmune diabetes J:125217
Cdk4tm1Kiyo/Cdk4+
Lin9tm1Orc/Lin9+
(involves: 129S1/Sv) 		decreased susceptibility to autoimmune diabetes J:111333
Cdkn1atm1Led/Cdkn1atm1Led
(involves: 129S6/SvEvTac) 		increased anti-double stranded DNA antibody level J:76041
increased anti-histone antibody level J:76041
increased anti-single stranded DNA antibody level J:76041
increased autoantibody level J:76041
Cdkn1atm1Led/Cdkn1atm1Led
Gadd45atm1Ajf/Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6)) 		increased anti-double stranded DNA antibody level J:76041
increased anti-histone antibody level J:76041
increased anti-single stranded DNA antibody level J:76041
increased autoantibody level J:76041
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(B6;129S2-Cdkn1atm1Tyj/J) 		decreased susceptibility to induced arthritis J:108569
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		abnormal self tolerance J:60292
increased anti-double stranded DNA antibody level J:60292
increased anti-histone antibody level J:60292
increased anti-nuclear antigen antibody level J:60292
Ceat1CBA/J/Ceat1NOD
(involves: CBA/J * NOD-H2k) 		increased susceptibility to experimental autoimmune thyroiditis J:77545
Ceat1NOD/Ceat1NOD
(involves: CBA/J * NOD-H2k) 		increased susceptibility to experimental autoimmune thyroiditis J:77545
Cfbtm1Pkna/Cfbtm1Pkna
(D1.129P2-Cfbtm1Pkna) 		decreased susceptibility to induced arthritis J:88872
Cfptm1Song/Cfptm1Song
(involves: 129 * C57BL/6) 		decreased susceptibility to induced arthritis J:165497
Cfptm2.1Song/Cfptm2.1Song
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * 129P2/OlaHsd * C57BL/6 * SJL) 		decreased susceptibility to induced arthritis J:165497
Cgnz1NZM2328/J/Cgnz1NZM2328/J
(involves: C57L/J * NZM2328/J) 		increased susceptibility to systemic lupus erythematosus J:71397
Chuktm2Mka/Chuktm2Mka
Tg(Tnfsf13b)1Fma/?
(B6.Cg-Chuktm2Mka Tg(Tnfsf13b)1Fma) 		increased anti-double stranded DNA antibody level J:113556
Cia2DBA/1J/Cia2DBA/1J
(involves: DBA/1J * FVB/N) 		increased susceptibility to induced arthritis J:116665
Cia5bRIIIS/J/?
(involves: C57BL/10 * RIIIS/J) 		decreased susceptibility to induced arthritis J:101767
Cia5bRIIIS/J/Cia5bRIIIS/J
Cia32B10.RIII/Cia32RIIIS/J
(involves: C57BL/10 * RIIIS/J) 		decreased susceptibility to induced arthritis J:101767
Cia5cRIIIS/J/?
(involves: C57BL/10 * RIIIS/J) 		decreased susceptibility to induced arthritis J:101767
Cia7DBA/1J/Cia7DBA/1J
(involves: B10.Q * DBA/1) 		increased susceptibility to induced arthritis J:122130
Cia30RIIIS/J/Cia30RIIIS/J
Cia5B10.RIII/Cia5B10.RIII
(involves: B10.RIII * RIIIS/J) 		decreased susceptibility to induced arthritis J:95848
Cia31B10.RIII/Cia31RIIIS/J
Cia5RIIIS/J/Cia5RIIIS/J
(involves: C57BL/10 * RIIIS/J) 		decreased susceptibility to induced arthritis J:101767
Cia34DBA/1J/Cia34DBA/1J
(involves: C57BL/10 * DBA/1J) 		decreased autoantibody level J:122130
decreased susceptibility to induced arthritis J:122130
Cia35C57BL/10SnSg/Cia35C57BL/10SnSg
Cia42DBA/1J/Cia42DBA/1J
(involves: B10.Q * DBA/1) 		decreased susceptibility to induced arthritis J:122130
Cia35C57BL/10SnSg/Cia35DBA/1J
(involves: C57BL/10 * DBA/1J) 		increased autoantibody level J:122130
increased susceptibility to induced arthritis J:122130
Cia35C57BL/10SnSg/Cia35DBA/1J
Cia42DBA/1J/Cia42DBA/1J
(involves: B10.Q * DBA/1) 		decreased susceptibility to induced arthritis J:122130
Cia35DBA/1J/Cia35DBA/1J
Cia42DBA/1J/Cia42DBA/1J
(involves: B10.Q * DBA/1) 		decreased susceptibility to induced arthritis J:122130
Cia36DBA/1J/Cia36DBA/1J
(involves: C57BL/10 * DBA/1J) 		decreased autoantibody level J:122130
decreased susceptibility to induced arthritis J:122130
Cia37C57BL/10SnSg/Cia37DBA/1J
(involves: C57BL/10 * DBA/1J) 		increased autoantibody level J:122130
increased susceptibility to induced arthritis J:122130
Cia38DBA/1J/Cia38DBA/1J
(involves: C57BL/10 * DBA/1J) 		increased autoantibody level J:122130
increased susceptibility to induced arthritis J:122130
Cia39C57BL/10Sn/Cia39C57BL/10Sn
(involves: B10.Q/Lund-H2q * B10.RIII/Lund-H2r) 		decreased susceptibility to induced arthritis J:97801
Cia40C57BL/10SnSg/Cia40C57BL/10SnSg
(involves: C57BL/10SnSg * DBA/1J * NFS/N) 		increased susceptibility to induced arthritis J:106522
Cia43DBA/1J/Cia43FVB/N
(involves: DBA/1J * FVB/N) 		increased susceptibility to induced arthritis J:146242
Cia43FVB/N/Cia43FVB/N
(involves: DBA/1J * FVB/N) 		increased susceptibility to induced arthritis J:146242
Ciaaq1DBA/1J/Ciaaq1DBA/1J
(involves: DBA/1J * FVB/NJ) 		increased autoantibody level J:122919
Ciaaq1DBA/1J/Ciaaq1FVB/NJ
(involves: DBA/1J * FVB/NJ) 		increased autoantibody level J:122919
Ciitatm1Ccum/Ciitatm1Ccum
(NOD.129S2(B6)-Ciitatm1Ccum) 		decreased susceptibility to autoimmune diabetes J:107051
Ciitatm1Jpyt/Ciitatm1Jpyt
(B6.129P2-Ciitatm1Jpyt) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:125654
Clec1atm1Yiw/Clec1atm1Yiw
(involves: C57BL/6J * C57BL/6NSlc) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:329240
Clec4a2tm1Yiw/Clec4a2tm1Yiw
(involves: 129P2/OlaHsd * C57BL/6J) 		increased anti-nuclear antigen antibody level J:217720
increased autoantibody level J:217720
increased susceptibility to induced arthritis J:217720
Clec4dtm1.1Shoy/Clec4dtm1.1Shoy
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:203159
Clec4etm1Tks/Clec4etm1Tks
(involves: 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:203159
Clec5atm1Cua/Clec5atm1Cua
(involves: C57BL/6) 		decreased susceptibility to induced arthritis J:158811
Cntftm1Mpin/Cntftm1Mpin
(B6.129S2-Cntftm1Mpin) 		increased susceptibility to experimental autoimmune encephalomyelitis J:126852
Cog6tm1a(EUCOMM)Wtsi/Cog6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cog6tm1a(EUCOMM)Wtsi/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
Col17a1tm1Shzu/Col17a1tm1Shzu
Tg(KRT14-COL17A1)1Shzu/0
(involves: 129S/SvEv * C57BL/6J * C57BL/6Ncr) 		decreased autoantibody level J:121695
Col17a1tm1Tiin/Col17a1tm1Tiin
(involves: C57BL/6) 		increased autoantibody level J:220622
Coro1aLmb3-C57BL/6Scr/Coro1aLmb3-C57BL/6Scr
(MRL.Cg-Coro1aC57BL/6Scr Faslpr) 		decreased autoantibody level J:125557
decreased susceptibility to systemic lupus erythematosus J:125557
Coro1aLmb3-MRL/MpScr/Coro1aLmb3-MRL/MpScr
(B6.MRL-Coro1aMRL/MpScr Faslpr) 		increased susceptibility to systemic lupus erythematosus J:125557
Cr2tm1Crr/Cr2tm1Crr
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased anti-double stranded DNA antibody level J:111811
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:98419
Cry1tm1Jhjh/Cry1tm1Jhjh
Cry2tm1Jhjh/Cry2tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to induced arthritis J:159504
Csf2tm1Dran/Csf2tm1Dran
Il3tm1Glli/Il3tm1Glli
(B6.129S2-Csf2tm1Dran Il3tm1Glli) 		increased anti-double stranded DNA antibody level J:83086
Csf2tm1Mlg/Csf2tm1Mlg
(involves: 129S2/SvPas) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:148120
Csf3tm1Ard/Csf3tm1Ard
Junbtm3Wag/Junbtm3Wag
Tg(KRT5-cre)1Tak/0
(involves: 129/Sv * 129P2/OlaHsd * C3H * C57BL/6) 		increased susceptibility to systemic lupus erythematosus J:155575
Ctla4tm1Saka/Ctla4tm1Saka
Foxp3tm1(cre)Saka/Y
(involves: BALB/c) 		increased autoantibody level J:140085
Ctla4tm1Shr/Ctla4tm1Shr
(B6.129S4-Ctla4tm1Shr) 		autoimmune response J:146644
Ctsbtm1Jde/Ctsb+
(NOD.129P2-Ctsbtm1Jde) 		decreased susceptibility to autoimmune diabetes J:153355
Ctsbtm1Jde/Ctsbtm1Jde
(NOD.129P2-Ctsbtm1Jde) 		decreased susceptibility to autoimmune diabetes J:153355
Ctsltm1Cptr/Ctsl+
(NOD.129P2-Ctsltm1Cptr) 		decreased susceptibility to autoimmune diabetes J:153355
Ctsltm1Cptr/Ctsltm1Cptr
(NOD.129P2-Ctsltm1Cptr) 		decreased susceptibility to autoimmune diabetes J:153355
Ctsstm1Eae/Ctsstm1Eae
(involves: C57BL/6 * DBA/1LacJ) 		decreased susceptibility to induced arthritis J:53399
Ctsstm1Eae/Ctsstm1Eae
(NOD.D1-Ctsstm1Eae) 		decreased susceptibility to autoimmune diabetes J:153355
Ctsstm1Hap/Ctsstm1Hap
(B6.129S2-Ctsstm1Hap) 		decreased susceptibility to experimental autoimmune myasthenia gravis J:96401
Cx3cr1tm1Litt/Cx3cr1+
(B6.129P2-Cx3cr1tm1Litt) 		increased susceptibility to experimental autoimmune encephalomyelitis J:129712
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(B6.129P2-Cx3cr1tm1Litt) 		increased susceptibility to experimental autoimmune encephalomyelitis J:129712
Cxcl10tm1Adl/Cxcl10tm1Adl
(B6.129S4-Cxcl10tm1Adl) 		increased susceptibility to experimental autoimmune encephalomyelitis J:87076
Cxcr2tm1a(EUCOMM)Wtsi/Cxcr2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cxcr2tm1a(EUCOMM)Wtsi/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
Cxcr2tm1Mwm/Cxcr2tm1Mwm
(C.129S2(B6)-Cxcr2tm1Mwm/J) 		decreased susceptibility to induced arthritis J:142880
Cxcr4tm1Yiw/Cxcr4tm1Yiw
Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd) 		decreased susceptibility to induced arthritis J:164872
Cybbtm1Din/Cybbtm1Din
(B6.129S-Cybbtm1Din/J) 		increased anti-double stranded DNA antibody level J:235399
increased anti-nuclear antigen antibody level J:235399
increased autoantibody level J:235399
increased susceptibility to systemic lupus erythematosus J:235399
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac * C57BL/6) 		increased autoantibody level J:92438
Cyp19a1tm1Sih/Cyp19a1tm1Sih
(involves: 129S/SvEv) 		increased anti-single stranded DNA antibody level J:216958
increased autoantibody level J:216958
increased susceptibility to autoimmune disorder J:216958
Cysltr2tm1Ykn/Cysltr2tm1Ykn
(C.B6-Cysltr2tm1Ykn) 		autoimmune response J:182213
Cytl1tm1Chun/Cytl1tm1Chun
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to induced arthritis J:175377
DbaclC57BL/6Jcl/DbaclC57BL/6Jcl
(NOD.B6-(D4Mit193-D4Mit17)) 		increased susceptibility to autoimmune diabetes J:144964
Dcbld2tm1a(KOMP)Wtsi/Dcbld2tm1a(KOMP)Wtsi
(C57BL/6N-Dcbld2tm1a(KOMP)Wtsi/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
Dclk1tm1a(EUCOMM)Wtsi/Dclk1+
(C57BL/6N-Dclk1tm1a(EUCOMM)Wtsi/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
Dclk1tm1a(EUCOMM)Wtsi/Dclk1tm1a(EUCOMM)Wtsi
(C57BL/6N-Dclk1tm1a(EUCOMM)Wtsi/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
Def6Gt(OST307148)Lex/Def6Gt(OST307148)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased anti-nuclear antigen antibody level J:106469
Del(1Aim2-Ifi205)1Stsn/+
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N) 		increased autoantibody level J:234263
Del(1Aim2-Ifi205)1Stsn/Del(1Aim2-Ifi205)1Stsn
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N) 		increased autoantibody level J:234263
Del(3Cd1d2-Cd1d1)1Crw/Del(3Cd1d2-Cd1d1)1Crw
Tg(TcraAV19AJ33)1Shima/0
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:112657
Del(3Cd1d2-Cd1d1)1Sbp/Del(3Cd1d2-Cd1d1)1Sbp
(either: B6NTac.129S6-Del(3Cd1d2-Cd1d1)1Sbp or (involves: 129S6/SvEvTac * C57BL/6NTac)) 		abnormal immune tolerance J:58315
Del(14Ltb4r2-Ltb4r1)1Bodd/+
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased susceptibility to induced arthritis J:131779
Del(14Ltb4r2-Ltb4r1)1Bodd/Del(14Ltb4r2-Ltb4r1)1Bodd
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased susceptibility to induced arthritis J:131779
Dffbem1(IMPC)Wtsi/Dffbem1(IMPC)Wtsi
(C57BL/6N-Dffbem1(IMPC)Wtsi/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
Dgkatm1Xpz/Dgkatm1Xpz
(involves: 129 * C57BL/6) 		abnormal lymphocyte anergy J:113564
Dgkztm1Gak/Dgkztm1Gak
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to induced arthritis J:293120
Dgkztm1Gak/Dgkztm1Gak
(B6.129X1-Dgkztm1Gak) 		abnormal lymphocyte anergy J:113564
Dh/Dh+
H2d/H2d
(NZB.Cg-Dh) 		increased anti-erythrocyte antigen antibody level J:12036
increased anti-nuclear antigen antibody level J:12036
increased anti-single stranded DNA antibody level J:12036
increased autoantibody level J:12036
Dicer1tm1Tara/Dicer1tm1Tara
Foxn1tm3(cre)Nrm/Foxn1+
(involves: 129P2/OlaHsd * C57BL/6NHsd) 		increased susceptibility to induced arthritis J:180783
Dnase1tm1Tmo/Dnase1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-nuclear antigen antibody level J:62549
Dnase1tm1Tmo/Dnase1tm1Tmo
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-nuclear antigen antibody level J:62549
increased susceptibility to systemic lupus erythematosus J:62549
Dnase1tm1Tmo/Dnase1tm1Tmo
(involves: 129P2/OlaHsd * CD-1) 		decreased susceptibility to systemic lupus erythematosus J:110060
Dnase1tm2092.1Arte/Dnase1tm2092.1Arte
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:277126
increased anti-histone antibody level J:277126
increased anti-nuclear antigen antibody level J:277126
increased autoantibody level J:277126
increased susceptibility to systemic lupus erythematosus J:277126
Dnase2atm1Osa/Dnase2atm1Osa
Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6) 		increased anti-double stranded DNA antibody level J:114982
increased autoantibody level J:238323
rheumatoid arthritis J:238323, J:114982
Dnase2atm1Osa/Dnase2atm2Osa
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6 * CBA) 		rheumatoid arthritis J:114982
Dntttm1Gfn/Dntttm1Gfn
Faslpr/Faslpr
(involves: 129S2/SvPas * C57BL/6 * MRL/MpJ) 		decreased autoantibody level J:110248
Dock2m1Hsd/Dock2m1Hsd
Siaetm1.2Avrk/Siaetm1.2Avrk
(B6NHsd.Cg-Siaetm1.2Avrk Dock2m1Hsd) 		increased anti-double stranded DNA antibody level J:144035
increased anti-histone antibody level J:144035
increased anti-single stranded DNA antibody level J:144035
Dock8pri/Dock8pri
(involves: C57BL/6JAnu) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:238772
Dock10tm1Thar/Dock10tm1Thar
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:300632
Dtx1tm1.1Mzl/Dtx1tm1.1Mzl
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		increased anti-double stranded DNA antibody level J:151605
increased anti-histone antibody level J:151605
increased autoantibody level J:151605
Dtx1tm1.2Mzl/Dtx1tm1.2Mzl
(B6.129-Dtx1tm1.2Mzl) 		abnormal T cell anergy J:151605
increased anti-double stranded DNA antibody level J:151605
increased anti-histone antibody level J:151605
Dusp1tm1Lex/Dusp1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased susceptibility to induced arthritis J:126383
Dusp2tm1Cmac/Dusp2tm1Cmac
(B6.Cg-Dusp2tm1Cmac) 		decreased susceptibility to induced arthritis J:112609
Dusp10tm1Flv/Dusp10tm1Flv
(involves: 129S6/SvEvTac) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:92104
Dusp14Gt(OST210117)Lex/Dusp14Gt(OST210117)Lex
(B6.129S5-Dusp14Gt(OST210117)Lex) 		increased susceptibility to experimental autoimmune encephalomyelitis J:209403
Dusp22tm1Tht/Dusp22tm1Tht
(B6.129S7-Dusp22tm1Tht) 		increased susceptibility to autoimmune disorder J:213253
increased susceptibility to experimental autoimmune encephalomyelitis J:213253
E2f1tm1Meg/E2f1tm1Meg
(NOD.Cg-E2f1tm1Meg) 		increased susceptibility to autoimmune diabetes J:93708
E2f2tm1Zubi/E2f2tm1Zubi
(involves: 129S1/Sv * C57BL/6) 		increased anti-double stranded DNA antibody level J:76318
increased susceptibility to autoimmune disorder J:76318
E2f2tm1Zubi/E2f2tm1Zubi
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2J) 		increased susceptibility to autoimmune disorder J:76318
Eae1A/J/Eae1A/J
(involves: A/J * C57BL/10SnJ) 		increased susceptibility to experimental autoimmune encephalomyelitis J:30574
Eae1PL/J/Eae1PL/J
(involves: C57BL/10SnJ * PL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:30574
Eae2RIIIS/J/Eae2RIIIS/J
(involves: B10.RIII * RIIIS/J) 		decreased susceptibility to induced arthritis J:95848
Eae4ABH/?
(involves: ABH * NOD) 		increased susceptibility to experimental autoimmune encephalomyelitis J:29171
Eae5B10.S/DvTe/Eae5SJL/J
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:49054
Eae5SJL/J/Eae5SJL/J
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:49054
Eae7B10.S/DvTe/Eae7B10.S/DvTe
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:49054
Eae7B10.S/DvTe/Eae7SJL/J
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:49054
Eae7SJL/J/Eae7SJL/J
(involves: B10.S/DvTe * SJL/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:49054
Eae9B10.S/DvTe/Eae9SJL/J
(involves: B10.S/DvTe * SJL/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:49054
Eae10SJL/J/Eae10SJL/J
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:49054
Eae11SJL/J/?
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:53193
Eae12SJL/J/Eae12SJL/J
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:53193
Eae13SJL/J/?
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:53193
Eae14C57BL/10/?
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:69083
Eae17SJL/J/?
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:69083
Eae18NOD/Eae18NOD
(involves: ABH * NOD) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:29171
Eae26B10.RIII/Eae26B10.RIII
(involves: B10.RIII * RIIIS/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:73850
Eae26B10.RIII/Eae26RIIIS/J
(involves: B10.RIII * RIIIS/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:73850
Eae33C57BL/10SnSg/?
(involves: B10.S * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:99793
Eae34C57BL/10SnSg/?
(involves: B10.S * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:99793
Eae35C57BL/10SnSg/?
(involves: B10.S * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:99793
Eae36SJL/J/?
(involves: B10.S * SJL/J) 		increased susceptibility to autoimmune disorder J:99793
Eae37C57BL/10SnSg/?
(involves: B10.S * SJL/J) 		increased susceptibility to autoimmune disorder J:99793
Eae38C57BL/10SnSg/?
(involves: B10.S * SJL/J) 		increased susceptibility to autoimmune disorder J:99793
Eae42C57BL/10SnSg/?
(involves: B10.S * SJL/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:34892
Eae42SJL/J/?
(involves: B10.S * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:34892
Eae43B10.S/DvTe/?
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:53193
Eae43B10.S/DvTe/Eae43B10.S/DvTe
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:49054
Eae44aB10.S/DvTe/Eae44aB10.S/DvTe
(involves: B10.S/DvTe * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:56752
Eae44bB10.S/DvTe/Eae44bSJL/J
(involves: B10.S/DvTe * SJL/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:56752
Eae44bSJL/J/Eae44bSJL/J
(involves: B10.S/DvTe * SJL/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:56752
Ecm1tm1Bsun/Ecm1tm1Bsun
(involves: 129 * C57BL/6) 		increased susceptibility to autoimmune disorder J:168252
Edil3Tg(lacZ)1Tq/Edil3Tg(lacZ)1Tq
(Not Specified) 		increased susceptibility to induced arthritis J:254384
Elavl1tm1.1Atas/Elavl1tm1.1Atas
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:207013
Endoutm1Tft/Endoutm1Tft
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6JSfd) 		increased autoantibody level J:208364
Entpd7tm1Ktak/Entpd7tm1Ktak
(B6.Cg-Entpd7tm1Ktak) 		increased susceptibility to experimental autoimmune encephalomyelitis J:191188
Ephb6tm1Jwu/Ephb6tm1Jwu
(involves: 129) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:94701
Erars1DBA/2J/?
(involves: BXD2/TyJ * C57BL/6J * DBA/2J) 		increased anti-nuclear antigen antibody level J:96064
Ergtm1.1Iwamo/Ergtm1.1Iwamo
Tg(Gdf5-cre,-ALPP)1Kng/?
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N) 		increased susceptibility to induced arthritis J:243715
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J) 		increased anti-double stranded DNA antibody level J:88156
Extl1em1Caox/Extl1em1Caox
Tg(Itgax-cre)1-1Reiz/0
(involves: C57BL/6 * CBA) 		increased susceptibility to autoimmune disorder J:333437
F2tm2Jld/F2+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2J) 		decreased susceptibility to induced arthritis J:174629
F2rl1tm1Wrf/F2rl1tm1Wrf
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to induced arthritis J:81119
F8tm1Kaz/Y
(involves: 129S4/SvJae * C57BL/6) 		abnormal immune tolerance J:178969
Faddtm1Mpa/Faddtm1Mpa
Mogtm1(cre)Gkl/Mog+
(involves: C57BL/6 * SJL) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:167475
Fam210bem1Cya/Fam210bem1Cya
(involves: C57BL/6N) 		increased anti-double stranded DNA antibody level J:351618
increased anti-nuclear antigen antibody level J:351618
Faslpr-cg/Faslpr-cg
(CBA/KlJms-Faslpr-cg/J) 		autoimmune response J:24805, J:81770
increased anti-nuclear antigen antibody level J:24805
increased autoantibody level J:81770
Faslpr/Faslpr
(MRL/Mp-Faslpr) 		increased anti-double stranded DNA antibody level J:27634, J:131138, J:6257
increased anti-erythrocyte antigen antibody level J:27634
increased anti-nuclear antigen antibody level J:27634, J:28885
increased anti-single stranded DNA antibody level J:27634
increased autoantibody level J:28885
increased susceptibility to autoimmune disorder J:108760
Faslpr/Faslpr
(NOD.MRL(B6)-Faslpr) 		decreased susceptibility to autoimmune diabetes J:64051
Faslpr/Faslpr
(MRL/MpJ-Faslpr/J) 		increased anti-double stranded DNA antibody level J:92084, J:122315, J:7454
increased anti-nuclear antigen antibody level J:111811, J:92084, J:14151, J:7454
increased autoantibody level J:92084, J:14151
increased susceptibility to systemic lupus erythematosus J:92084
Faslpr/Faslpr
(NOD.MRL-Faslpr) 		decreased susceptibility to autoimmune diabetes J:78679
Faslpr/Faslpr
(involves: C3H * MRL/Mp) 		autoimmune response J:1060
increased anti-nuclear antigen antibody level J:34296
increased susceptibility to systemic lupus erythematosus J:34296
Faslpr/Faslpr
(B6.MRL-Faslpr/J) 		increased anti-double stranded DNA antibody level J:132217
increased anti-histone antibody level J:132217
increased anti-nuclear antigen antibody level J:132217
increased anti-single stranded DNA antibody level J:132217
increased autoantibody level J:132217
Faslpr/Faslpr
(MRL-Faslpr) 		increased anti-double stranded DNA antibody level J:126261
increased anti-nuclear antigen antibody level J:126261
Faslpr/Faslpr
(MRL.Cg-Irf1tm1Mak Faslpr) 		increased anti-double stranded DNA antibody level J:114771
Faslpr/Faslpr
(C3.MRL-Faslpr/J) 		increased anti-double stranded DNA antibody level J:7454
increased anti-nuclear antigen antibody level J:7454
increased autoantibody level J:7454
Faslpr/Faslpr
(B6.MRL-Faslpr) 		increased anti-double stranded DNA antibody level J:7454
increased anti-nuclear antigen antibody level J:6638, J:135036
increased autoantibody level J:135036, J:7454
Faslpr/Faslpr
(AK.MRL-Faslpr) 		increased anti-double stranded DNA antibody level J:7454
increased anti-nuclear antigen antibody level J:7454
increased autoantibody level J:7454
Faslpr/Faslpr
(MRL/MpJ-Faslpr) 		autoimmune response J:125114
increased anti-nuclear antigen antibody level J:137066
increased autoantibody level J:137066
Faslpr/Faslpr
(involves: C57BL/6 * MRL/Mp) 		increased anti-double stranded DNA antibody level J:73396
increased anti-single stranded DNA antibody level J:73396
Faslpr/Faslpr
Fcer1gtm1Tks/Fcer1gtm1Tks
(MRL.Cg-Fcer1gtm1Tks Faslpr) 		increased anti-double stranded DNA antibody level J:106188
Faslpr/Faslpr
Havcr1tm1Kuch/Havcr1tm1Kuch
(B6.Cg-Havcr1tm1Kuch Faslpr) 		increased anti-double stranded DNA antibody level J:186484
increased autoantibody level J:186484
increased susceptibility to systemic lupus erythematosus J:186484
Faslpr/Faslpr
Hspa13tm1.1Smoc/Hspa13tm1.1Smoc
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S * C57BL/6 * MRL/Mp) 		decreased autoantibody level J:303927
decreased susceptibility to systemic lupus erythematosus J:303927
Faslpr/Faslpr
Ifnar1tm1Agt/Ifnar1tm1Agt
(MRL.Cg-Ifnar1tm1Agt Faslpr) 		increased anti-nuclear antigen antibody level J:92084
increased autoantibody level J:92084
increased susceptibility to systemic lupus erythematosus J:92084
Faslpr/Faslpr
Ifnar1tm1Agt/Ifnar1tm1Agt
Ifngr1tm1Agt/Ifngr1tm1Agt
(MRL.Cg-Ifngr1tm1Agt Ifnar1tm1Agt Faslpr) 		decreased anti-nuclear antigen antibody level J:92084
decreased autoantibody level J:92084
decreased susceptibility to systemic lupus erythematosus J:92084
increased susceptibility to systemic lupus erythematosus J:92084
Faslpr/Faslpr
Ifngtm1Ts/Ifng+
(MRL.Cg-Ifngtm1Ts Faslpr) 		increased autoantibody level J:123834
Faslpr/Faslpr
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp) 		decreased anti-double stranded DNA antibody level J:39600
decreased anti-nuclear antigen antibody level J:39600
decreased autoantibody level J:39600
decreased susceptibility to systemic lupus erythematosus J:39600
Faslpr/Faslpr
Ifngr1tm1Agt/Ifngr1tm1Agt
(MRL.Cg-Ifngr1tm1Agt Faslpr) 		decreased anti-nuclear antigen antibody level J:92084
decreased autoantibody level J:92084
decreased susceptibility to systemic lupus erythematosus J:92084
Faslpr/Faslpr
Igh-Jtm2(3H9-VDJ*)Mwg/Igh-J+
(MRL.Cg-Faslpr Igh-Jtm2(3H9-VDJ*)Mwg) 		increased anti-double stranded DNA antibody level J:131138
Faslpr/Faslpr
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas * C57BL/6 * MRL/Mp) 		increased autoantibody level J:119584
Faslpr/Faslpr
Il4tm1Cgn/Il4tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6J * MRL/Mp) 		decreased anti-nuclear antigen antibody level J:39600
decreased susceptibility to systemic lupus erythematosus J:39600
Faslpr/Faslpr
Il27ratm1Mak/Il27ratm1Mak
(MRL.Cg-Il27ratm1Mak Faslpr) 		decreased anti-double stranded DNA antibody level J:122148
decreased susceptibility to systemic lupus erythematosus J:122148
Faslpr/Faslpr
Irf1tm1Mak/Irf1+
(MRL.Cg-Irf1tm1Mak Faslpr) 		increased anti-double stranded DNA antibody level J:114771
Faslpr/Faslpr
Irf1tm1Mak/Irf1tm1Mak
(MRL.Cg-Irf1tm1Mak Faslpr) 		decreased anti-double stranded DNA antibody level J:114771
Faslpr/Faslpr
Itfg2Gt(OST215121)Lex/Itfg2Gt(OST215121)Lex
(involves: 129S5/SvEvBrd * C57BL/6J * MRL/Mp) 		increased anti-double stranded DNA antibody level J:205951
increased anti-nuclear antigen antibody level J:205951
increased susceptibility to systemic lupus erythematosus J:205951
Faslpr/Faslpr
Pou2af1tm1Pmt/Pou2af1tm1Pmt
(involves: 129P2/OlaHsd * C57BL/6 * MRL) 		autoimmune response J:125114
Faslpr/Faslpr
Sh2d1arpl/Sh2d1arpl
(MRL/Mp-Faslpr Sh2d1arpl) 		increased anti-nuclear antigen antibody level J:126261
Faslpr/Faslpr
Spp1tm1Rit/Spp1tm1Rit
(involves: 129S7/SvEvBrd * C57BL/6 * MRL/Mp) 		increased anti-double stranded DNA antibody level J:73396
increased anti-single stranded DNA antibody level J:73396
Faslpr/Faslpr
Tcratm1Mjo/Tcratm1Mjo
(involves: 129P2/OlaHsd * 129S2/SvPas * MRL) 		decreased autoantibody level J:38492
Faslpr/Faslpr
Tg(CD2-Foxj1)#Stlp/0
(MRL.Cg-Faslpr Tg(CD2-Foxj1)#Stlp) 		decreased susceptibility to systemic lupus erythematosus J:122222
increased anti-nuclear antigen antibody level J:122222
Faslpr/Faslpr
Tg(Ins2-Fasl)24Ach/0
(NOD.Cg-Faslpr Tg(Ins2-Fasl)24Ach) 		decreased susceptibility to autoimmune diabetes J:81416
Faslpr/Faslpr
Tg(INS-Il10)#Sar/0
(NOD.Cg-Faslpr Tg(INS-Il10)#Sar) 		increased susceptibility to autoimmune diabetes J:64051
Faslpr/Faslpr
Tlr7tm1Flv/Y
(involves: 129S1/Sv * C57BL/6 * MRL/Mp) 		decreased autoantibody level J:113557
decreased susceptibility to systemic lupus erythematosus J:113557
increased anti-chromatin antibody level J:113557
increased autoantibody level J:113557
Faslpr/Faslpr
Tlr9tm1Aki/Tlr9tm1Aki
(B6.Cg-Tlr9tm1Aki Faslpr) 		autoimmune response J:135036
Faslpr/Faslpr
Tlr9tm1Aki/Tlr9tm1Aki
(MRL.Cg-Tlr9tm1Aki Faslpr) 		decreased autoantibody level J:113557
increased autoantibody level J:113557
increased susceptibility to systemic lupus erythematosus J:113557
Faslpr/Faslpr
Tnfrsf9tm1Byk/Tnfrsf9tm1Byk
(MRL.Cg-Tnfrsf9tm1Byk Faslpr) 		increased anti-nuclear antigen antibody level J:127197
increased susceptibility to systemic lupus erythematosus J:127197
Fastheo/Fastheo
(either: (involves: C57BL/6JAnu * C57BL/10SnSg * C57BR/cd) or (involves: C57BL/6JAnu * C57BL/10SnSg * C57BR/cd * CBA/CaJAnu)) 		increased anti-nuclear antigen antibody level J:104190
Fastm1Ach/Fastm1Ach
Tg(GZMB-cre)1Jcb/?
(involves: C57BL/6 * FVB/N) 		increased anti-nuclear antigen antibody level J:123556
Fastm1Ach/Fastm1Ach
Tg(Itgax-cre,-EGFP)4097Ach/?
(Not Specified) 		increased anti-nuclear antigen antibody level J:123556
Fastm1Ach/Fastm1Ach
Tg(Lck-cre)548Jxm/?
(involves: C57BL/6 * CBA) 		increased anti-nuclear antigen antibody level J:123556
Fastm1Cgn/Fastm1Cgn
Cd19tm1(cre)Cgn/Cd19+
Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Cd19tm1(cre)Cgn Fastm1Cgn) 		increased anti-single stranded DNA antibody level J:114948
Fastm1Cgn/Fastm1Cgn
Mogtm1(cre)Gkl/Mog+
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:114741
Fastm1Cgn/Fastm1Cgn
Mogtm1(cre)Gkl/Mog+
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
(involves: 129S2/SvPas * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:114741
Fastm1Cgn/Fastm1Cgn
Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Fastm1Cgn) 		increased anti-single stranded DNA antibody level J:114948
Fastm1Cgn/Fastm1Cgn
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
(involves: 129S2/SvPas * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:114741
Fastm1Osa/Fastm1Osa
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal T cell clonal deletion J:32125
increased anti-double stranded DNA antibody level J:32125
increased anti-single stranded DNA antibody level J:32125
increased autoantibody level J:32125
Fastm1Vbo/Fastm1Vbo
Tg(Ins2-cre)25Mgn/0
Tg(Ins2-HA)165Bri/0
Tg(Tcra/Tcrb)1Vbo/0
(Not Specified) 		increased susceptibility to autoimmune diabetes J:85985
Faslgld/Faslgld
(C3H/HeJ-Faslgld/J) 		increased anti-double stranded DNA antibody level J:7306
increased anti-nuclear antigen antibody level J:7306, J:29572
increased autoantibody level J:7306
Faslgld/Faslgld
(involves: C3H/HeJ * C57BL/6) 		increased anti-nuclear antigen antibody level J:153501
increased susceptibility to systemic lupus erythematosus J:153501
Faslgld/Faslgld
(B6.C3-Faslgld) 		increased anti-nuclear antigen antibody level J:91058
increased autoantibody level J:91058
Fasltm1.1Ast/Fasltm1.1Ast
(involves: BALB/cJ * C57BL/6) 		increased anti-double stranded DNA antibody level J:153501
increased anti-nuclear antigen antibody level J:153501
increased susceptibility to systemic lupus erythematosus J:153501
Fasltm1.1Lest/Fasltm1.1Lest
(involves: 129 * C57BL/6) 		autoimmune response J:87990
Fbn1tm2.1Hcd/Fbn1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		increased anti-nuclear antigen antibody level J:206074
increased autoantibody level J:206074
Fbn1tm3.1Hcd/Fbn1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		increased anti-nuclear antigen antibody level J:206074
increased autoantibody level J:206074
Fbn1Tsk/Fbn1+
(B6.Cg-Fbn1Tsk) 		increased autoantibody level J:21987, J:14166
Fbn1Tsk/Fbn1+
Il4ratm1Sz/Il4ra+
(involves: BALB/cJ * C57BL/6J * C57BL/10 * DBA/2) 		increased autoantibody level J:68448
Fcer1gtm1Rav/Fcer1gtm1Rav
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:126520
Fcer1gtm1Rav/Fcer1gtm1Rav
Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to autoimmune diabetes J:122114
Fcer1gtm1Tks/Fcer1gtm1Tks
(C57BL/6-Fcer1gtm1Tks) 		decreased susceptibility to autoimmune hemolytic anemia J:145432
Fcgr1tm1Jsv/Fcgr1tm1Jsv
(involves: 129P2/OlaHsd * BALB/c) 		decreased susceptibility to autoimmune hemolytic anemia J:83995
decreased susceptibility to induced arthritis J:83995
Fcgr2btm1.2Jsv/Fcgr2b+
X/Yaa
(involves: C57BL/6 * FVB/N * SB/Le) 		increased anti-chromatin antibody level J:179175
increased anti-double stranded DNA antibody level J:179175
increased susceptibility to systemic lupus erythematosus J:179175
Fcgr2btm1.2Jsv/Fcgr2btm1.2Jsv
Sle16C57BL/6/Sle16C57BL/6
(involves: C57BL/6 * FVB/N) 		increased susceptibility to induced arthritis J:179175
Fcgr2btm1Kgcs/Fcgr2b+
(involves: C57BL/6) 		increased anti-chromatin antibody level J:190890
increased anti-double stranded DNA antibody level J:190890
increased susceptibility to induced arthritis J:190890
Fcgr2btm1Ttk/Fcgr2btm1.2Jsv
Sle21129P2/Ola/Sle21C57BL/6
(involves: 129P2/Ola * 129S4/SvJae * C57BL/6 * FVB/N) 		increased anti-chromatin antibody level J:179175
increased anti-double stranded DNA antibody level J:179175
increased anti-histone antibody level J:179175
increased anti-single stranded DNA antibody level J:179175
increased susceptibility to systemic lupus erythematosus J:179175
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(Not Specified) 		increased susceptibility to induced arthritis J:106191
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Il17atm1Yiw/Il17atm1Yiw
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		decreased susceptibility to systemic lupus erythematosus J:191090
increased anti-double stranded DNA antibody level J:191090
increased anti-nuclear antigen antibody level J:191090
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Pdcd1tm1Hon/Pdcd1tm1Hon
(involves: 129S2/SvPas * 129S4/SvJae * BALB/c) 		increased autoantibody level J:207275
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Sle21129P2/Ola/Sle21129P2/Ola
(B6.129S4-Fcgr2btm1Ttk) 		increased anti-chromatin antibody level J:179175
increased anti-double stranded DNA antibody level J:179175
increased anti-histone antibody level J:179175
increased anti-single stranded DNA antibody level J:179175
increased autoantibody level J:179175
increased susceptibility to induced arthritis J:179175
increased susceptibility to systemic lupus erythematosus J:179175
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: 129S4/SvJae * C57BL/6) 		increased susceptibility to autoimmune diabetes J:122114
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Tlr7tm1Flv/Y
X/Yaa
(B6.Cg-Fcgr2btm1Ttk Tlr7tm1Flv Yaa) 		autoimmune response J:127600
increased anti-nuclear antigen antibody level J:127600
increased susceptibility to systemic lupus erythematosus J:127600
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Traf3ip2tm1Sbn/Traf3ip2+
(involves: 129 * 129S4/SvJae * C57BL/6) 		increased anti-double stranded DNA antibody level J:191090
increased anti-nuclear antigen antibody level J:191090
increased autoantibody level J:191090
increased susceptibility to systemic lupus erythematosus J:191090
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Traf3ip2tm1Sbn/Traf3ip2tm1Sbn
(involves: 129 * 129S4/SvJae * C57BL/6) 		decreased susceptibility to systemic lupus erythematosus J:191090
increased anti-double stranded DNA antibody level J:191090
increased anti-nuclear antigen antibody level J:191090
increased autoantibody level J:191090
Fcgr2btm1Ttk/Fcgr2btm1Ttk
X/Yaa
(B6.Cg-Fcgr2btm1Ttk Yaa) 		autoimmune response J:127600
increased anti-nuclear antigen antibody level J:127600
increased susceptibility to systemic lupus erythematosus J:127600
Fcgr3tm1Jsv/Fcgr3tm1Jsv
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to autoimmune hemolytic anemia J:83995
Fcgr3tm1Jsv/Fcgr3tm1Jsv
(B6.129P2-Fcgr3tm1Jsv/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:126520
decreased susceptibility to induced arthritis J:106191
Fcgr3tm1Jsv/Fcgr3tm1Jsv
Sle21129P2/Ola/Sle21129P2/Ola
(B6.129P2-Fcgr3tm1Jsv) 		increased anti-chromatin antibody level J:179175
increased anti-double stranded DNA antibody level J:179175
increased anti-histone antibody level J:179175
increased anti-single stranded DNA antibody level J:179175
Fcgr4tm1.1Rav/Fcgr4tm1.1Rav
(involves: C57BL/6) 		decreased susceptibility to induced arthritis J:167375
Fcmrtm1Ohno/Fcmrtm1Ohno
(B6.129-Fcmrtm1Ohno) 		increased anti-chromatin antibody level J:190117
increased anti-double stranded DNA antibody level J:190117
Fcrlbtm1Pdb/Fcrlbtm1Pdb
(B6.129-Fcrlbtm1Pdb) 		increased anti-nuclear antigen antibody level J:165408
Fen1tm3.1Bhsh/Fen1+
(Not Specified) 		increased anti-double stranded DNA antibody level J:231218
increased anti-nuclear antigen antibody level J:231218
increased susceptibility to autoimmune disorder J:231218
Fen1tm3.1Bhsh/Fen1tm3.1Bhsh
(Not Specified) 		increased anti-double stranded DNA antibody level J:231218
increased anti-nuclear antigen antibody level J:231218
increased susceptibility to autoimmune disorder J:231218
Ffar2tm1Dgen/Ffar2tm1Dgen
(involves: C57BL/6) 		increased susceptibility to induced arthritis J:153951
Fgl1tm1b(EUCOMM)Hmgu/Fgl1tm1b(EUCOMM)Hmgu
(involves: BALB/cJ * C57BL/6N) 		increased anti-double stranded DNA antibody level J:269578
Flicrem1Doi/Flicrem1Doi
(NOD/ShiLtDoi-Flicrem1Doi) 		decreased susceptibility to autoimmune diabetes J:241346
Foxo1tm1Flv/Foxo1tm1Flv
Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased anti-double stranded DNA antibody level J:147057
increased anti-nuclear antigen antibody level J:147057
Foxp3tm1(cre)Saka/Y
(involves: BALB/c) 		increased autoantibody level J:140085
Foxp3tm1.1Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ) 		increased susceptibility to autoimmune disorder J:82560
Foxp3tm1.1Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to autoimmune disorder J:117743
Foxp3tm1.1Ayr/Foxp3tm1.1Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to autoimmune disorder J:117743
Foxp3tm1Ayr/Y
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		increased susceptibility to autoimmune disorder J:97029
Foxp3tm1Kuch/?
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:123352
Foxp3tm2.1(EGFP/cre)Shori/Y
Pdcd1tm1Hon/Pdcd1tm1Hon
(involves: 129 * 129S2/SvPas * C57BL/6) 		increased susceptibility to autoimmune disorder J:234397
Foxp3tm2Flv/Y
(involves: C57BL/6) 		increased autoantibody level J:118631
Foxp3tm3(HBEGF/GFP)Ayr/Foxp3+
Gpr174tm1Cys/Gpr174+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:222307
Foxp3tm3(HBEGF/GFP)Ayr/Foxp3tm3(HBEGF/GFP)Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to autoimmune disorder J:117743
Foxp3tm4(YFP/icre)Ayr/Y
Zfp91tm1Smoc/Zfp91tm1Smoc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to autoimmune disorder J:306129
Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr
Ikzf4tm1Djr/Ikzf4tm1Djr
(involves: 129S1/Sv * 129X1/SvJ) 		increased susceptibility to experimental autoimmune encephalomyelitis J:294549
Foxp3tm8Ayr/Y
(B6.129-Foxp3tm8Ayr) 		autoimmune response J:157377
Fpr2tm1Rjf/Fpr2tm1Rjf
(involves: 129S/SvEv * C57BL/6) 		increased susceptibility to induced arthritis J:159658
Fyntm1Sor/Fyntm1Sor
(either: 129S7/SvEvBrd-Fyntm1Sor or (involves: 129S7/SvEvBrd * C57BL/6J)) 		abnormal T cell clonal deletion J:2242
Fyntm1Yik/Fyntm1Yik
(involves: C57BL/6 * CBA) 		increased susceptibility to experimental autoimmune uveoretinitis J:99347
Gabrb3tm2.1Geh/Gabrb3tm2.1Geh
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		increased susceptibility to experimental autoimmune encephalomyelitis J:333883
Gadd45atm1Ajf/Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129X1/SvJ * C57BL/6)) 		increased anti-double stranded DNA antibody level J:76041
increased anti-histone antibody level J:76041
increased anti-single stranded DNA antibody level J:76041
increased autoantibody level J:76041
Gadd45btm1Flv/Gadd45btm1Flv
(B6.129S6-Gadd45btm1Flv) 		increased susceptibility to experimental autoimmune encephalomyelitis J:118837
Gadd45btm1Flv/Gadd45btm1Flv
Gadd45gtm1Flv/Gadd45gtm1Flv
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6) 		increased anti-double stranded DNA antibody level J:118837
increased anti-histone antibody level J:118837
Gata1tm6Sho/Gata1tm6Sho
(C.129S1-Gata1tm6Sho) 		autoimmune response J:182213
Gcc2em1Cya/Gcc2em1Cya
(C57BL/6J-Gcc2em1Cya) 		increased autoantibody level J:346915
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c) 		decreased susceptibility to autoimmune diabetes J:59132
Ghrhtm1Salv/Ghrhtm1Salv
(involves: 129 * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:177054
Ghrhrlit/Ghrhrlit
(C57BL/6J-Ghrhrlit) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:85381
Gm614tm1.1Cya/Gm614tm1.1Cya
Ighg1tm1(cre)Cgn/Ighg1+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N) 		decreased susceptibility to systemic lupus erythematosus J:307345
Gna12tm1Citb/Gna12tm1Citb
Gna13tm2.1Soff/Gna13tm2.1Soff
Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		increased susceptibility to autoimmune diabetes J:149560
Gpa33tm1Jkhh/Gpa33tm1Jkhh
(B6.129-Gpa33tm1Jkhh) 		abnormal immune tolerance J:224768
Gpr132tm1Witt/Gpr132tm1Witt
(involves: 129X1/SvJ * BALB/c) 		increased anti-nuclear antigen antibody level J:69473
Gpr174tm1Cys/Y
(B6.129-Gpr174tm1Cys) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:222307
Gpr174tm1Cys/Gpr174+
(B6.129-Gpr174tm1Cys) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:222307
Gpsm3Gt(IST12408A1)Tigm/Gpsm3Gt(IST12408A1)Tigm
(involves: C57BL/6N) 		decreased susceptibility to induced arthritis J:193270
Gpx7tm1Whle/Gpx7tm1Whle
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-nuclear antigen antibody level J:193993
Grk6tm1.1Mca/Grk6tm1.1Mca
(B6.129S4-Grk6tm1.1Mca) 		increased anti-double stranded DNA antibody level J:225063
Gt(ROSA)26Sortm1(DTA)Jpmb/Gt(ROSA)26Sor+
Tg(Plp1-cre/ERT)3Pop/0
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		autoimmune response J:234435
Gt(ROSA)26Sortm1(Ptpn22*)Draw/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-double stranded DNA antibody level J:201448
increased autoantibody level J:201448
Gt(ROSA)26Sortm2.1(Cd74/MOG)Awai/Gt(ROSA)26Sor+
(involves: C57BL/6 * BALB/cJ) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:140751
Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky/Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky
Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca) 		increased anti-double stranded DNA antibody level J:133215
increased anti-single stranded DNA antibody level J:133215
Gvhd4DBA/2J/Gvhd4DBA/2J
(involves: C57BL/10 * DBA/2J) 		increased anti-single stranded DNA antibody level J:66655
Gvhd4DBA/2J/Gvhd4DBA/2J
Gvhd5DBA/2J/Gvhd5DBA/2J
(involves: C57BL/10 * DBA/2J) 		increased anti-single stranded DNA antibody level J:66655
Gvhd5DBA/2J/Gvhd5DBA/2J
(involves: C57BL/10 * DBA/2J) 		increased anti-single stranded DNA antibody level J:66655
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Rag1tm1Mom/Rag1tm1Mom
Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
(NOD.Cg-Rag1tm1Mom H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell) 		increased autoantibody level J:113267
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell/Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell
(NOD.Cg-H2-Ab1b-tm1Gru Tg(CD2-CD4,HLA-DQA1,HLA-DQB1)1Ell) 		autoimmune response J:87013, J:86540
decreased susceptibility to autoimmune disorder J:87013
increased autoantibody level J:113267
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell/Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell
(NOD.Cg-H2-Ab1b-tm1Gru Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell) 		increased autoantibody level J:113509
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(HLA-DQA1,HLA-DQB1)1Dv/0
Tg(HLA-DRB1)31Dmz/0
Tg(Ins2-CD80)3B7Flv/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/10SnJ * CBA * SJL) 		decreased susceptibility to autoimmune diabetes J:68641
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(HLA-DQA1,HLA-DQB1)1Dv/0
Tg(Ins2-CD80)3B7Flv/0
(B6.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)1Dv Tg(Ins2-CD80)3B7Flv) 		increased susceptibility to autoimmune diabetes J:59245
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(HLA-DQA1,HLA-DQB1)1Dv/0
Tg(Ins2-CD80)3B7Flv/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/10SnJ * CBA) 		increased susceptibility to autoimmune diabetes J:68641
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(HLA-DQA1,HLA-DQB1)70Myl/0
(NOD.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)70Myl) 		increased autoantibody level J:88055
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(HLA-DQA1,HLA-DQB1)73Myl/0
(NOD.Cg-H2-Ab1b-tm1Gru Tg(HLA-DQA1,HLA-DQB1)73Myl) 		increased autoantibody level J:88055
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(HLA-DRB1)31Dmz/0
Tg(Ins2-CD80)3B7Flv/0
(involves: 129S2/SvPas * C57BL/6 * CBA * SJL) 		decreased susceptibility to autoimmune diabetes J:68641
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(Ins2-CD80)3B7Flv/0
(involves: 129S2/SvPas * C57BL/6 * CBA) 		decreased susceptibility to autoimmune diabetes J:68641
H2-Ab1b-tm1Wug/H2-Ab1b-tm1Wug
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:204951
H2-Ab1b-tm1Wug/H2-Ab1b-tm1Wug
Cd19tm1(cre)Cgn/Cd19+
(involves: 129S2/SvPas * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:204951
H2-Ab1bm12/H2-Ab1bm12
(B6(C)-H2-Ab1bm12/KhEgJ) 		decreased susceptibility to autoimmune disorder J:100123
decreased susceptibility to experimental autoimmune myasthenia gravis J:100213
H2-Ab1bm12/H2-Ab1bm12
(NZB.B6(C)-H2-Ab1bm12) 		autoimmune response J:4554
increased anti-double stranded DNA antibody level J:104189
increased anti-erythrocyte antigen antibody level J:4554
increased anti-single stranded DNA antibody level J:104189
H2-Ab1g7-em1Dvs/H2-Ab1g7-em1Dvs
H2-D1b-em5Dvs/H2-D1b-em5Dvs
H2-K1d-em1Dvs/H2-K1d-em1Dvs
(NOD/ShiLtDvs-H2-K1d-em1Dvs H2-Ab1g7-em1Dvs H2-D1em5Dvs/Dvs) 		decreased susceptibility to autoimmune diabetes J:257229
H2-D1b-em1Dvs/H2-D1b-em1Dvs
(NOD/ShiLtDvs-H2-D1b-em1Dvs/Dvs) 		decreased susceptibility to autoimmune diabetes J:257229
H2-D1b-em2Dvs/H2-D1b-em2Dvs
(NOD/ShiLtDvs-H2-D1b-em2Dvs/Dvs) 		decreased susceptibility to autoimmune diabetes J:257229
H2-D1b-em3Dvs/H2-D1b-em3Dvs
(NOD/ShiLtDvs-H2-D1b-em3Dvs/Dvs) 		decreased susceptibility to autoimmune diabetes J:257229
H2-D1b-em4Dvs/H2-D1b-em4Dvs
(NOD/ShiLtDvs-H2-D1b-em4Dvs/Dvs) 		decreased susceptibility to autoimmune diabetes J:257229
H2-D1b-em5Dvs/H2-D1b-em5Dvs
H2-K1d-em1Dvs/H2-K1d-em1Dvs
(NOD/ShiLtDvs-H2-K1d-em1Dvs H2-D1b-em5Dvs/Dvs) 		decreased susceptibility to autoimmune diabetes J:257229
H2-D1b-em5Dvs/H2-D1b-em5Dvs
H2-K1d-em1Dvs/H2-K1d-em1Dvs
Tg(HLA-A/H2-D/B2M)1Dvs/?
(NOD/ShiLtDvs-H2-K1d-em1Dvs H2-D1b-em5Dvs Tg(HLA-A/H2-D/B2M)1Dvs/Dvs) 		autoimmune response J:257229
increased susceptibility to autoimmune diabetes J:257229
H2-D1b-em5Dvs/H2-D1b-em5Dvs
H2-K1d-em1Dvs/H2-K1d-em1Dvs
Tg(HLA-B39/H2-D/B2m)2Dvs/?
(NOD/ShiLtDvs-H2-K1d-em1Dvs H2-D1b-em5Dvs Tg(HLA-B39/H2-D/B2M)2Dvs/Dvs) 		autoimmune response J:257229
increased susceptibility to autoimmune diabetes J:257229
H2-D1b-tm1Bpe/H2-D1b-tm1Bpe
H2-K1b-tm1Bpe/H2-K1b-tm1Bpe
X/Yaa
(BXSB.129P2(B6)-H2-K1b-tm1Bpe H2-D1b-tm1Bpe/Dcr) 		increased susceptibility to systemic lupus erythematosus J:179430
H2-DMatm1Luc/H2-DMatm1Luc
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:72243
H2-DMatm1Luc/H2-DMatm1Luc
(B6.129S4-H2-Dmatm1Luc) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:125654
H2-K1d-em4Dvs/H2-K1d-em4Dvs
(NOD/ShiLtDvs-H2-K1d-em4Dvs/Dvs) 		decreased susceptibility to autoimmune diabetes J:257229
H2-K1d-em5Dvs/H2-K1d-em5Dvs
(NOD/ShiLtDvs-H2-K1d-em5Dvs/Dvs) 		decreased susceptibility to autoimmune diabetes J:257229
H2-K1d-em7Dvs/H2-K1d-em7Dvs
(NOD/ShiLtDvs-H2-K1d-em7Dvs/Dvs) 		decreased susceptibility to autoimmune diabetes J:257229
H2-T23tm1Cant/H2-T23tm1Cant
(involves: 129S6/SvEvTac * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:89808
H2-T23tm2Cant/H2-T23tm2Cant
(B6.129S6-H2-T23tm2Cant) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:142087
H2-T23tm2Cant/H2-T23tm2Cant
Tg(Tcra2D2,Tcrb2D2)1Kuch/?
(involves: 129S6/SvEvTac) 		increased susceptibility to experimental autoimmune encephalomyelitis J:142087
H2-T23tm3Cant/H2-T23tm3Cant
(B6.129S6-H2-T23tm3Cant) 		increased susceptibility to experimental autoimmune encephalomyelitis J:142087
H2b/H2b
(NOD.B10SnJ-H2b) 		decreased susceptibility to autoimmune diabetes J:14178
H2b/H2d
((C57BL/6 x DBA/2)F1) 		increased autoantibody level J:106141
H2b/H2g7
(NOD.B10SnJ-H2b) 		decreased susceptibility to autoimmune diabetes J:14178
H2b/H2g7
Tg(TcraR28,TcrbR28)KRNDim/0
(involves: C57BL/6 * NOD * SJL) 		rheumatoid arthritis J:36815, J:275827
H2d/H2d
(DBA/2) 		increased autoantibody level J:106141
H2d/H2d
Tg(TcraP1.5,TcrbP1.5)29Amsv/0
Trap1atm1.1Jvde/Y
(involves: 129 * BALB/cJ * C57BL/10 * DBA/2) 		abnormal T cell clonal deletion J:180807
H2d/H2d
Trap1atm1.1Jvde/Y
(involves: 129 * BALB/cJ * C57BL/10 * DBA/2) 		abnormal immune tolerance J:180807
H2dlAb1-Ea/H2dlAb1-Ea
Tg(HLA-DRA,HLA-DRB5*0101)hiKito/0
Tg(TRATL3A6,TRBTL3A6)#Kito/0
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:189816
H2dlAb1-Ea/H2dlAb1-Ea
Tg(HLA-DRA,HLA-DRB5*0101)loKito/0
Tg(TRATL3A6,TRBTL3A6)#Kito/0
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:189816
H2g7/H2g7
Ins2tm1Jja/Ins2tm1Jja
Rag1tm1Mom/Rag1tm1Mom
Tg(TcraBDC12-4.1)10Jos/0
Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6 * FVB * NOD) 		increased susceptibility to autoimmune diabetes J:111874
H2g7/H2g7
Rag1tm1Mom/Rag1tm1Mom
Tg(TcraBDC12-4.1)10Jos/0
Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD) 		increased susceptibility to autoimmune diabetes J:111874
H2g7/H2g7
Tg(Ins2-Vtcn1)#Xxz/0
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: C57BL/6 * NOD * SJL) 		decreased susceptibility to autoimmune diabetes J:177612
H2g7/H2g7
Tg(TcraAI4)1Dvs/0
Tg(TcrbAI4)1Dvs/0
(B6.NOD-(D17Mit21-D17Mit10) Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs) 		increased susceptibility to autoimmune diabetes J:167508
H2g7/H2g7
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(B6.Cg-H2g7 Tg(TcraBDC2.5,TcrbBDC2.5)1Doi) 		decreased susceptibility to autoimmune diabetes J:86926
H2g7/H2g7
Tg(TcraBDC12-4.1)10Jos/0
Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD) 		decreased susceptibility to autoimmune diabetes J:111874
H2g7/H2q
Rag1tm1Mom/Rag1tm1Mom
Tg(TcraBDC12-4.1)10Jos/0
Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD) 		increased susceptibility to autoimmune diabetes J:111874
H2h2/H2g7
(NOD.Cg-H2h2) 		decreased susceptibility to autoimmune diabetes J:14178
H2h2/H2h2
(NOD.Cg-H2h2) 		decreased susceptibility to autoimmune diabetes J:14178
H2h4/H2g7
(NOD.Cg-H2h4) 		decreased susceptibility to autoimmune diabetes J:14178
H2h4/H2h4
(NOD.Cg-H2h4) 		decreased susceptibility to autoimmune diabetes J:14178
H2i5/H2g7
(NOD.Cg-H2i5) 		decreased susceptibility to autoimmune diabetes J:14178
H2i5/H2i5
(NOD.Cg-H2i5) 		decreased susceptibility to autoimmune diabetes J:14178
H2i7/H2g7
(NOD.Cg-H2i7) 		decreased susceptibility to autoimmune diabetes J:14178
H2i7/H2i7
(NOD.Cg-H2i7) 		decreased susceptibility to autoimmune diabetes J:14178
H2k/H2g7
(NOD.Cg-H2k) 		decreased susceptibility to autoimmune diabetes J:14178
H2k/H2k
(NOD.Cg-H2k) 		increased susceptibility to autoimmune diabetes J:14178
H2q/?
Ncf1m1J/Ncf1m1J
(B6.Cg-Ncf1m1J H2q) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:92437
increased susceptibility to experimental autoimmune encephalomyelitis J:92437
increased susceptibility to induced arthritis J:92437
rheumatoid arthritis J:92437
H2q/H2q
Rag1tm1Mom/Rag1tm1Mom
Tg(TcraBDC12-4.1)10Jos/0
Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD) 		decreased susceptibility to autoimmune diabetes J:111874
H2u/H2u
Rag1tm1Mom/Rag1tm1Mom
Tg(Tcra19,Tcrb19)#Stl/0
(either: (involves: 129S7/SvEvBrd * C57BL/6 * PL/J) or (involves: 129S7/SvEvBrd * C57BL/6 * C57BL/10 * PL/J)) 		increased susceptibility to autoimmune disorder J:19795
H2u/H2u
Tg(Tcra19,Tcrb19)#Stl/0
(either: (involves: C57BL/6 * PL/J) or (involves: C57BL/6 * C57BL/10 * PL/J)) 		increased susceptibility to autoimmune disorder J:19795
increased susceptibility to experimental autoimmune encephalomyelitis J:19795
H2u/H2u
Tg(TCRA)B1Jg/?
Tg(TCRB)C14Jg/?
(involves: C57BL/6 * C57BL/10SnSg * DBA/2 * PL/J) 		increased autoantibody level J:92991
increased susceptibility to experimental autoimmune encephalomyelitis J:92991
Havcr1tm1Kuch/Havcr1tm1Kuch
(B6.Cg-Havcr1tm1Kuch) 		autoimmune response J:186484
increased anti-double stranded DNA antibody level J:186484
Hc0/Hc0
Tg(TcrbBL17)1Lmor/0
(involves: DBA/1J * SWR/J) 		decreased susceptibility to induced arthritis J:134111
Hc1/?
Tg(TcrbBL17)1Lmor/0
(involves: DBA/1J * SWR/J) 		increased susceptibility to induced arthritis J:134111
Hcsttm1.1Dnax/Hcsttm1.1Dnax
(involves: C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:148086
Hif1atm3Rsjo/Hif1atm3Rsjo
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		decreased susceptibility to induced arthritis J:107682
Hmox1tm1.1Gkl/Hmox1tm1.1Gkl
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * 129P2/OlaHsd * BALB/cJ * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:148498
HrUSP/HrUSP
(either: (involves: A/J * BALB/c) or (involves: BALB/c * C57BL/6) or (involves: BALB/c * DBA/2)) 		increased susceptibility to autoimmune disorder J:21316
Hrh3Eae8-r/?
(B10.S-H2s/SgMcdJ) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:34892
Hrh3Eae8-r/Hrh3Eae8-r
(involves: B10.S/DvTe * SJL/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:49054
Hrh3Eae8-s/?
(involves: B10.S * SJL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:49054
Hrh3tm1Twl/Hrh3tm1Twl
(B6.129X1-Hrh3tm1Twl) 		increased susceptibility to experimental autoimmune encephalomyelitis J:122269
Hspa13tm1.1Smoc/Hspa13tm1.1Smoc
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S * C57BL/6) 		decreased autoantibody level J:303927
Ica1tm1Mdos/Ica1tm1Mdos
(NOD.129-Ica1tm1Mdos) 		decreased susceptibility to autoimmune diabetes J:83526
Icam1tm1Jcgr/Icam1tm1Jcgr
Tg(INS-Il10)#Sar/0
(NOD.Cg-Icam1tm1Jcgr Tg(INS-Il10)#Sar) 		decreased susceptibility to autoimmune diabetes J:66103
Icostm1Flv/Icostm1Flv
(involves: 129/Sv * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:87123
Icostm1Flv/Icostm1Flv
(NOD.129S1-Icostm1Flv) 		decreased anti-insulin autoantibody level J:131529
decreased autoantibody level J:131529
decreased susceptibility to autoimmune diabetes J:131529
Id3tm1Zhu/Id3tm1Zhu
(involves: 129S4/SvJaeSor) 		increased autoantibody level J:93916
Idd3A/J/Idd3A/J
(NOD.A-Idd3A/J) 		increased susceptibility to autoimmune diabetes J:120349
Idd3C57BL/6/Idd3C57BL/6
(NOD.B6-Idd3C57BL/6) 		decreased susceptibility to autoimmune diabetes J:120349
Idd3CAST/EiJ/Idd3CAST/EiJ
(NOD.CAST-Idd3CAST/EiJ) 		increased susceptibility to autoimmune diabetes J:120349
Idd3CZECHI/EiJ/Idd3CZECHI/EiJ
(NOD.CZECH-Idd3CZECHI/EiJ) 		decreased susceptibility to autoimmune diabetes J:120349
Idd3SWR/J/Idd3SWR/J
(NOD.SWR-Idd3SWR/J) 		increased susceptibility to autoimmune diabetes J:120349
Idd4.3C57L/Idd4.3C57L
(involves: C57L/J * NOD) 		increased susceptibility to autoimmune diabetes J:118951
Idd6.1C3H/HeJ/Idd6.1C3H/HeJ
(involves: C3H/HeJ * NOD) 		decreased susceptibility to autoimmune diabetes J:115021
Idd6.2C3H/HeJ/Idd6.2C3H/HeJ
(involves: C3H/HeJ * NOD) 		decreased susceptibility to autoimmune diabetes J:115021
Idd6.3C3H/HeJ/Idd6.3C3H/HeJ
(involves: C3H/HeJ * NOD) 		decreased susceptibility to autoimmune diabetes J:115021
Idd7NOD/ShiLt/Idd7NOD/ShiLt
(involves: C57BL/6 * NOD/ShiLt) 		abnormal T cell clonal deletion J:131557
Ifih1Rgsc422/Ifih1+
(D2JJcl.B6JJcl-Ifih1Rgsc422) 		autoimmune response J:209917
increased anti-double stranded DNA antibody level J:209917
increased anti-nuclear antigen antibody level J:209917
increased susceptibility to systemic lupus erythematosus J:209917
Ifih1Rgsc422/Ifih1Rgsc422
(D2JJcl.B6JJcl-Ifih1Rgsc422) 		increased susceptibility to systemic lupus erythematosus J:209917
Ifnb1tm1Tl/Ifnb1tm1Tl
(B10.129P2-Ifnb1tm1Tl) 		increased susceptibility to experimental autoimmune encephalomyelitis J:83021
Ifngtm1Ts/Ifngtm1Ts
(NOD.129S7-Ifngtm1Ts) 		abnormal susceptibility to autoimmune disorder J:33427
decreased susceptibility to autoimmune diabetes J:95105
Ifngtm1Ts/Ifngtm1Ts
(NOD.Cg-Ifngtm1Ts Prkdcscid) 		decreased susceptibility to autoimmune diabetes J:72818
Ifngtm1Ts/Ifngtm1Ts
(NOD.129S7(B6)-Ifngtm1Ts/DvsJ) 		decreased susceptibility to autoimmune diabetes J:72818
Ifngtm1Ts/Ifngtm1Ts
(B6.129S7-Ifngtm1Ts/J) 		abnormal immune tolerance J:45665
Ifngtm1Ts/Ifngtm1Ts
(C.129S7-Ifngtm1Ts) 		abnormal immune tolerance J:45665
increased susceptibility to experimental autoimmune encephalomyelitis J:34161
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp) 		decreased anti-double stranded DNA antibody level J:39600
decreased anti-nuclear antigen antibody level J:39600
decreased autoantibody level J:39600
decreased susceptibility to autoimmune disorder J:39600
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * A/WySn * C57BL/10SnSg * Swiss) 		decreased susceptibility to autoimmune disorder J:119207
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd) 		increased susceptibility to experimental autoimmune encephalomyelitis J:38363
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased susceptibility to experimental autoimmune myasthenia gravis J:53577
increased susceptibility to experimental autoimmune uveoretinitis J:99347
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd * DBA/1OlaHsd) 		increased susceptibility to induced arthritis J:40634
Ifngr2tm1Pbro/Ifngr2tm1Pbro
(NOD.129S1-Ifngr2tm1Pbro) 		decreased susceptibility to autoimmune diabetes J:72818
Igh-7tm1Led/Igh-7tm1Led
Lyntm1Ard/Lyntm1Ard
(involves: 129P2/OlaHsd * 129S4/SvJae) 		increased anti-double stranded DNA antibody level J:161523
increased anti-nuclear antigen antibody level J:161523
Igh-Jtm1(CB20)Riho/Igh-J+
(involves: C57BL/10 * DBA/1) 		increased susceptibility to induced arthritis J:179456
Igh-Jtm1(CB20)Riho/Igh-Jtm1(CB20)Riho
(involves: C57BL/10 * DBA/1) 		increased susceptibility to induced arthritis J:179456
Igh-Jtm1.1Lave/Igh-Jtm1.1Lave
Igk-Jtm1.1Lave/Igk-Jtm1.1Lave
(Not Specified) 		abnormal B cell clonal deletion J:179317
Igh-Jtm1Aigl/Igh-J+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:111543
Igh-Jtm1Aigl/Igh-J+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased susceptibility to experimental autoimmune encephalomyelitis J:111543
Igh-Jtm1Aigl/Igh-J+
Mogtm1Dpd/Mogtm1Dpd
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:151335
Igh-Jtm1Aigl/Igh-J+
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:151335
Igh-Jtm1Aigl/Igh-Jtm1Aigl
Tg(H2-Kb-Tcra,-Tcrb)1640Kurs/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N * SJL/J) 		increased autoantibody level J:149511
increased susceptibility to experimental autoimmune encephalomyelitis J:149511
Igh-Jtm2(3H9-VDJ*)Mwg/Igh-J+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		increased anti-double stranded DNA antibody level J:126940
Igh-Jtm2(3H9-VDJ*)Mwg/Igh-J+
(involves: 129P2/OlaHsd * BALB/c) 		increased anti-double stranded DNA antibody level J:131138
Igh-Jtm2(3H9-VDJ*)Mwg/Igh-J+
(B6.129P2-Igh-Jtm2(3H9-VDJ*)Mwg) 		increased anti-double stranded DNA antibody level J:142389
Igh-Jtm3(3H9-VDJ*)Mwg/Igh-Jtm3(3H9-VDJ*)Mwg
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		increased anti-double stranded DNA antibody level J:126940
Ightm1(Ighppc1-5)Cche/Igh+
(B6.Cg-Ightm1(Ighppc1-5)Cche) 		increased autoantibody level J:138356
Ightm1Rbr/Igh+
Tg(IgkHyHEL10)1Rbr/0
Tg(ML5sHEL)5Ccg/0
(involves: C57BL/6 * C57BL/6JSfd) 		abnormal B cell anergy J:132538
Ightm2.1Hws/Ightm2.1Hws
(involves: BALB/c) 		increased anti-nuclear antigen antibody level J:142069
Ighg1em1Wliu/Ighg1em1Wliu
(C57BL/6-Ighg1em1Wliu) 		increased anti-double stranded DNA antibody level J:266937
increased anti-nuclear antigen antibody level J:266937
increased autoantibody level J:266937
Ighmtm1Cgn/Ighm+
(NOD.129S2-Ighmtm1Cgn) 		increased susceptibility to autoimmune diabetes J:37287
Ighmtm1Cgn/Ighm+
Tg(Igh-6/Igh-V125)2Jwt/0
Tg(Igk-C/Igk-V125)1Jwt/0
(NOD.Cg-Ighmtm1Cgn Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt) 		increased susceptibility to autoimmune diabetes J:91865
Ighmtm1Cgn/Ighmtm1Cgn
(NOD.129S2-Ighmtm1Cgn) 		decreased susceptibility to autoimmune diabetes J:37287
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas) 		increased susceptibility to induced arthritis J:157619
Ighmtm1Cgn/Ighmtm1Cgn
(NOD.129S2-Ighmtm1Cgn/DvsJ) 		decreased susceptibility to autoimmune diabetes J:80859
Ighmtm1Cgn/Ighmtm1Cgn
Tg(Igh-VB1-8/Igh-6m)1Mjsk/?
(NODCaj.Cg-Ighmtm1Cgn Tg(Igh-VB1-8/Igh-6m)1Mjsk/FswJ) 		increased susceptibility to autoimmune diabetes J:93190
Ighmtm1Cgn/Ighmtm1Cgn
Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg
(NOD.Cg-Ighmtm1Cgn Tg(IghelMD4)4Ccg/DvsJ) 		decreased susceptibility to autoimmune diabetes J:80859
Ighmtm1Cgn/Ighmtm1Cgn
X/Yaa
(BXSB.129S2(B6)-Ighmtm1Cgn/Dcr) 		decreased susceptibility to systemic lupus erythematosus J:206236
Ighmtm1Msn/Ighmtm1Msn
(involves: 129S/SvEv * C57BL/6) 		increased anti-double stranded DNA antibody level J:111817
increased autoantibody level J:111817
Igktm1Dhu/Igktm1Dhu
Tg(H2-Ea-HA)HACIIAjca/0
Tg(TcraS106-1,TcrbS106-1)TS1SWAjca/0
(C.Cg-Igktm1Dhu Tg(H2-Ea-HA)HACIIAjca Tg(TcraS106-1,TcrbS106-1)TS1SWAjca) 		decreased susceptibility to autoimmune disorder J:209872
Igkrstm1Nemz/Igkrstm1Nemz
Tg(BCL2)22Wehi/?
(involves: 129 * C57BL) 		increased anti-double stranded DNA antibody level J:132125
Igkrstm1Nemz/Igkrstm1Nemz
Tg(UBC-scFv)2Nemz/?
(involves: 129 * C57BL/6 * DBA/2) 		abnormal B cell clonal deletion J:132125
Ikzf3tm1Kge/Ikzf3tm1Kge
(involves: 129S4/SvJae * C57BL/6) 		autoimmune response J:81805
increased anti-double stranded DNA antibody level J:81805
increased anti-histone antibody level J:81805
increased anti-nuclear antigen antibody level J:81805
increased anti-single stranded DNA antibody level J:81805
increased autoantibody level J:81805, J:50626
Ikzf4tm1.1Etms/Ikzf4tm1.1Etms
(Not Specified) 		increased susceptibility to experimental autoimmune encephalomyelitis J:295208
Il1atm1Yiw/Il1atm1Yiw
Il1btm1Yiw/Il1btm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:165513
Il1btm1Lvp/Il1btm1Lvp
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased susceptibility to experimental autoimmune myasthenia gravis J:67001
Il1r1em1Qizh/Il1r1em1Qizh
(C57BL/6-Il1r1em1Qizh) 		increased susceptibility to induced arthritis J:338375
Il1r1tm1Imx/Il1r1tm1Imx
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased susceptibility to experimental autoimmune uveoretinitis J:115094
Il1r1tm1Imx/Il1r1tm1Imx
(B6.129S7-Il1r1tm1Imx/J) 		increased susceptibility to induced arthritis J:125570
Il1r1tm1Imx/Il1r1tm1Imx
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased susceptibility to experimental autoimmune uveoretinitis J:115094
Il1r1tm1Imx/Il1r1tm1Imx
Vsig4tm1Gne/Vsig4tm1Gne
(B6.Cg-Il1r1tm1Imx Vsig4tm1Gne) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:281762
Il1r1tm1Roml/Il1r1tm1Roml
(NOD.Cg-Il1r1tm1Roml) 		decreased susceptibility to autoimmune diabetes J:87251
Il1r1tm1Roml/Il1r1tm1Roml
(involves: 129S1/Sv) 		decreased susceptibility to induced arthritis J:120707
Il1r2tm1Yiw/Il1r2tm1Yiw
(B6.129P2-Il1r2tm1Yiw) 		increased susceptibility to induced arthritis J:274653
Il1rntm1.1Cga/Il1rntm1.1Cga
Lyz2tm1(cre)Ifo/Lyz2+
(D1.Cg-Il1rntm1.1Cga Lyz2tm1(cre)Ifo) 		increased susceptibility to induced arthritis J:162760
Il1rntm1Nick/Il1rntm1Nick
(involves: BALB/cAnNHsd) 		rheumatoid arthritis J:89034
Il1rntm1Nick/Il1rntm1Nick
(involves: BALB/cAnNHsd * C57BL/6) 		rheumatoid arthritis J:89034
Il1rntm1Yiw/Il1rntm1Yiw
(C.129-Il1rntm1Yiw) 		rheumatoid arthritis J:143719
Il1rntm1Yiw/Il1rntm1Yiw
Il17atm1Yiw/Il17a+
(involves: 129P2/OlaHsd * BALB/cA * C57BL/6J) 		decreased susceptibility to induced arthritis J:83408
Il2tm1.1Flv/Il2tm1.1Flv
(NOD/ShiLtJ-Il2tm1.1Flv) 		abnormal susceptibility to autoimmune disorder J:150823
Il2tm1Hor/Il2+
(NOD.129P2(B6)-Il2tm1Hor/DvsJ) 		increased susceptibility to autoimmune diabetes J:120349
Il2tm1Hor/Il2tm1Hor
(C.129P2-Il2tm1Hor) 		increased susceptibility to autoimmune hemolytic anemia J:29799
Il2tm1Hor/Il2tm1Hor
(B6.129P2-Il2tm1Hor/J) 		increased susceptibility to autoimmune disorder J:113547
Il2rbtm1Mak/Il2rbtm1Mak
(either: (involves: 129P2/OlaHsd) or (involves: 129S2/SvPas)) 		increased anti-nuclear antigen antibody level J:25940
increased susceptibility to autoimmune hemolytic anemia J:25940
Il2rbtm1Mak/Il2rbtm1Mak
(B6.129-Il2rbtm1Mak) 		increased anti-double stranded DNA antibody level J:113547
increased susceptibility to autoimmune hemolytic anemia J:113547
Il2rbtm1Mak/Il2rbtm1Mak
(C.129-Il2rbtm1Mak) 		abnormal T cell clonal deletion J:113547
increased anti-double stranded DNA antibody level J:113547
increased susceptibility to autoimmune hemolytic anemia J:113547
Il2rbtm1Mak/Il2rbtm1Mak
(D2.129-Il2rbtm1Mak) 		abnormal T cell clonal deletion J:113547
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(C.129P2/OlaHsd-Il4/Il13tm3Anjm) 		decreased susceptibility to autoimmune disorder J:91403
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(C.129P2/OlaHsd-Il4/Il13tm3Anjm) 		decreased susceptibility to autoimmune disorder J:91403
Il4tm1Cgn/Il4tm1Cgn
(NOD.129P2-Il4tm1Cgn) 		decreased susceptibility to autoimmune disorder J:95105
increased susceptibility to autoimmune disorder J:95105
Il4tm1Cgn/Il4tm1Cgn
(either: NOD.129-Il4tm1Cgn or (involves: 129 * NOD)) 		autoimmune response J:85924
Il4tm1Cgn/Il4tm1Cgn
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(NOD.Cg-Il4tm1Cgn Tg(TcraBDC2.5,TcrbBDC2.5)1Doi) 		decreased susceptibility to autoimmune diabetes J:85924
Il4tm1Kopf/Il4tm1Kopf
Lyntm1Ard/Lyntm1Ard
(involves: 129P2/OlaHsd * 129S2/SvPas) 		increased anti-double stranded DNA antibody level J:161523
increased anti-nuclear antigen antibody level J:161523
Il4tm1Nnt/Il4tm1Nnt
(involves: C57BL/6) 		decreased susceptibility to autoimmune disorder J:91403
Il4tm2Nnt/Il4tm2Nnt
(BALB/c-Il4tm2Nnt/J) 		decreased susceptibility to autoimmune disorder J:141937
Il5ratm1Ktk/Il5ratm1Ktk
Lyntm1Tya/Lyntm1Tya
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-double stranded DNA antibody level J:91089
Il6tm1Kopf/Il6tm1Kopf
(B6.129S2-Il6tm1Kopf/J) 		decreased susceptibility to induced arthritis J:208213
Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv * C57BL/6) 		increased susceptibility to induced arthritis J:142883
Il6sttm1Thir/Il6sttm1Thir
(involves: 129 * C57BL/6) 		abnormal T cell clonal deletion J:133059
increased anti-double stranded DNA antibody level J:133059
increased anti-nuclear antigen antibody level J:133059
increased anti-single stranded DNA antibody level J:133059
increased autoantibody level J:133059
rheumatoid arthritis J:133059
Il9rtm1Jcrd/Il9rtm1Jcrd
(involves: C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:151907
Il10raNZW/Il10ra+
((NZB x NZW)F1) 		increased anti-chromatin antibody level J:102087
Il10ratm1.1Tlg/Il10ratm1.1Tlg
Tg(Cd4-cre)1Cwi/?
(B6.Cg-Tg(Cd4-cre)1Cwi Il10ratm1.1Tlg) 		autoimmune response J:189797
Il12atm1Cab/Il12atm1Cab
Il23atm1.1Thak/Il23atm1.1Thak
(B6.Cg-Il12atm1Cab Il23atm1.1Thak) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:143970
Il12rb2tm1Jm/Il12rb2tm1Jm
(B6;129S1-Il12rb2tm1Jm/J) 		increased anti-nuclear antigen antibody level J:106805
Il13tm1.1Anjm/Il13tm1.1Anjm
(C.129P2-Il13tm1.1Anjm) 		decreased susceptibility to autoimmune disorder J:141937, J:91403
Il13tm2Anjm/Il13tm2Anjm
(B6.129P2-Il13tm2Anjm) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:131969
Il15tm1Imx/Il15tm1Imx
X/Yaa
(BXSB.B6-Il15tm1Imx/Dcr) 		increased susceptibility to systemic lupus erythematosus J:179430
Il17atm1Cdon/Il17atm1Cdon
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:136279
Il17atm1Yiw/Il17atm1Yiw
Il1rntm1Yiw/Il1rntm1Yiw
(involves: 129P2/OlaHsd * BALB/cA * C57BL/6J) 		decreased susceptibility to induced arthritis J:83408
Il17atm1Yiw/Il17atm1Yiw
Il17ftm1Yiw/Il17ftm1Yiw
Il1rntm1Yiw/Il1rntm1Yiw
(involves: 129 * BALB/c) 		rheumatoid arthritis J:143719
Il17atm1Yiw/Il17atm1Yiw
Tg(CD2-Rorc)#Staka/0
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to autoimmune disorder J:230700
Il17ctm1.1Cdon/Il17ctm1.1Cdon
(involves: 129S6/SvEvTac) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:177650
Il17ftm1Cdon/Il17ftm1Cdon
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:136279
Il17ftm1Yiw/Il17ftm1Yiw
Il1rntm1Yiw/Il1rntm1Yiw
(involves: 129 * BALB/c) 		rheumatoid arthritis J:143719
Il17rctm1Lex/Il17rctm1Lex
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:159874
Il21tm1Lex/Il21tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:123351
increased susceptibility to experimental autoimmune encephalomyelitis J:137377
Il21rtm1Kopf/Il21rtm1Kopf
(B6.129-Il21rtm1Kopf) 		increased susceptibility to experimental autoimmune encephalomyelitis J:137377
Il21rtm1Wjl/Il21rtm1Wjl
(NOD.Cg-Il21rtm1Wjl) 		decreased susceptibility to autoimmune diabetes J:139075
Il21rtm1Wjl/Il21rtm1Wjl
X/Yaa
(BXSB.129(Cg)-Il21rtm1Wjl/Dcr) 		decreased susceptibility to systemic lupus erythematosus J:144484
Il23atm1.1Thak/Il23atm1.1Thak
(C57BL/6-Il23atm1.1Thak) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:143970
Il23atm1Dnax/Il23atm1Dnax
(involves: 129 * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:95542
Il23rtm1Kuch/Il23rtm1Kuch
(C57BL/6-Il23rtm1Kuch) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:148248
Il25tm1Dart/Il25tm1Dart
(involves: C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:125296
Il27tm1Cua/Il27tm1Cua
(C57BL/6-Il27tm1Cua) 		increased susceptibility to experimental autoimmune encephalomyelitis J:147706
Il27ratm1Mak/Il27ratm1Mak
(B6.129P2-Il27ratm1Mak) 		decreased susceptibility to experimental autoimmune uveoretinitis J:116610
Il27ratm1Mak/Il27ratm1Mak
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to induced arthritis J:151552
Imh1NZB/Imh1NZB
(involves: NZB * NZW) 		increased susceptibility to systemic lupus erythematosus J:26266
Imh1NZB/Imh1NZW
(involves: NZB * NZW) 		increased susceptibility to systemic lupus erythematosus J:22353
Inpp5dtm1Rav/Inpp5dtm1Rav
Cd79atm1(cre)Reth/Cd79a+
Tg(IghAb36-65)1Wys/0
(involves: 129 * BALB/c * C57BL/6 * FVB/N) 		abnormal B cell anergy J:178833
increased autoantibody level J:178833
Ins1tm1Jja/Ins1tm1Jja
(NOD.129S2-Ins1tm1Jja) 		decreased susceptibility to autoimmune diabetes J:85309
Ins1tm1Jja/Ins1tm1Jja
Ins2tm1Jja/Ins2tm1Jja
Tg(Ins2*Y16A)1Ell/0
(NOD.Cg-Ins1tm1Jja Ins2tm1Jja Tg(Ins2*Y16A)1Ell) 		decreased susceptibility to autoimmune diabetes J:98583
Ins1tm1Jja/Ins1tm1Jja
Ins2tm1Jja/Ins2tm1Jja
Tg(Ins2*Y16A)3Ell/0
(NOD.Cg-Ins1tm1Jja Ins2tm1Jja Tg(Ins2*Y16A)3Ell) 		decreased anti-insulin autoantibody level J:98583
decreased susceptibility to autoimmune diabetes J:98583
Ins1tm1Jja/Ins1tm1Jja
Ins2tm1Mnt/Ins2tm1Mnt
Tg(Aire-cre)1Mnt/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N) 		increased anti-insulin autoantibody level J:152798
Ins1tm1Jja/Ins1tm1Jja
Tg(Ins2*Y16A)1Ell/0
(NOD.Cg-Ins1tm1Jja Tg(Ins2*Y16A)1Ell) 		increased susceptibility to autoimmune diabetes J:98583
Ins1tm1Jja/Ins1tm1Jja
Tg(Ins2*Y16A)3Ell/0
(NOD.Cg-Ins1tm1Jja Tg(Ins2*Y16A)3Ell) 		autoimmune response J:98583
Ins2C95S/Ins2+
(C3HeB/FeJ-Ins2C95S) 		increased susceptibility to autoimmune diabetes J:122098
Ins2C95S/Ins2C95S
(C3HeB/FeJ-Ins2C95S) 		increased susceptibility to autoimmune diabetes J:122098
Ins2tm1Jja/Ins2tm1Jja
(NOD.129S2-Ins2tm1Jja) 		increased anti-insulin autoantibody level J:85309
Ins2tm1Jja/Ins2tm1Jja
Tg(Ins2*Y16A)3Ell/0
(NOD.Cg-Ins2tm1Jja Tg(Ins2*Y16A)3Ell) 		autoimmune response J:98583
increased anti-insulin autoantibody level J:98583
Irak1tm1Jth/Y
(B6.Cg-Irak1tm1Jth) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:82302
Irak1tm1Jth/Irak1tm1Jth
(B6.Cg-Irak1tm1Jth) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:82302
Irak3tm1Flv/Irak3tm1Flv
(NOD.129S1(B6)-Irak3tm1Flv) 		increased anti-insulin autoantibody level J:229884
increased susceptibility to autoimmune diabetes J:229884
Irf1tm1Cwe/Irf1tm1Cwe
(involves: 129/Sv * C57BL/6) 		decreased susceptibility to induced arthritis J:43086
Irf1tm1Cwe/Irf1tm1Cwe
(involves: 129) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:84367
Irs1tm1Mfw/Irs1tm1Mfw
Irs2tm2Mfw/Irs2tm2Mfw
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		increased susceptibility to autoimmune diabetes J:137845
Irs1tm2Tka/Irs1tm2Tka
Irs2tm2Tka/Irs2tm2Tka
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA) 		increased susceptibility to autoimmune diabetes J:137846
Itgavtm2Hyn/Itgavtm2.1Hyn
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * FVB) 		increased autoantibody level J:125508
Itgavtm2Hyn/Itgavtm2.1Hyn
Tg(Tek-cre)1Ywa/?
(involves: 129S2/SvPas * C57BL/6 * FVB * SJL) 		increased autoantibody level J:125508
Itgaxtm1Bll/Itgaxtm1Bll
(B6.129S7-Itgaxtm1Bll) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:122187
Itgb2tm1Bay/Itgb2tm1Bay
Psrs1PL/J/Psrs1PL/J
(B6.Cg-(D10Mit126-D10Mit38) Itgb2tm1Bay) 		rheumatoid arthritis J:134251
Itgb2tm1Bay/Itgb2tm1Bay
Psrs1PL/J/Psrs1PL/J
(B6.Cg-(D10Mit75-D10Mit271) Itgb2tm1Bay) 		rheumatoid arthritis J:134251
Jak1M1Mhda/Jak1+
(C3HeB/FeJ-Jak1M1Mhda) 		increased anti-nuclear antigen antibody level J:199153
Junbtm3Wag/Junbtm3Wag
Tg(KRT5-cre)1Tak/0
(involves: 129/Sv * 129P2/OlaHsd * C3H * C57BL/6) 		increased anti-histone antibody level J:155575
increased susceptibility to systemic lupus erythematosus J:155575
KitW-sh/KitW-sh
Lyntm1Ard/Lyntm1Ard
(involves: 101 * 129P2/OlaHsd * C3H/HeH) 		increased anti-double stranded DNA antibody level J:161523
increased anti-nuclear antigen antibody level J:161523
KitW/KitW-v
((WB KitW x B6.Cg-KitW-v)F1) 		decreased susceptibility to induced arthritis J:178942
Ksr1tm1Shaw/Ksr1tm1Shaw
(Not Specified) 		decreased susceptibility to induced arthritis J:140520
Lag3tm1Daav/Lag3+
Tg(Foxp3-EGFP/cre)1cJbs/0
(NOD.Cg-Lag3tm1Daav Tg(Foxp3-EGFP/cre)1cJbs) 		decreased susceptibility to autoimmune diabetes J:260063
Lag3tm1Daav/Lag3tm1Daav
Tg(Foxp3-EGFP/cre)1cJbs/0
(NOD.Cg-Lag3tm1Daav Tg(Foxp3-EGFP/cre)1cJbs) 		decreased susceptibility to autoimmune diabetes J:260063
Laq1MRL/Laq1MRL
(involves: C57BL/6 * MRL) 		increased susceptibility to autoimmune disorder J:45708
Lat2tm1Mal/Lat2tm1Mal
(B6.129S2-Lat2tm1Mal) 		increased anti-nuclear antigen antibody level J:126321
Lat2tm1Mal/Lat2tm1Mal
Lime1tm1.1Mal/Lime1tm1.1Mal
(involves: 129 * C57BL/6) 		increased anti-nuclear antigen antibody level J:126321
Lat2tm1Wz/Lat2tm1Wz
(B6.Cg-Lat2tm1Wz) 		increased anti-double stranded DNA antibody level J:116157
increased autoantibody level J:116157
Lat2tm2Wz/Lat2tm2Wz
Tg(Lck-cre)548Jxm/0
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:116157
Lattm1.1Lov/Lattm1.1Lov
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased anti-double stranded DNA antibody level J:116157
increased anti-nuclear antigen antibody level J:77099
increased autoantibody level J:77099
Lattm1.1Lov/Lattm1.1Lov
Lat2tm1Wz/Lat2tm1Wz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased anti-double stranded DNA antibody level J:116157
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas) 		increased anti-chromatin antibody level J:125722
increased anti-erythrocyte antigen antibody level J:125722
increased anti-nuclear antigen antibody level J:125722
increased susceptibility to autoimmune hemolytic anemia J:125722
Lbric-J/Lbr+
((NZW/LacJ x C57BL/6J-Lbric-J/J)F1) 		increased anti-chromatin antibody level J:234168
increased anti-nuclear antigen antibody level J:234168
increased autoantibody level J:234168
increased susceptibility to systemic lupus erythematosus J:234168
Lbw2NZB/BlScr/Lbw2NZB/BlScr
(involves: NZB * NZW) 		increased anti-chromatin antibody level J:98150
increased autoantibody level J:98150
Lbw2NZB/BlScr/Lbw2NZW/LacScr
(involves: NZB * NZW) 		increased anti-chromatin antibody level J:98150
increased autoantibody level J:98150
Lbw2NZW/LacScr/Lbw2NZW/LacScr
(involves: NZB * NZW) 		decreased autoantibody level J:98150
Lbw5NZW/LacScr/Lbw5NZB/BlScr
(involves: NZB/BlScr * NZW/LacScr) 		increased susceptibility to systemic lupus erythematosus J:20991
Lbw5NZW/LacScr/Lbw5NZW/LacScr
(involves: NZB/BlScr * NZW/LacScr) 		increased susceptibility to systemic lupus erythematosus J:20991
Lbw6NZW/LacScr/Lbw6NZW/LacScr
(involves: NZB/BlScr * NZW/LacScr) 		increased susceptibility to systemic lupus erythematosus J:20991
Lbw7NZB/BlScr/Lbw7NZB/BlScr
(involves: NZB/BlScr * NZW/LacScr) 		increased susceptibility to systemic lupus erythematosus J:20991
Lbw7NZB/BlScr/Lbw7NZW/LacScr
(involves: NZB/BlScr * NZW/LacScr) 		increased susceptibility to systemic lupus erythematosus J:20991
Lbw8NZB/BlScr/Lbw8NZB/BlScr
(involves: NZB/BlScr * NZW/LacScr) 		increased susceptibility to autoimmune disorder J:20991
Lbw8NZB/BlScr/Lbw8NZW/LacScr
(involves: NZB/BlScr * NZW/LacScr) 		increased susceptibility to autoimmune disorder J:20991
Lcp2twm/Lcp2twm
(C57BL/6JSfdAnu-Lcp2twm/Anu) 		autoimmune response J:104190
Lctlp1FVB/NJ/Lctlp1FVB/NJ
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:122919
Lctlp2FVB/NJ/Lctlp2FVB/NJ
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:122919
Leprdb/Leprdb
(involves: C57BLKS/J) 		increased susceptibility to autoimmune diabetes J:7005
Lgals1tm1Rob/Lgals1tm1Rob
(involves: 129S/SvEv) 		increased susceptibility to experimental autoimmune encephalomyelitis J:123416
Lgals9tm1Glp/Lgals9tm1Glp
(B6.129S6-Lgals9tm1Glp) 		increased susceptibility to induced arthritis J:132889
Lig4tm2.1Fwa/Lig4tm2.1Fwa
(involves: 129S6/SvEvTac) 		increased anti-chromatin antibody level J:157574
increased anti-double stranded DNA antibody level J:157574
ll/ll
X/Yaa
(BXSB/MpJScr-ll) 		decreased anti-nuclear antigen antibody level J:10973
decreased susceptibility to autoimmune disorder J:10973
Lmb1C57BL/6Scr/Lmb1C57BL/6Scr
(involves: C57BL/6-Faslpr * MRL-Faslpr) 		increased anti-double stranded DNA antibody level J:45708
Lmb1C57BL/6Scr/Lmb1MRL/MpScr
(involves: C57BL/6-Faslpr * MRL-Faslpr) 		increased anti-double stranded DNA antibody level J:45708
Lmb2C57BL/6Scr/Lmb2MRL/MpScr
(involves: C57BL/6-Faslpr * MRL-Faslpr) 		increased anti-double stranded DNA antibody level J:45708
Lmb2MRL/MpScr/Lmb2MRL/MpScr
(involves: C57BL/6-Faslpr * MRL-Faslpr) 		increased anti-double stranded DNA antibody level J:45708
Lrch1em1Hwa/Lrch1em1Hwa
(Not Specified) 		increased susceptibility to experimental autoimmune encephalomyelitis J:238772
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(involves: 129/Sv * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:115225
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(B6.129-Lta/Tnftm1Eug) 		decreased susceptibility to induced arthritis J:115034
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(involves: 129/Sv * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:115225
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(B6.129-Lta/Tnftm1Eug) 		decreased susceptibility to induced arthritis J:115034
Lta/Tnftm1Jods/Lta/Tnftm1Jods
(C57BL/6-Lta/Tnftm1Jods) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:47428
Lta/Tnftm1Jods/Lta/Tnftm1Jods
(C57BL/6-Lta/Tnftm1Jods) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:47428
Ltb4r1tm1Bodd/Ltb4r1tm1Bodd
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased susceptibility to autoimmune disorder J:108446
Ltb4r1tm1Bodd/Ltb4r1tm1Bodd
(involves: 129S4/SvJaeSor) 		decreased susceptibility to induced arthritis J:131779
Ltb4r1tm1Bodd/Ltb4r1tm1Bodd
(either: (involves: 129S4/SvJaeSor * BALB/c ) or (involves: 129S4/SvJaeSor * C57BL/6)) 		decreased susceptibility to induced arthritis J:163271
Ltb4r2tm1Bodd/Ltb4r2tm1Bodd
(involves: 129S4/SvJaeSor * C57BL/6) 		decreased susceptibility to induced arthritis J:163271
Ltc4stm1Blam/Ltc4stm1Blam
(C.129S7-Ltc4stm1Blam) 		autoimmune response J:182213
Lxw1BXSB/Scr/?
(involves: BXSB/Scr * NZW/LacScr) 		increased anti-chromatin antibody level J:86924
Lxw3NZW/LacScr/?
(involves: BXSB/Scr * NZW/LacScr) 		increased anti-chromatin antibody level J:86924
Lynmld4/Lynmld4
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:144799
Lyntm1.1Calo/Lyntm1.1Calo
Tg(Itgax-cre)1-1Reiz/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased autoantibody level J:200745
Lyntm1Ard/Lyntm1Ard
(involves: 129P2/OlaHsd) 		increased anti-double stranded DNA antibody level J:161523
increased anti-nuclear antigen antibody level J:161523
Lyntm1Ard/Lyntm1Ard
(B6.129P2-Lyntm1Ard) 		increased anti-double stranded DNA antibody level J:144799
increased anti-nuclear antigen antibody level J:144799
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJae) 		increased anti-double stranded DNA antibody level J:42037
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor) 		increased anti-double stranded DNA antibody level J:146161
increased autoantibody level J:200745
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor * C57BL/6) 		increased anti-double stranded DNA antibody level J:71174
increased susceptibility to systemic lupus erythematosus J:71174
Lyntm1Tya/Lyntm1Tya
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-double stranded DNA antibody level J:29751
Lynweeb/Lynweeb
(C57BL/6-Lynweeb) 		increased anti-double stranded DNA antibody level J:146161
Lyz2tm1(cre)Ifo/Lyz2tm1(cre)Ifo
Nrrostm1Wouy/Nrrostm1Wouy
(involves: 129P2/OlaHsd) 		increased susceptibility to experimental autoimmune encephalomyelitis J:209569
Man2a1tm1Jxm/Man2a1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal self tolerance J:74579
Map4k1tm1Tht/Map4k1tm1Tht
(B6.129S7-Map4k1tm1Tht) 		increased susceptibility to experimental autoimmune encephalomyelitis J:116613
Map4k3Gt(RRO270)Byg/Map4k3Gt(RRO270)Byg
(involves: 129P2/OlaHsd) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:177642
Mapk3tm1Gela/Mapk3tm1Gela
(either: 129(Cg)-Mapk3tm1Gela or B6.129-Mapk3tm1Gela) 		increased susceptibility to experimental autoimmune encephalomyelitis J:107504
Mapk11tm1Jda/Mapk11tm1Jda
Mapk14tm1Jda/Mapk14tm1Jda
(involves: 129 * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:165966
decreased susceptibility to induced arthritis J:165966
Mbpshi/Mbpshi
(involves: BALB/c * C3HeB/Fe * SWV) 		increased susceptibility to experimental autoimmune encephalomyelitis J:48412
Mcph1Tg(HLA-A2.1)1Enge/Mcph1+
(involves: C57BL/6) 		abnormal immune tolerance J:52612
Mcph1Tg(HLA-A2.1)1Enge/Mcph1+
(NOD.B6-Mcph1Tg(HLA-A2.1)1Enge) 		increased susceptibility to autoimmune diabetes J:109851
Mcph1Tg(HLA-A2.1)1Enge/Mcph1Tg(HLA-A2.1)1Enge
(NOD.B6-Mcph1Tg(HLA-A2.1)1Enge) 		increased susceptibility to autoimmune diabetes J:109851
Mertktm1Gkm/Mertktm1Gkm
(NOD.129P2-Mertktm1Gkm) 		decreased susceptibility to autoimmune diabetes J:147153
Mertktm1Gkm/Mertktm1Gkm
(B6.129P2-Mertktm1Gkm) 		decreased autoantibody level J:136377
Mex3btm1.1Mbld/Mex3btm1.1Mbld
Plekha5Tg(AMH-cre)1Flor/Plekha5+
(involves: C57BL/6 * SJL) 		increased anti-sperm antibody level J:213588
Mfge8tm1Osa/Mfge8tm1Osa
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased anti-double stranded DNA antibody level J:225063
Mfge8tm1Osa/Mfge8tm1Osa
Timd4tm1Osa/Timd4tm1Osa
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased anti-double stranded DNA antibody level J:187181
increased anti-nuclear antigen antibody level J:187181
Mir125atm1Smoc/Mir125atm1Smoc
(involves: C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:224880
Mir140tm1.1Asah/Mir140tm1.1Asah
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		increased susceptibility to induced arthritis J:160358
Mir146tm1.1Bal/Mir146tm1.1Bal
(involves: C57BL/6 * FVB/N) 		abnormal immune tolerance J:173671
Mir146tm1.1Lfl/Mir146tm1.1Lfl
Tg(Cr2-cre)3Cgn/0
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:266124
Mir146tm2.1Bal/Mir146tm2.1Bal
(involves: 129S1/Sv * C57BL/6 * FVB/N) 		abnormal immune tolerance J:173671
increased anti-double stranded DNA antibody level J:173671
Mir155tm1.1Rsky/Mir155tm1.1Rsky
(B6.Cg-Mir155tm1Rsky/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:226678
Mir210tm1.1Wtsi/Mir210tm1.1Wtsi
(involves: C57BL/6J * C57BL/6N) 		increased anti-chromatin antibody level J:205868
increased anti-double stranded DNA antibody level J:205868
increased anti-nuclear antigen antibody level J:205868
Mirc33tm1.1Cwh/Mirc33tm1.1Cwh
(involves: 129X1/SvJ) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:189763
Mmdtm1Beij/Mmdtm1Beij
(Not Specified) 		decreased susceptibility to induced arthritis J:304637
Mmp2tm1Ito/Mmp2tm1Ito
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:94099
Mmp9tm1Arnd/Mmp9tm1Arnd
(involves: 129P2/OlaHsd) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:58833
Mmp9tm1Tvu/Mmp9tm1Tvu
(C3N.129S6-Mmp9tm1Tvu) 		decreased susceptibility to induced arthritis J:150311
Mogtm1(cre)Gkl/Mogtm1(cre)Gkl
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(C57BL/6-Mogtm1(cre)Gkl Tg(Tcra2D2,Tcrb2D2)1Kuch) 		increased susceptibility to experimental autoimmune encephalomyelitis J:151335
Mogtm1Dpd/Mogtm1Dpd
(B6.129S2-Mogtm1Dpd) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:85155
Mogtm1Dpd/Mogtm1Dpd
Rag2tm1Cgn/Rag2tm1Cgn
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:151335
Mogtm1Dpd/Mogtm1Dpd
Tg(H2-Kb-Tcra,-Tcrb)1640Kurs/0
(SJL.Cg-Mogtm1Dpd Tg(H2-Kb-Tcra,-Tcrb)1640Kurs) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:149511
Mogtm1Dpd/Mogtm1Dpd
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:151335
Mogtm1Reid/Mogtm1Reid
(B6.129S1/Sv-Mogtm1Reid) 		increased susceptibility to experimental autoimmune encephalomyelitis J:86663
Mogtm1Reid/Mogtm1Reid
(129/Sv-Mogtm1Reid) 		increased susceptibility to experimental autoimmune encephalomyelitis J:86663
Mpgtm1Lds/Mpgtm1Lds
(involves: 129P2/OlaHsd * C57BL/6) 		autoimmune response J:118148
decreased susceptibility to autoimmune diabetes J:118148
Mpotm1Lus/Mpotm1Lus
(involves: 129X1/SvJ * C57BL/6J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:102965
Mpztm1Msch/Mpz+
(B6.129S7-Mpztm1Msch) 		autoimmune response J:59319
Mr1tm1Gfn/Mr1tm1Gfn
(B6.129P2-Mr1tm1Gfn) 		increased susceptibility to experimental autoimmune encephalomyelitis J:112657
Mt1tm1Bri/Mt1tm1Bri
Mt2tm1Bri/Mt2tm1Bri
(involves: 129S7/SvEvBrd) 		increased susceptibility to experimental autoimmune encephalomyelitis J:103102
mt-Nd2m1
(ALR/Lt) 		decreased susceptibility to autoimmune diabetes J:117602, J:97969
Mta2tm1.1Yzha/Mta2tm1.1Yzha
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		increased anti-double stranded DNA antibody level J:137101
increased autoantibody level J:137101
increased susceptibility to systemic lupus erythematosus J:137101
Mtus1Gt(RRA048)Byg/Mtus1Gt(RRA048)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to systemic lupus erythematosus J:212144
Mtv7BALB/c/Mtv7BALB/c
(involves: B10.Q * BALB/c * DBA/2) 		increased susceptibility to induced arthritis J:27701
Mtv7BALB/c/Mtv7DBA/2
(involves: B10.Q * BALB/c * DBA/2) 		decreased susceptibility to induced arthritis J:27701
Mtv7DBA/2/Mtv7DBA/2
(C.D2-Mtv7DBA/2) 		decreased susceptibility to induced arthritis J:27701
Muc19sld/Muc19sld
(NFS/N-Muc19sld) 		increased susceptibility to autoimmune disorder J:216958, J:20364
Myd88tm1Aki/Myd88tm1Aki
(involves: 129P2/OlaHsd) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:105435
Myd88tm1Aki/Myd88tm1Aki
(C.129P2-Myd88tm1Aki) 		decreased susceptibility to induced arthritis J:178054
Myd88tm1Aki/Myd88tm1Aki
Tanktm1Aki/Tanktm1Aki
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		increased anti-double stranded DNA antibody level J:151757
Myl3tm1a(EUCOMM)Hmgu/Myl3tm1a(EUCOMM)Hmgu
Tg(Col2a1-cre/ERT)KA3Smac/0
(involves: C57BL/6J * C57BL/6N * FVB/N) 		increased susceptibility to induced arthritis J:343166
Nba4NZB/Nba4NZB
(involves: NZB * SWR) 		increased anti-double stranded DNA antibody level J:96060
increased anti-histone antibody level J:96263
increased anti-single stranded DNA antibody level J:96060
Nba4NZB/Nba4SWR
(involves: NZB * SWR) 		increased anti-histone antibody level J:96263
Nba10NZB/?
(involves: C57BL/6 * NZB * SB/Le) 		increased anti-chromatin antibody level J:95829
increased anti-double stranded DNA antibody level J:95829
Nba10NZB/Nba10NZB
Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J * NZB) 		increased anti-chromatin antibody level J:134128
increased anti-double stranded DNA antibody level J:134128
increased susceptibility to systemic lupus erythematosus J:134128
Nba10NZB/Nba10NZB
Tlr7tm1Aki/Y
X/Yaa
(B6.Cg-Nba10NZB Tlr7tm1Aki Yaa) 		increased anti-chromatin antibody level J:137656
Nba10NZB/Nba10NZB
X/Yaa
(C57BL/6-Nba2 Yaa) 		increased anti-chromatin antibody level J:137656
increased anti-nuclear antigen antibody level J:95829
increased autoantibody level J:137656
increased susceptibility to autoimmune disorder J:95829
Nba12NZB/Nba12NZB
(involves: NZB * SWR) 		increased anti-double stranded DNA antibody level J:96263
Nba12NZB/Nba12SWR
(involves: NZB * SWR) 		increased anti-double stranded DNA antibody level J:96263
Nbwa1NZB/?
(involves: BALB/c * NZB * NZW) 		increased anti-chromatin antibody level J:88464
increased anti-double stranded DNA antibody level J:88464
increased anti-single stranded DNA antibody level J:88464
increased susceptibility to systemic lupus erythematosus J:88464
Nbwa2NZB/?
(involves: BALB/c * NZB * NZW) 		increased susceptibility to systemic lupus erythematosus J:88464
Nbwa2NZW/?
(involves: BALB/c * NZB * NZW) 		increased anti-double stranded DNA antibody level J:88464
increased susceptibility to systemic lupus erythematosus J:88464
Ncf2tm1b(EUCOMM)Wtsi/Ncf2+
(NZM2328.B6(Cg)-Ncf2tm1b(EUCOMM)Wtsi) 		increased anti-double stranded DNA antibody level J:260777
increased susceptibility to systemic lupus erythematosus J:260777
Ncf2tm1b(EUCOMM)Wtsi/Ncf2tm1b(EUCOMM)Wtsi
(NZM2328.B6(Cg)-Ncf2tm1b(EUCOMM)Wtsi) 		increased anti-double stranded DNA antibody level J:260777
increased susceptibility to systemic lupus erythematosus J:260777
Ndst2tm1Rls/Ndst2tm1Rls
(B6.Cg-Ndst2tm1Rls) 		decreased susceptibility to induced arthritis J:142880
Nek7M1Btlr/Nek7M1Btlr
(C57BL/6J-Nek7M1Btlr) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:226677
Nfatc1tm1.1Fbs/Nfatc1tm1.1Fbs
(C57BL/6-Nfatc1tm1.1Fbs) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:305649
Nfatc1tm1Rao/Nfatc1tm1Rao
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:177319
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * ICR) 		increased anti-double stranded DNA antibody level J:104016
increased anti-nuclear antigen antibody level J:104016
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6) 		increased susceptibility to experimental autoimmune uveoretinitis J:150597
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk
(B6.129X1-Nfe2l2tm1Ywk) 		increased anti-double stranded DNA antibody level J:165602
Nfil3tm1.1Kubo/Nfil3tm1.1Kubo
(B6.Cg-Nfil3tm1.1Kubo) 		increased susceptibility to experimental autoimmune encephalomyelitis J:172134
Nfkb1tm1Bal/Nfkb1tm1Bal
(B6;129P-Nfkb1tm1Bal/J) 		decreased susceptibility to autoimmune diabetes J:118907
Nfkb2Lym1/Nfkb2Lym1
(involves: BALB/c) 		autoimmune response J:154812
Nfkbiatm1.1Pjc/Nfkbiatm1.1Pjc
(involves: C57BL/6) 		autoimmune response J:163686
increased anti-insulin autoantibody level J:163686
increased anti-nuclear antigen antibody level J:163686
Nfkbibtm1Bal/Nfkbibtm1Bal
(B6.129S1-Nfkbibtm1Bal) 		decreased susceptibility to induced arthritis J:163302
Ngfrtm1Jae/Ngfrtm1Jae
(B6.129S4-Ngfrtm1Jae) 		increased susceptibility to experimental autoimmune encephalomyelitis J:112769
Ninj1tm1Gto/Ninj1+
(B6.129P2-Ninj1tm1Gto) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:209516
Ninj1tm1Gto/Ninj1tm1Gto
(B6.129P2-Ninj1tm1Gto) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:209516
Nlrp3M6Btlr/Nlrp3M6Btlr
(C57BL/6J-Nlrp3M6Btlr) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:226677
Nlrp3tm1Wstr/Nlrp3+
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:150053
Nlrp3tm2Hhf/Nlrp3tm2Hhf
Vsig4tm1Gne/Vsig4tm1Gne
(B6.Cg-Nlrp3tm2Hhf Vsig4tm1Gne) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:281762
Nlrp10tm1Seis/Nlrp10tm1Seis
(B6.Cg-Nlrp10tm1Seis) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:183989
Nod2tm1Flv/Nod2tm1Flv
(C.129S1-Nod2tm1Flv) 		decreased susceptibility to induced arthritis J:178054
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd * PL/J) 		increased susceptibility to experimental autoimmune encephalomyelitis J:46192
Nr3c1tm2.1Gsc/Nr3c1+
(B6.129P2-Nr3c1tm2.1Gsc) 		increased susceptibility to experimental autoimmune encephalomyelitis J:137157
Nr3c1tm2Gsc/Nr3c1tm2Gsc
Tg(Lck-cre)I57Jxm/0
(B6.Cg-Nr3c1tm2Gsc Tg(Lck-cre)I57Jxm) 		increased susceptibility to experimental autoimmune encephalomyelitis J:137157
Nrrostm1Lex/Nrrostm1Lex
(B6.129S5-Nrrostm1Lex) 		increased susceptibility to experimental autoimmune encephalomyelitis J:209569
Nudt7em1Ejj/Nudt7em1Ejj
(involves: C57BL/6N) 		increased susceptibility to induced arthritis J:266261
Nwa2NZW/LacJ/Nwa2NZW/LacJ
(involves: BALB/cJ * NZW/LacJ) 		increased anti-histone antibody level J:35434
increased anti-single stranded DNA antibody level J:35434
Otub1tm1c(EUCOMM)Hmgu/Otub1tm1c(EUCOMM)Hmgu
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N) 		increased anti-double stranded DNA antibody level J:280549
increased anti-nuclear antigen antibody level J:280549
increased susceptibility to autoimmune disorder J:280549
increased susceptibility to systemic lupus erythematosus J:280549
Paam1MRL/MpJ/Paam1MRL/MpJ
(involves: C3H/HeJ * MRL/MpJ) 		increased susceptibility to autoimmune disorder J:76107
Paam2MRL/MpJ/Paam2MRL/MpJ
(involves: C3H/HeJ * MRL/MpJ) 		increased susceptibility to autoimmune disorder J:76107
Padi2tm1Lex/Padi2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		autoimmune response J:190651
Panx3tm1c(KOMP)Wtsi/Panx3tm1c(KOMP)Wtsi
Tg(Col2a1-cre)1Star/0
(involves: C3H * C57BL/6 * C57BL/6J * C57BL/6N) 		decreased susceptibility to induced arthritis J:233542
Panx3tm1d(KOMP)Wtsi/Panx3tm1d(KOMP)Wtsi
(involves: BALB/cJ * C3H * C57BL/6 * C57BL/6N) 		decreased susceptibility to induced arthritis J:233542
Pbat1BXSB/Slc/Pbat1BXSB/Slc
(involves: BXSB/Slc * NZW/Slc) 		increased autoantibody level J:49899
Pbat1BXSB/Slc/Pbat1NZW/Slc
(involves: BXSB/Slc * NZW/Slc) 		increased autoantibody level J:49899
Pbat2BXSB/Slc/Pbat2BXSB/Slc
(involves: BXSB/Slc * NZW/Slc) 		increased autoantibody level J:49899
Pbat2BXSB/Slc/Pbat2NZW/Slc
(involves: BXSB/Slc * NZW/Slc) 		increased autoantibody level J:49899
Pdcd1tm1.1Shr/Pdcd1tm1.1Shr
Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6) 		abnormal immune tolerance J:153040
increased susceptibility to autoimmune diabetes J:153040
Pdcd1tm1Hon/Pdcd1tm1Hon
(C.129S2(B6)-Pdcd1tm1Hon) 		increased autoantibody level J:66979
Pdcd1tm1Hon/Pdcd1tm1Hon
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S2/SvPas) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:140751
Pdcd1tm1Hon/Pdcd1tm1Hon
Vsirtm1Lex/Vsirtm1Lex
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S2/SvPas * 129S5/SvEvBrd * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:222944
Pdcd1tm1Llc/Pdcd1tm1Llc
(involves: 129S5/SvEvBrd) 		increased susceptibility to experimental autoimmune encephalomyelitis J:126829
Pdcd1lg2tm3Shr/Pdcd1lg2tm3Shr
(involves: C57BL/6 * NOD/MrkTac) 		increased susceptibility to autoimmune diabetes J:123785
Pdcd4tm1Yhcn/Pdcd4tm1Yhcn
(B6.129S6-Pdcd4tm1Yhcn) 		decreased susceptibility to autoimmune diabetes J:120583
decreased susceptibility to experimental autoimmune encephalomyelitis J:120583
Pecam1tm1Mak/Pecam1+
(D1.129P2-Pecam1tm1Mak) 		increased susceptibility to induced arthritis J:106275
Pecam1tm1Mak/Pecam1tm1Mak
(D1.129P2-Pecam1tm1Mak) 		increased susceptibility to induced arthritis J:106275
Pgam1tm1.1Hiko/Pgam1tm1.1Hiko
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:293746
Pgap3tm1.1Ymra/Pgap3tm1.1Ymra
(involves: 129 * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:181221
Pgap3tm1.1Ymra/Pgap3tm1.1Ymra
(B6.Cg-Pgap3tm1.1Ymra) 		increased anti-double stranded DNA antibody level J:203443
increased anti-single stranded DNA antibody level J:203443
Pgia1BALB/cCrl/Pgia1DBA/2Crl
(involves: BALB/cCrl * DBA/2Crl) 		increased autoantibody level J:66460
increased susceptibility to autoimmune disorder J:66460
Pgia2BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased autoantibody level J:66460
Pgia3DBA/2Crl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased autoantibody level J:66460
Pgia4BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased autoantibody level J:66460
Pgia6BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased autoantibody level J:66460
Pgia7BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased autoantibody level J:66460
Pgia8DBA/2/Pgia8DBA/2
(C.D2-(D15Mit12-D15Mit267)) 		decreased susceptibility to induced arthritis J:137478
Pgia8DBA/2/Pgia8DBA/2
(involves: BALB/c * DBA/2) 		decreased susceptibility to induced arthritis J:137478
Pgia9DBA/2/Pgia9DBA/2
(C.D2-(D15Mit267-D15Mit41)) 		decreased susceptibility to induced arthritis J:137478
Pgia9DBA/2/Pgia9DBA/2
(involves: BALB/c * DBA/2) 		decreased susceptibility to induced arthritis J:137478
Pgia10BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased autoantibody level J:66460
Pgia11BALB/cCrl/?
(involves: BALB/cCrl * DBA/2Crl) 		increased autoantibody level J:66460
Pgia13C3H/HeJCr/Pgia13C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6) 		increased susceptibility to induced arthritis J:65424
Pgia14C3H/HeJCr/Pgia14C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6) 		increased susceptibility to induced arthritis J:65424
Pgia15C3H/HeJCr/Pgia15C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6) 		increased susceptibility to induced arthritis J:65424
Pgia16C3H/HeJCr/Pgia16C3H/HeJCr
(involves: C3H/HeJCr * C57BL/6) 		increased susceptibility to autoimmune disorder J:65424
Pgia39DBA/2Crl/Pgia39DBA/2Crl
Pgia6DBA/2Crl/Pgia6DBA/2Crl
(involves: BALB/cCrl * DBA/2Crl) 		increased susceptibility to induced arthritis J:84150
Pgia39DBA/2Crl/Pgia39DBA/2Crl
Pgia26BALB/cCrl/Pgia26BALB/cCrl
(involves: BALB/cCrl * DBA/2Crl) 		increased susceptibility to induced arthritis J:84150
Pgis1DBA/2/Pgis1DBA/2
(involves: BALB/c * DBA/2) 		increased susceptibility to induced arthritis J:107496
Pgis1DBA/2/Pgis1DBA/2
Pgis2BALB/c/Pgis2BALB/c
(involves: BALB/c * DBA/2) 		increased susceptibility to induced arthritis J:107496
Pgis1DBA/2/Pgis1DBA/2
Pgis2BALB/c/Pgis2DBA/2
(involves: BALB/c * DBA/2) 		increased susceptibility to induced arthritis J:107496
Pgis2BALB/c/Pgis2BALB/c
(involves: BALB/c * DBA/2) 		increased susceptibility to induced arthritis J:107496
Pgis2BALB/c/Pgis2DBA/2
(involves: BALB/c * DBA/2) 		increased susceptibility to induced arthritis J:107496
Pglyrp1tm1Rdz/Pglyrp1tm1Rdz
(C.129S-Pglyrp1tm1Rdz) 		increased susceptibility to induced arthritis J:178054
Pglyrp1tm1Rdz/Pglyrp1tm1Rdz
Pglyrp2tm1Rdz/Pglyrp2tm1Rdz
(C.129S-Pglyrp1tm1Rdz Pglyrp2tm1Rdz) 		decreased susceptibility to induced arthritis J:178054
Pglyrp2tm1Rdz/Pglyrp2tm1Rdz
(C.129S-Pglyrp2tm1Rdz) 		decreased susceptibility to induced arthritis J:178054
Pik3c2aGt(OST288105)Lex/Pik3c2aGt(OST288105)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased anti-double stranded DNA antibody level J:169710
Pik3cdtm1Tnr/Pik3cdtm1Tnr
(B6.129S4-Pik3cdtm1Tnr) 		decreased susceptibility to induced arthritis J:134324
Pik3cdtm1Tnr/Pik3cdtm1Tnr
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(B6.129-Pik3cdtm1Tnr Pik3cgtm1Pngr) 		decreased susceptibility to induced arthritis J:134324
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(B6.129P2-Pik3cgtm1Pngr) 		decreased susceptibility to induced arthritis J:134324
Pkn1tm1Kik/Pkn1tm1Kik
(B6.129P2-Pkn1tm1Kik) 		increased anti-double stranded DNA antibody level J:193187
Pla1aem1Appsc/Pla1aem1Appsc
(C57BL/6J-Pla1aem1Appsc) 		decreased susceptibility to induced arthritis J:333902
Pla2g4atm1Tksh/Pla2g4atm1Tksh
(B6.129P2-Pla2g4atm1Tksh) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:107430
Plautm1Mlg/Plautm1Mlg
(B6.Cg-Plautm1Mlg) 		decreased susceptibility to induced arthritis J:75303
Plcg1tm1Gcrp/Plcg1tm1Rwen
Tg(Cd4-cre)1Cwi/0
(either: B6.Cg-Plcg1tm1Gcrp/Plcg1tm1Rwen Tg(Cd4-cre)1Cwi or (involves: 129X1/SvJ * C57BL/6 * DBA/2)) 		increased anti-double stranded DNA antibody level J:157757
Plcg2tm1Jni/Plcg2tm1Jni
(involves: 129P2/OlaHsd) 		decreased susceptibility to induced arthritis J:157619
Plcl2tm1Tta/Plcl2tm1Tta
(involves: 129P2/OlaHsd) 		increased anti-nuclear antigen antibody level J:85960
Pld4thss/Pld4thss
(BALB/cJ-Pld4thss/GrsrJ) 		increased anti-nuclear antigen antibody level J:278304
plt/plt
(either: B6.DDD-plt or C.DDD-plt) 		increased susceptibility to autoimmune disorder J:110910
Polbtm1.1Jbsw/Polb+
(involves: 129/Sv * C57BL/6) 		increased anti-nuclear antigen antibody level J:206872
Polbtm1.1Jbsw/Polbtm1.1Jbsw
(involves: 129/Sv * C57BL/6) 		increased anti-nuclear antigen antibody level J:206872
increased susceptibility to systemic lupus erythematosus J:206872
Ppargtm1.1Gonz/Ppargtm1.1Gonz
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6) 		increased anti-double stranded DNA antibody level J:168799
increased anti-nuclear antigen antibody level J:168799
increased anti-single stranded DNA antibody level J:168799
increased autoantibody level J:168799
Ppargtm1Tka/Pparg+
(involves: C57BL/6 * CBA * ICR) 		increased susceptibility to induced arthritis J:58222
Ppargtm2Rev/Ppargtm2Rev
Tg(Cd4-cre)1Cwi/?
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased susceptibility to experimental autoimmune encephalomyelitis J:153358
Prdm1tm1Clme/Prdm1tm1Clme
Tg(Itgax-cre)1-1Reiz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		increased anti-double stranded DNA antibody level J:178876
increased anti-nuclear antigen antibody level J:178876
increased autoantibody level J:178876
Prf1tm1Clrk/Prf1tm1Clrk
(involves: 129S7/SvEvBrd * BALB/c * NOD) 		decreased susceptibility to autoimmune diabetes J:64051
Prf1tm1Clrk/Prf1tm1Clrk
Tg(INS-Il10)#Sar/0
(involves: 129S7/SvEvBrd * BALB/c * NOD) 		decreased susceptibility to autoimmune diabetes J:64051
Prf1tm1Sdz/Prf1+
(NOD.B6-Prf1tm1Sdz) 		decreased susceptibility to autoimmune diabetes J:43468
Prf1tm1Sdz/Prf1tm1Sdz
(NOD.B6-Prf1tm1Sdz) 		decreased susceptibility to autoimmune diabetes J:43468
Prf1tm1Sdz/Prf1tm1Sdz
X/Yaa
(BXSB.B6-Prf1tm1Sdz/Dcr) 		autoimmune response J:179430
Prkcdtm1Kin/Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-chromatin antibody level J:76135
Prkcdtm1Qxu/Prkcdtm1Qxu
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-nuclear antigen antibody level J:76134
Prkcdtm1Qxu/Prkcdtm1Qxu
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal self tolerance J:76134
autoimmune response J:76134
Prkcitm1Rfar/Prkci+
Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		increased susceptibility to autoimmune diabetes J:123964
Prkcqtm1Litt/Prkcqtm1Litt
(B6.129P2-Prkcqtm1Litt) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:129421
Prkcqtm1Litt/Prkcqtm1Litt
Tg(TcrLCMV)327Sdz/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		abnormal T cell anergy J:123989
Prkdcscid/Prkdcscid
Tg(Ins2-Fasl)24Ach/0
(NOD.Cg-Prkdcscid Tg(Ins2-Fasl)24Ach) 		decreased susceptibility to autoimmune diabetes J:81416
increased susceptibility to autoimmune diabetes J:81416
Prkdcscid/Prkdcscid
Tg(INS-Il10)#Sar/0
(NOD.Cg-Prkdcscid Tg(INS-Il10)#Sar) 		increased susceptibility to autoimmune diabetes J:66103
Prkdcscid/Prkdcscid
Tg(TcraAI4)1Dvs/0
Tg(TcrbAI4)1Dvs/0
(NOD.Cg-Prkdcscid Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs) 		increased susceptibility to autoimmune diabetes J:93553
Psen1tm1Bdes/Psen1+
Psen2tm1Bdes/Psen2tm1Bdes
(involves: 129P2/OlaHsd) 		autoimmune response J:91235
increased anti-single stranded DNA antibody level J:91235
increased susceptibility to autoimmune disorder J:91235
Psmb11tm1(Psmb8)Khog/Psmb11tm1(Psmb8)Khog
(involves: C57BL/6) 		abnormal self tolerance J:196156
Pstpip2Lupo/Pstpip2Lupo
(either: (involves: C3HeB/FeJ) or (involves: C3HeB/FeJ * C57BL/6J)) 		increased autoantibody level J:125785
Pstpip2m1Bcs/Pstpip2m1Bcs
(involves: C57BL/6) 		autoimmune response J:196534
Ptger4tm1Bhk/Ptger4tm1Bhk
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased susceptibility to induced arthritis J:78964
rheumatoid arthritis J:78964
Ptgs1tm1Unc/Ptgs1tm1Unc
(B6.129P2-Ptgs1tm1Unc) 		decreased susceptibility to induced arthritis J:110716
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6.129P2-Ptgs2tm1Unc) 		decreased susceptibility to induced arthritis J:110716
Ptpn6m1Btlr/Ptpn6m1Btlr
(C57BL/6J-Ptpn6m1Btlr/Mmucd) 		increased anti-chromatin antibody level J:142845
Ptpn6me-v/Ptpn6me-v
(C57BL/6J-Ptpn6me-v) 		rheumatoid arthritis J:20845
Ptpn6me/Ptpn6me
(C57BL/6J-Ptpn6me/J) 		autoimmune response J:5579
Ptpn6me/Ptpn6me
(involves: C3H/HeN * C57BL/6J * NFS) 		increased autoantibody level J:30994
Ptpn12tm1Vei/Ptpn12tm1Vei
Tg(Lck-cre)1Cwi/0
(B6.Cg-Ptpn12tm1Vei Tg(Lck-cre)1Cwi) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:163910
Ptpn22tm1.1Draw/Ptpn22+
(involves: 129 * C57BL/6) 		autoimmune response J:201448
increased anti-double stranded DNA antibody level J:201448
Ptpn22tm1.1Draw/Ptpn22tm1.1Draw
(involves: 129 * C57BL/6) 		autoimmune response J:201448
increased anti-double stranded DNA antibody level J:201448
increased anti-insulin autoantibody level J:201448
Ptpn22tm2Achn/Ptpn22tm2Achn
Ptprctm1Weis/Ptprctm1Weis
(B6.Cg-Ptprctm1Weis Ptpn22tm2Achn) 		increased autoantibody level J:147129
Ptprctm1Weis/Ptprc+
(involves: 129X1/SvJ * C57BL/6) 		increased anti-double stranded DNA antibody level J:66501
increased susceptibility to autoimmune disorder J:66501
Ptprctm1Weis/Ptprctm1Weis
(involves: 129X1/SvJ * C57BL/6) 		increased anti-double stranded DNA antibody level J:66501
increased susceptibility to autoimmune disorder J:66501
Ptprntm1Aln/Ptprntm1Aln
(NOD.129S4-Ptprntm1Aln) 		increased susceptibility to autoimmune diabetes J:107161
Ptprz1tm1Schl/Ptprz1tm1Schl
(involves: 129 * Swiss Webster) 		increased susceptibility to experimental autoimmune encephalomyelitis J:79860
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd * C57BL/6) 		autoimmune response J:138466
Rag1tm1Mom/Rag1tm1Mom
Tg(TcraAI4)1Dvs/0
Tg(TcrbAI4)1Dvs/0
(NOD.Cg-Rag1tm1Mom Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs/Dvs) 		increased susceptibility to autoimmune diabetes J:94192
Rag1tm1Mom/Rag1tm1Mom
Tg(TcraBDC12-4.1)10Jos/0
Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD) 		increased susceptibility to autoimmune diabetes J:111874
Rag1tm1Mom/Rag1tm1Mom
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6) 		rheumatoid arthritis J:54056
Rag2tm1.1Cgn/Rag2tm1.1Cgn
Tg(HLA-DR2)#Lfug/0
Tg(TCROb.1A12)#Lfug/0
(involves: C57BL/6 * DBA/2) 		autoimmune response J:134764
Rasgrp1lag/Rasgrp1lag
(involves: 129 * C57BL/6) 		increased susceptibility to systemic lupus erythematosus J:85189
Rasgrp1m1Anu/Rasgrp1+
(involves: C57BL/6JSfdAnu * CBA/J) 		increased anti-nuclear antigen antibody level J:207898
Rasgrp1m1Anu/Rasgrp1m1Anu
(C57BL/6JSfdAnu-Rasgrp1m1Anu) 		autoimmune response J:104190
Rasgrp1m1Anu/Rasgrp1m1Anu
(involves: C57BL/6JSfdAnu * CBA/J) 		increased anti-nuclear antigen antibody level J:207898
Rasgrp1tm1.1Wz/Rasgrp1tm1.1Wz
(B6.Cg-Rasgrp1tm1.1Wz) 		increased autoantibody level J:225109
Rasgrp4tm1(cre)Rls/Rasgrp4tm1(cre)Rls
(C57BL/6-Rasgrp4tm1(cre)Rls) 		decreased susceptibility to induced arthritis J:186519
Rassf5tm1Kina/Rassf5tm1Kina
(B6.Cg-Rassf5tm1Kina) 		increased anti-double stranded DNA antibody level J:168749
Rc3h1san/Rc3h1san
(either: C57BL/6JSfdAnu-Rc3h1san/Anu or (involves: C57BL/6JSfdAnu * CBA/Ca)) 		increased anti-double stranded DNA antibody level J:98938
increased anti-nuclear antigen antibody level J:98938
Reltm1Hcl/Reltm1Hcl
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to autoimmune diabetes J:118907
decreased susceptibility to experimental autoimmune encephalomyelitis J:79107
Rftn1tm1Ayos/Rftn1tm1Ayos
(B6.Cg-Rftn1tm1Ayos) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:150299
Rnaseh2bem1Anu/Rnaseh2b+
Tlr7em2Anu/Tlr7+
(C57BL/6NCrl-Rnaseh2bem1Anu Tlr7em2Anu) 		increased autoantibody level J:324448
Rnf128tm1.1Flv/Y
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal peripheral T cell anergy J:153216
Rnf128tm1.1Flv/Y
Tg(TcraTcrb)425Cbn/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6) 		abnormal peripheral T cell anergy J:153216
Rnf128tm1.1Flv/Rnf128tm1.1Flv
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal peripheral T cell anergy J:153216
Rnf128tm1.1Flv/Rnf128tm1.1Flv
Tg(TcraTcrb)425Cbn/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6) 		abnormal peripheral T cell anergy J:153216
Rnf128tm1Cdon/Rnf128+
(involves: 129 * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:160681
Rnf128tm1Cdon/Rnf128tm1Cdon
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:160681
Rnf128tm1Cdon/Rnf128tm1Cdon
(involves: 129 * C57BL/6) 		abnormal immune tolerance J:160681
increased anti-double stranded DNA antibody level J:160681
increased susceptibility to experimental autoimmune encephalomyelitis J:160681
Rnf128tm1Cdon/Rnf128tm1Cdon
Tg(TcraTcrb)425Cbn/0
(involves: 129 * BALB/c * C57BL/6) 		abnormal immune tolerance J:160681
Ro60tm1Woln/Ro60+
(involves: 129S1/Sv * C57BL/6) 		increased anti-nuclear antigen antibody level J:84627
Ro60tm1Woln/Ro60tm1Woln
(involves: 129S1/Sv * C57BL/6) 		increased anti-chromatin antibody level J:84627
increased anti-double stranded DNA antibody level J:84627
increased anti-histone antibody level J:84627
increased anti-nuclear antigen antibody level J:84627
increased anti-single stranded DNA antibody level J:84627
Rorctm1.1Zsun/Rorctm1.1Zsun
(B6(129S4)-Rorctm1.1Zsun) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:248565
Rorctm1Litt/Rorctm1Litt
(involves: 129P2/OlaHsd) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:248565
Rpl13atm1.1Jesc/Rpl13atm1.1Jesc
(NOD.129S5(Cg)-Rpl13atm1.1Jesc) 		decreased susceptibility to autoimmune diabetes J:237822
Rr17tm1.1Cdon/Rr17tm1.1Cdon
(involves: 129S6/SvEvTac * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:181186
Rragcem1Efe/Rragc+
Tg(Vav-BCL2)69Jad/0
(Not Specified) 		decreased susceptibility to autoimmune disorder J:320567
Rthyd1NOD/MrkTac/?
(involves: B10.Br/SgSnJ * NOD-H2k) 		abnormal T cell clonal deletion J:94684
Rthyd2B10.Br/SgSnJ/?
(involves: B10.Br/SgSnJ * NOD-H2k) 		abnormal T cell clonal deletion J:94684
Rthyd3B10.Br/SgSnJ/?
(involves: B10.Br/SgSnJ * NOD-H2k) 		abnormal T cell clonal deletion J:94684
Rthyd5NOD/MrkTac/?
(involves: B10.Br/SgSnJ * NOD-H2k) 		abnormal T cell clonal deletion J:94684
Rubcnem1Dgre/Rubcnem1Dgre
(involves: C57BL/6 * C57BL/6N) 		increased anti-double stranded DNA antibody level J:235399
increased anti-nuclear antigen antibody level J:235399
increased autoantibody level J:235399
increased susceptibility to systemic lupus erythematosus J:235399
Rxratm1Krc/Rxratm1Krc
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		increased anti-double stranded DNA antibody level J:168799
increased anti-nuclear antigen antibody level J:168799
increased anti-single stranded DNA antibody level J:168799
increased autoantibody level J:168799
S1pr1tm1Jch/S1pr1tm1Jch
Tg(GFAP-cre)25Mes/?
(involves: C57BL/6J * FVB/N) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:168824
S1pr1tm1Jch/S1pr1tm1Jch
Tg(Nes-cre)1Kln/0
(involves: C57BL/6J * SJL) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:168824
Satb1tm2Kos/Satb1tm2Kos
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca) 		increased anti-nuclear antigen antibody level J:252606
increased autoantibody level J:252606
increased susceptibility to autoimmune disorder J:252606
Scara5tm1Ktry/Scara5tm1Ktry
(B6N.129X1-Scara5tm1Ktry) 		increased anti-nuclear antigen antibody level J:195536
Scarf1tm1Tkms/Scarf1tm1Tkms
(involves: C57BL/6) 		increased anti-histone antibody level J:208237
increased anti-nuclear antigen antibody level J:208237
increased anti-single stranded DNA antibody level J:208237
increased susceptibility to systemic lupus erythematosus J:208237
Secia1DBA/1J/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
Secia2DBA/1J/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
Secia3FVB/NJ/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
Secia4DBA/1J/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
Secia5DBA/1J/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
Secia6DBA/1J/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
Secia7FVB/NJ/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
Secia8FVB/NJ/?
(involves: DBA/1J * FVB/NJ) 		increased susceptibility to induced arthritis J:123131
Selltm1Flv/Sell+
(involves: C57BL/6 * NOD) 		decreased susceptibility to autoimmune diabetes J:88947
Selltm1Flv/Selltm1Flv
(involves: C57BL/6 * NOD) 		decreased susceptibility to autoimmune disorder J:88947
Selptm1Bay/Selptm1Bay
(D1.129S7(B6J)-Selptm1Bay) 		increased susceptibility to induced arthritis J:57086
Senp1tm1Wami/Senp1tm1Wami
Tg(Fabp4-cre)#Abel/0
(B6.Cg-Senp1tm1Wami Tg(Fabp4-cre)#Abel) 		increased anti-insulin autoantibody level J:228009
increased susceptibility to autoimmune diabetes J:228009
Shcbp1tm1c(EUCOMM)Wtsi/Shcbp1tm1c(EUCOMM)Wtsi
Tg(Lck-cre)1Cwi/?
(involves: C57BL/6 * DBA/2) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:212898
Shcbp1tm1d(EUCOMM)Wtsi/Shcbp1tm1d(EUCOMM)Wtsi
(involves: C57BL/6N * FVB/N) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:212898
Siglec1tm1(HBEGF)Mtka/Siglec1tm1(HBEGF)Mtka
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/?
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		abnormal immune tolerance J:123958
Siglecgtm1Lnit/Siglecgtm1Lnit
(involves: BALB/c) 		autoimmune response J:123353
Sirt1tm1Mcby/Sirt1tm1Mcby
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased anti-nuclear antigen antibody level J:160869
Sirt1tm1Mcby/Sirt1tm1Mcby
(involves: 129S1/Sv * 129X1/SvJ) 		increased autoantibody level J:241633
Sit1tm1Lsmn/Sit1tm1Lsmn
(B6.Cg-Sit1tm1Lsmn) 		increased susceptibility to experimental autoimmune encephalomyelitis J:100408
Skap2Gt(VICTR20)21Lex/Skap2Gt(VICTR20)21Lex
(B6.129S5-Skap2Gt(VICTR20)21Lex) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:101373
Slamf9em1Isha/Slamf9em1Isha
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:279164
Slc1a5tm1Tac/Slc1a5tm1Tac
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:254980
Slc5a2tm1Lex/Slc5a2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		decreased susceptibility to autoimmune diabetes J:195941
Sle1NZW/Sle1NZW
Sles1NZW/Sles1NZW
(involves: C57BL/6 * NZW) 		decreased susceptibility to systemic lupus erythematosus J:100678
Sle1NZW/Sle1NZW
Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J * NZW) 		increased susceptibility to systemic lupus erythematosus J:134128
Sle1aC57BL/6J/Sle1aNZM2410/J
(involves: C57BL/6J * NZM2410/J) 		increased anti-chromatin antibody level J:67544
Sle1aNZM2410/J/Sle1aNZM2410/J
(involves: C57BL/6J * NZM2410/J) 		increased anti-chromatin antibody level J:67544
Sle1bC57BL/6J/Sle1bNZM2410/J
(involves: C57BL/6J * NZM2410/J) 		increased anti-chromatin antibody level J:67544
Sle1bNZM2410/J/Sle1bNZM2410/J
(involves: C57BL/6J * NZM2410/J) 		increased anti-chromatin antibody level J:67544
Sle1cC57BL/6J/Sle1cNZM2410/J
(involves: C57BL/6J * NZM2410/J) 		increased anti-chromatin antibody level J:67544
Sle1cNZB/Sle1cNZM2410/J
(involves: C57BL/6J * NZB * NZM2410/J) 		increased autoantibody level J:145133
Sle1cNZM2410/J/Sle1cNZM2410/J
(involves: C57BL/6J * NZM2410/J) 		increased anti-chromatin antibody level J:67544
Sle6NZW/Sle6NZW
(involves: C57BL/6 * NZW) 		increased susceptibility to systemic lupus erythematosus J:57246
Sle9BXSB/J/Sle9BXSB/J
(involves: BXSB/J * C57BL/10Ola) 		increased anti-nuclear antigen antibody level J:60445
Sle16129S6/SvEvTac/Sle16129S6/SvEvTac
(B6.129-Sle16129S6/SvEvTac) 		increased autoantibody level J:122132
increased susceptibility to systemic lupus erythematosus J:122132
Sles1C57BL/6/Sles1C57BL/6
(involves: C57BL/6 * NZW) 		increased susceptibility to systemic lupus erythematosus J:57246
Sles1NZW/Sles1NZW
(involves: C57BL/6 * NZW) 		decreased susceptibility to systemic lupus erythematosus J:57246
Sles2C57BL/6/Sles2C57BL/6
(involves: C57BL/6 * NZW) 		increased susceptibility to systemic lupus erythematosus J:57246
Sles2C57BL/6/Sles2NZW
(involves: C57BL/6 * NZW) 		increased susceptibility to systemic lupus erythematosus J:57246
Sles2NZW/Sles2NZW
(involves: C57BL/6 * NZW) 		decreased susceptibility to systemic lupus erythematosus J:57246
Sles3C57BL/6/Sles3C57BL/6
(involves: C57BL/6 * NZW) 		increased susceptibility to systemic lupus erythematosus J:57246
Sles3C57BL/6/Sles3NZW
(involves: C57BL/6 * NZW) 		increased susceptibility to systemic lupus erythematosus J:57246
Sles3NZW/Sles3NZW
(involves: C57BL/6 * NZW) 		decreased susceptibility to systemic lupus erythematosus J:57246
Sles4C57BL/6/Sles4C57BL/6
(involves: C57BL/6 * NZW) 		increased susceptibility to systemic lupus erythematosus J:57246
Sles4C57BL/6/Sles4NZW
(involves: C57BL/6 * NZW) 		increased susceptibility to systemic lupus erythematosus J:57246
Sles4NZW/Sles4NZW
(involves: C57BL/6 * NZW) 		decreased susceptibility to systemic lupus erythematosus J:57246
Slfn8tm1Aki/Slfn8tm1Aki
(involves: 129X1/SvJ * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:258797
Smad7tm1.1Ink/Smad7tm1.1Ink
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:184670
Socs1tm1.1Ayr/Socs1tm1.1Ayr
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:226678
Socs1tm1Ayos/Socs1tm1Ayos
Tg(Lck-cre)1Jtak/0
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:132905
Socs3tm1Robb/Socs3tm1Robb
(involves: C57BL/6) 		increased susceptibility to induced arthritis J:145513
Sod3tm1Mrkl/Sod3tm1Mrkl
(D1.129P2-Sod3tm1Mrkl) 		increased susceptibility to induced arthritis J:106273
Spink14tm1e(KOMP)Wtsi/Spink14tm1e(KOMP)Wtsi
(C57BL/6N-Spink14tm1e(KOMP)Wtsi/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
Spntm1Bam/Spntm1Bam
(B6;129S4-Spntm1Bam/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:86932
Spp1tm1Blh/Spp1tm1Blh
(B6.129S6-Spp1tm1Blh) 		decreased susceptibility to experimental autoimmune uveoretinitis J:116272
St14tm2Bug/St14tm3Bug
Tg(MMTV-cre)4Mam/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J * FVB/NJ * N:Black Swiss) 		increased anti-nuclear antigen antibody level J:213072
increased autoantibody level J:213072
Stat4tm1Gru/Stat4tm1Gru
(NOD.129S2-Stat4tm1Gru) 		decreased susceptibility to autoimmune diabetes J:90600
Stat4tm1Gru/Stat4tm1Gru
Tg(Ins2-GP)34-20Olds/0
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		abnormal susceptibility to autoimmune disorder J:107047
Stat4tm1Gru/Stat4tm1Gru
Tg(Ins2-NP)25-3Olds/0
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		decreased susceptibility to autoimmune diabetes J:107047
Stat4tm1Jni/Stat4tm1Jni
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to autoimmune diabetes J:96338
Stat4tm1Jni/Stat4tm1Jni
Stat6tm1Jni/Stat6tm1Jni
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6) 		increased susceptibility to autoimmune diabetes J:96338
Stat6tm1Jni/Stat6tm1Jni
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to autoimmune diabetes J:96338
Stim1tm1Kuro/Stim1tm1Kuro
Stim2tm1.1Kuro/Stim2tm1.1Kuro
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:172608
Stk17btm1Hed/Stk17btm1Hed
(B6.129X1-Stk17btm1Hed) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:94685
Swap70tm1Jess/Swap70tm1Jess
(involves: 129T2/SvEms * 129X1/SvJ) 		increased autoantibody level J:71160
Swrl2SWR/Swrl2SWR
(involves: NZB * SWR) 		increased anti-single stranded DNA antibody level J:96060
Swrl3NZB/Swrl3SWR
(involves: NZB * SWR) 		increased anti-double stranded DNA antibody level J:96060
increased anti-histone antibody level J:96060
increased anti-nuclear antigen antibody level J:73097
Swrl3SWR/Swrl3SWR
(involves: NZB * SWR) 		increased anti-double stranded DNA antibody level J:96060
increased anti-histone antibody level J:96060
increased anti-nuclear antigen antibody level J:73097
Syktm2.1(ZAP70)Fkfr/Syktm2.1(ZAP70)Fkfr
(B6.129-Syktm2.1(ZAP70)Fkfr) 		increased anti-insulin autoantibody level J:188422
Syt7tm1Nan/Syt7tm1Nan
(involves: 129S1/Sv * C57BL/6) 		increased anti-nuclear antigen antibody level J:85201
increased susceptibility to autoimmune disorder J:85201
Syvn1tm1Tn/Syvn1+
(D1.Cg-Syvn1tm1Tn) 		decreased susceptibility to induced arthritis J:86009
Tanktm1Aki/Tanktm1Aki
(involves: 129/Sv * C57BL/6) 		increased anti-double stranded DNA antibody level J:151757
increased anti-nuclear antigen antibody level J:151757
Tap1tm1Arp/Tap1tm1Arp
X/Yaa
(BXSB.129S2(B6)-Tap1tm1Arp/Dcr) 		increased susceptibility to systemic lupus erythematosus J:179430
Tarm1tm1Yiw/Tarm1tm1Yiw
(involves: C57BL/6 * C57BL/6NSlc) 		decreased susceptibility to induced arthritis J:301164
Tbc1d10ctm1.1Psou/Tbc1d10ctm1.2Psou
Cd79atm1(cre)Reth/Cd79a+
(involves: 129S2/SvPas * BALB/c * C57BL/6J) 		increased anti-double stranded DNA antibody level J:211913
increased susceptibility to systemic lupus erythematosus J:211913
Tbc1d10ctm1.2Psou/Tbc1d10ctm1.2Psou
(involves: 129S2/SvPas * C57BL/6J) 		increased anti-double stranded DNA antibody level J:211913
increased susceptibility to systemic lupus erythematosus J:211913
Tbk1tm1Arte/Tbk1tm1Arte
Cd19tm1(cre)Cgn/Cd19+
(involves: 129/SvEv * 129P2/OlaHsd * C57BL/6) 		increased anti-double stranded DNA antibody level J:188560
increased anti-nuclear antigen antibody level J:188560
Tbx21tm1Glm/Tbx21tm1Glm
(C.129S6-Tbx21tm1Glm/J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:111932
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(B6.129-Tcra-Jtm1Tgi) 		decreased susceptibility to induced arthritis J:99107
Tcratm1Mjo/Tcra+
(NOD.129P2-Tcratm1Mjo) 		decreased susceptibility to autoimmune diabetes J:108590
Tcratm1Mjo/Tcratm1Mjo
(involves: 129P2/OlaHsd * BALB/c) 		increased anti-double stranded DNA antibody level J:111129
increased anti-nuclear antigen antibody level J:111129
increased autoantibody level J:111129
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
(B6.129P2-Tcrbtm1Mom Tcrdtm1Mom/J) 		decreased autoantibody level J:187766
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
Igh-Jtm2(3H9-VDJ*)Mwg/Igh-J+
(B6.129P2-Tcrbtm1Mom Igh-Jtm2(3H9-VDJ*)Mwg Tcrdtm1Mom) 		increased anti-double stranded DNA antibody level J:142389
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(B6.129-Tcrbtm1Mom Traf3ip2tm1.1Lix Tcrdtm1Mom) 		increased anti-chromatin antibody level J:187766
increased anti-double stranded DNA antibody level J:187766
increased anti-histone antibody level J:187766
increased autoantibody level J:187766
Tet1tm1.2Jae/Tet1tm1.2Jae
Tet2tm1.1Iaai/Tet2tm1.1Iaai
Tet3tm1.1Yzhg/Tet3tm1.1Yzhg
Tg(Rorc-cre)1Litt/0
(involves: 129 * 129S/SvEv * 129S4/SvJae * C57BL/6 * FVB) 		increased susceptibility to autoimmune disorder J:333574
Tg(ACTB-TNFRSF6B)754Jwu/?
(B6.Cg-Tg(Actb-TNFRSF6B)754Jwu) 		increased anti-double stranded DNA antibody level J:148162
increased autoantibody level J:148162
Tg(BCL2)22Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi) 		increased susceptibility to autoimmune disorder J:93111
Tg(BCL2)36Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi) 		increased susceptibility to autoimmune disorder J:93111
Tg(CAG-C1qtnf6)#Yiw/0
(involves: C57BL/6JJcl) 		decreased susceptibility to induced arthritis J:227217
Tg(CAG-p35)1Miur/0
(involves: C57BL/6) 		autoimmune response J:126593
Tg(CAG-p35)1Miur/0
Tg(Mbp-cre)29Miur/0
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:126593
Tg(CAG-SYVN1)1Tn/?
(D1.Cg-Tg(CAG-SYVN1)1Tn) 		rheumatoid arthritis J:86009
Tg(CD2-Lrch1)#Liux/0
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:238772
Tg(CD2-Rorc)#Staka/0
(involves: C57BL/6) 		increased anti-nuclear antigen antibody level J:230700
increased autoantibody level J:230700
increased susceptibility to autoimmune disorder J:230700
Tg(Cd2-Smad7)#Chbe/0
(involves: C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:184670
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6 * C57BL/10) 		abnormal T cell clonal deletion J:217939
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0
Tg(LCKprBCL2)36Sjk/0
(involves: C57BL/6 * C57BL/10) 		abnormal T cell clonal deletion J:217939
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6) 		abnormal T cell clonal deletion J:217939
increased anti-nuclear antigen antibody level J:217939
increased autoantibody level J:217939
increased susceptibility to autoimmune disorder J:217939
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6 * CBA/J) 		abnormal T cell clonal deletion J:217939
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
Tg(Nr4a1-EGFP/cre)820Khog/0
(involves: C57BL/6 * C57BL/6J) 		abnormal T cell clonal deletion J:217939
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J) 		abnormal T cell clonal deletion J:217939
Tg(Cd4-CD4)2362Litt/0
Tg(HLA-DR2)#Lfug/0
Tg(TCROb.1A12)#Lfug/0
(involves: C57BL/6 * DBA/2 * SJL) 		increased susceptibility to experimental autoimmune encephalomyelitis J:134764
Tg(Cd4-cre)1Cwi/?
Tg(TcraTcrb)425Cbn/?
Traf6tm2Ywc/Traf6tm2Ywc
(involves: C57BL/6 * DBA/2) 		abnormal lymphocyte anergy J:130882
Tg(Cd4-DsRed)4Lt/0
(NOD/ShiLt-Tg(Cd4-DsRed)4Lt) 		decreased susceptibility to autoimmune diabetes J:127785
Tg(CD4-Il17re)#Cdon/0
(involves: C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:177650
Tg(Cd4-TGFBR2)16Flv/?
(involves: C3H * C57BL/6 * C57BL/10 * C57BR/cd) 		increased anti-nuclear antigen antibody level J:97554
Tg(Cd152Ig)1Jbs/0
(involves: C3H * NOD) 		increased susceptibility to autoimmune diabetes J:35353
Tg(Cebpb-tTA)5Bjd/0
Tg(tetO-MYC,-OVAL)#Gtgm/0
(B6J.Cg-Tg(Cebpb-tTA)5Bjd Tg(tetO-MYC,-OVAL)#Gtgm) 		abnormal immune tolerance J:186226
Tg(CKMM-tTA)A3Rhvh/0
Tg(tetO-H2-K1)#Papl/0
(B6.Cg-Tg(CKMM-tTA)A3Rhvh Tg(tetO-H2-K1)#Papl) 		increased anti-nuclear antigen antibody level J:205907
increased autoantibody level J:205907
Tg(Col2a1-Mir140)#Asah/0
(C57BL/6-Tg(Col2a1-Mir140)#Asah) 		decreased susceptibility to induced arthritis J:160358
Tg(Emu-TXLNA)1Amjr/0
(B6.Cg-Tg(Emu-TXLNA)1Amjr) 		increased autoantibody level J:117018
increased susceptibility to autoimmune disorder J:117018, J:145185
Tg(FCGR2A)11Mkz/Tg(FCGR2A)11Mkz
(involves: C57BL/6 * SJL) 		increased anti-histone antibody level J:136516
increased susceptibility to induced arthritis J:136516
Tg(H2-Ea-G6pc2)69Tkay/?
(NOD-Tg(H2-Ea-G6pc2)69Tkay) 		abnormal immune tolerance J:117352
increased anti-insulin autoantibody level J:117352
increased susceptibility to autoimmune diabetes J:117352
Tg(H2-Ea-Ins2)1Wehi/Tg(H2-Ea-Ins2)1Wehi
(NOD/ShiLtJWehi-Tg(H2-Ea-Ins2)1Wehi) 		decreased anti-insulin autoantibody level J:117352
Tg(H2-Ead)5Lt/0
(NOD/ShiLt-Tg(H2-Ead)5Lt) 		autoimmune response J:36435
decreased susceptibility to autoimmune diabetes J:36435
Tg(H2-Ead)12Lt/0
(NOD/ShiLt-Tg(H2-Ead)12Lt) 		autoimmune response J:36435
decreased susceptibility to autoimmune diabetes J:36435
Tg(H2-K-MC159/EGFP)13Fkmc/Tg(H2-K-MC159/EGFP)13Fkmc
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:138050
Tg(H2-K-TcrbP14)128Mak/?
(involves: C57BL/6 * C57L * DBA/2) 		abnormal T cell clonal deletion J:111265
Tg(H2-Kb-Tcra,-Tcrb)1640Kurs/0
(SJL.FVB-Tg(H2-Kb-Tcra,-Tcrb)1640Kurs) 		increased autoantibody level J:149511
increased susceptibility to experimental autoimmune encephalomyelitis J:149511
Tg(H2KePCC)2403Stoe/?
(involves: C57BL/6 * SJL) 		abnormal immune tolerance J:92997
Tg(H2KePCC)2403Stoe/?
Tg(TcraTcrbAD10)1Hed/?
(involves: C57BL/6 * SJL) 		abnormal immune tolerance J:92997
abnormal T cell anergy J:92997
Tg(H2KmPCC)2939Stoe/?
(involves: C57BL/6 * SJL) 		abnormal immune tolerance J:92997
Tg(H2KmPCC)2939Stoe/?
Tg(TcrAND)53Hed/?
(involves: C57BL/6 * SJL) 		abnormal immune tolerance J:92997
abnormal T cell anergy J:92997
Tg(H2KmPCC)2939Stoe/?
Tg(TcraTcrbAD10)1Hed/?
(involves: C57BL/6 * SJL) 		abnormal immune tolerance J:92997
abnormal T cell anergy J:92997
Tg(HLA-A/H2-D/B2M)1Dvs/0
(NOD/ShiLtDvs-Tg(HLA-A/H2-D/B2M)1Dvs) 		increased susceptibility to autoimmune diabetes J:121685
Tg(HLA-B27)30-4Trg/?
(involves: C57BL/6J * NOD) 		decreased susceptibility to autoimmune diabetes J:109851
Tg(HLA-DQA1,HLA-DQB1)1Dv/0
Tg(Ins2-CD80)3B7Flv/0
(B6.Cg-Tg(HLA-DQA1,HLA-DQB1)1Dv Tg(Ins2-CD80)3B7Flv) 		decreased susceptibility to autoimmune diabetes J:59245
Tg(HLA-DR2)#Lfug/0
Tg(TCROb.1A12)#Lfug/0
(involves: C57BL/6 * DBA/2) 		increased susceptibility to experimental autoimmune encephalomyelitis J:134764
Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz/Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz
(involves: C57BL/6 * C57BL/10Sn * SJL/J) 		increased autoantibody level J:108635
increased susceptibility to induced arthritis J:108635
Tg(Igh3H9)41Mwg/?
(involves: C57BL/6 * SJL) 		increased anti-single stranded DNA antibody level J:119625
Tg(Igh-6-Cd80)1Gjf/0
(NOD.FVB-Tg(Igh-6-Cd80)1Gjf/JbsJ) 		decreased susceptibility to autoimmune diabetes J:131077
Tg(Igh-6/Igh-V125)2Jwt/0
Tg(Igk-C/Igk-V125)1Jwt/0
(NOD.B6-Tg(Igh-6/Igh-V125)2Jwt Tg(Igk-C/Igk-V125)1Jwt) 		increased susceptibility to autoimmune diabetes J:91865
Tg(Igh-6/Igh-V281)3Jwt/0
(NOD.B6-Tg(Igh-6/Igh-V281)3Jwt) 		decreased susceptibility to autoimmune diabetes J:91865
Tg(Igh-V-CD40lg)#Tsub/0
(C57BL/6-Tg(Igh-V-CD40lg)#Tsub) 		increased anti-double stranded DNA antibody level J:128824
increased anti-histone antibody level J:128824
increased anti-single stranded DNA antibody level J:128824
Tg(Igh-V-CD40lg)#Tsub/0
(involves: C57BL/6) 		increased autoantibody level J:89855
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0
(NOD.B6-Tg(IghelMD4)4Ccg Tg(ML5sHEL)5Ccg/Dvs) 		abnormal B cell anergy J:89156
abnormal B cell clonal deletion J:89156
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0
(C57BL/6-Tg(IghelMD4)4Ccg Tg(ML5sHEL)5Ccg) 		abnormal B cell anergy J:89156, J:78308
abnormal central B cell anergy J:109923
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0
(involves: C57BL/6) 		abnormal B cell anergy J:73608, J:132538
Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg
(NOD.B6-Tg(IghelMD4)4Ccg/DvsJ) 		increased susceptibility to autoimmune diabetes J:80859
Tg(IghH280)48Dvs/?
(NOD/ShiLtDvs-Tg(IghH280)48Dvs/J) 		increased susceptibility to autoimmune diabetes J:274578
Tg(IghH280)48Dvs/?
Tg(IgkH280)934Dvs/?
(NOD/ShiLtDvs-Tg(IghH280)48Dvs Tg(IgkH280)934Dvs/Dvs) 		increased susceptibility to autoimmune diabetes J:274578
Tg(Ighm-Ctla4Ig/Cd80)1Jbs/0
(NOD.FVB-Tg(Ighm-Ctla4Ig/Cd80)1Jbs) 		decreased susceptibility to autoimmune diabetes J:113109
Tg(IgkH280)934Dvs/?
(NOD/ShiLtDvs-Tg(IgkH280)934Dvs/J) 		increased susceptibility to autoimmune diabetes J:274578
Tg(Ins1-Cat,Tyr)25Pne/0
(NOD.FVB-Tg(Ins1-Cat,Tyr)25Pne) 		increased susceptibility to autoimmune diabetes J:108415
Tg(Ins1-EGFP/GH1)14Hara/0
(NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara) 		increased susceptibility to autoimmune diabetes J:127015
Tg(Ins1-EGFP/GH1)14Hara/Tg(Ins1-EGFP/GH1)14Hara
(NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara) 		decreased susceptibility to autoimmune disorder J:127015
Tg(Ins2*Y16A)1Ell/0
(NOD-Tg(Ins2*Y16A)1Ell) 		increased susceptibility to autoimmune diabetes J:98583
Tg(Ins2*Y16A)3Ell/0
(NOD-Tg(Ins2*Y16A)3Ell) 		increased susceptibility to autoimmune diabetes J:98583
Tg(Ins2-CD80)3B7Flv/?
(involves: C57BL/6 * CBA/Ca * NOD/Caj) 		increased susceptibility to autoimmune diabetes J:26618
Tg(Ins2-CD80)3B7Flv/0
Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * CBA/Ca * SJL) 		increased susceptibility to autoimmune diabetes J:93555
Tg(Ins2-CD80)3B7Flv/0
Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6 * CBA/Ca) 		increased susceptibility to autoimmune diabetes J:93555
Tg(Ins2-CD86)12B70Flv/0
(involves: C57BL/6 * CBA/Ca) 		decreased susceptibility to autoimmune diabetes J:93555
Tg(Ins2-CD86)12B70Flv/0
Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * CBA/Ca * SJL) 		increased susceptibility to autoimmune diabetes J:93555
Tg(Ins2-CD86)12B70Flv/0
Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6 * CBA/Ca) 		increased susceptibility to autoimmune diabetes J:93555
Tg(Ins2-Cd274)2Mdos/?
(NOD/ShiLt-Tg(Ins2-Cd274)2Mdos) 		increased susceptibility to autoimmune diabetes J:118934
Tg(Ins2-cre)5Lt/0
(NOD/ShiLt-Tg(Ins2-cre)5Lt) 		increased susceptibility to autoimmune diabetes J:127015
Tg(Ins2-cre)5Lt/Tg(Ins2-cre)5Lt
(NOD/ShiLt-Tg(Ins2-cre)5Lt) 		decreased susceptibility to autoimmune disorder J:127015
Tg(Ins2-crmA)27Ngkh/?
(NOD-Tg(Ins2-CrmA)27Ngkh) 		increased susceptibility to autoimmune diabetes J:132052
Tg(Ins2-E3)1Dvs/?
(NOD.Cg-Tg(Ins2-E3)1Dvs) 		decreased susceptibility to autoimmune diabetes J:68996
Tg(Ins2-E3*309)5Dvs/?
(NOD/ShiLtDvs-Tg(Ins2-E3*309)5Dvs/Dvs) 		decreased susceptibility to autoimmune diabetes J:83195
Tg(Ins2-E3*704)2Dvs/?
(NOD/ShiLtDvs-Tg(Ins2-E3*704)2Dvs) 		decreased susceptibility to autoimmune diabetes J:83195
Tg(Ins2-E3*734)3Dvs/0
(NOD/ShiLtDvs-Tg(Ins2-E3*734)3Dvs/DvsJ) 		decreased susceptibility to autoimmune diabetes J:106340
Tg(Ins2-E3*734)4Dvs/?
(NOD/ShiLtDvs-Tg(Ins2-E3*734)4Dvs/DvsJ) 		decreased susceptibility to autoimmune diabetes J:106340
Tg(Ins2-Fas*I246N)1Ach/0
(NOD-Tg(Ins2-Fas*I246N)1Ach) 		decreased susceptibility to autoimmune diabetes J:81416
Tg(Ins2-Fas*I246N)1Ach/0
Tg(Ins2-Fasl)24Ach/0
(NOD-Tg(Ins2-Fas*I246N)1Ach Tg(Ins2-Fasl)24Ach) 		decreased susceptibility to autoimmune diabetes J:81416
Tg(Ins2-Fasl)24Ach/0
(NOD-Tg(Ins2-Fasl)24Ach/J) 		increased susceptibility to autoimmune diabetes J:78679, J:81416
Tg(Ins2-GAD2)2Lt/0
(NOD/ShiLt-Tg(Ins2-GAD2)2Lt) 		decreased susceptibility to autoimmune diabetes J:100251
Tg(Ins2-GP)34-20Olds/0
(involves: BALB/c * C57BL/6) 		increased susceptibility to autoimmune diabetes J:81287
Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * SJL) 		decreased susceptibility to autoimmune diabetes J:93555
Tg(Ins2-Iapp)6Soel/Tg(Ins2-Iapp)6Soel
(involves: FVB/N) 		decreased susceptibility to autoimmune diabetes J:130022
Tg(Ins2-IAPP)RHFSoel/Tg(Ins2-IAPP)RHFSoel
(involves: FVB/N) 		increased susceptibility to autoimmune diabetes J:130022
Tg(Ins2-NP)25-3Olds/0
(involves: BALB/c * C57BL/6) 		decreased susceptibility to autoimmune diabetes J:81287
increased susceptibility to autoimmune diabetes J:81287
Tg(Ins2-OVA)59Wehi/?
(involves: BALB/c * C57BL/6) 		increased susceptibility to autoimmune diabetes J:99560
Tg(Ins2-OVA)307Wehi/?
(involves: BALB/c * C57BL/6) 		increased susceptibility to autoimmune diabetes J:99560
Tg(Ins2-OVA)307Wehi/0
Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6 * C57BL/6JWehi) 		autoimmune response J:99451
Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: C57BL/6) 		increased susceptibility to autoimmune diabetes J:122114
Tg(INS-Il10)#Sar/0
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
(involves: 129S2/SvPas * C57BL/6J * NOD) 		increased susceptibility to autoimmune diabetes J:64051
Tg(INS-Il10)#Sar/0
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129S2/SvPas * C57BL/6J * NOD) 		increased susceptibility to autoimmune diabetes J:64051
Tg(KRT5-rtTA)1Glk/0
Tg(tetO/CMV-Tslp)#Sfz/0
(C.Cg-Tg(KRT5-rtTA)1Glk Tg(tetO/CMV-Tslp)#Sfz) 		increased autoantibody level J:182756
increased susceptibility to autoimmune hemolytic anemia J:182756
Tg(Lck-Socs3)1Kubo/0
(Not Specified) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:132905
Tg(Lck-Stk17b)26.1Wals/?
(B6.Cg-Tg(Lck-Stk17b)26.1Wals) 		increased anti-nuclear antigen antibody level J:149973
increased susceptibility to experimental autoimmune encephalomyelitis J:149973
Tg(Lck-Tnfsf14)24Yxf/?
(C57BL/6-Tg(Lck-Tnfsf14)24Yxf) 		increased anti-double stranded DNA antibody level J:129951
increased anti-nuclear antigen antibody level J:128976
increased autoantibody level J:129951
Tg(Lck-Tslp)1Chea/0
(B6.Cg-Tg(Lck-Tslp)1Chea) 		increased anti-nuclear antigen antibody level J:72982
Tg(Lck/Emu-Rftn1)1Ayos/?
(involves: C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:150299
Tg(LCKprBCL2)36Sjk/0
(involves: C57BL/6 * CBA/J) 		abnormal T cell clonal deletion J:217939
Tg(LCKprBCL2)36Sjk/0
Tg(Nr4a1-EGFP/cre)820Khog/0
(involves: C57BL/6 * C57BL/6J) 		abnormal T cell clonal deletion J:217939
Tg(LCKprBCL2)36Sjk/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J) 		abnormal T cell clonal deletion J:217939
Tg(Mir125a)#Smoc/0
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:224880
Tg(ML5sHEL)5Ccg/0
(C57BL/6-Tg(ML5sHEL)5Ccg) 		abnormal B cell anergy J:78308
Tg(ML5sHEL)5Ccg/0
(involves: C57BL/6JSfd * CBA) 		abnormal B cell anergy J:78308
abnormal T cell anergy J:78308
Tg(OMP-SV40T)13Bse/0
(involves: C57BL/6 * SJL) 		abnormal immune tolerance J:54269
Tg(Plp1-Eif2ak3*)18Pop/0
(C57BL/6J-Tg(Plp1-Eif2ak3*)18Pop) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:238042
Tg(Psp-Rbbp4)1Yoha/0
(involves: C57BL/6) 		increased autoantibody level J:141378
increased susceptibility to autoimmune disorder J:141378
Tg(SV40-Igh-64C8)H3Hon/0
Tg(SV40-Igk4C8)L1Hon/0
(involves: C57BL/6) 		abnormal B cell clonal deletion J:139864
increased anti-erythrocyte antigen antibody level J:139864
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: C57BL/6) 		increased susceptibility to autoimmune disorder J:83278
increased susceptibility to experimental autoimmune encephalomyelitis J:83278
Tg(Tcra,Tcrb)3Ayr/0
(involves: C57BL/6 * DBA/2) 		abnormal lymphocyte anergy J:80775
Tg(Tcra,Tcrb)24Efro/0
(D1.Cg-Tg(Tcra,Tcrb)24Efro) 		autoimmune response J:104243
increased autoantibody level J:104243
increased susceptibility to autoimmune disorder J:104243
Tg(TcraAI4)1Dvs/0
(NOD-Tg(TcraAI4)1Dvs) 		increased susceptibility to autoimmune diabetes J:93553
Tg(TcraAI4)1Dvs/0
Tg(TcrbAI4)1Dvs/0
(NOD-Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs) 		increased susceptibility to autoimmune diabetes J:94192
Tg(TcraAV19AJ33)1Shima/?
(involves: 129S4/SvJae * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:112657
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(NOD.Cg-Tg(TcraBDC2.5,TcrbBDC2.5)1Doi) 		decreased susceptibility to autoimmune diabetes J:87251
Tg(TcraR28,TcrbR28)KRNDim/0
(involves: C57BL/6 * NOD * SJL) 		abnormal T cell anergy J:36815
abnormal T cell clonal deletion J:36815
rheumatoid arthritis J:36815
Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6) 		abnormal T cell clonal deletion J:92867
Tg(TcraTcrbNY4.1)1Pesa/0
(NOD.Cg-Tg(TcraTcrbNY4.1)1Pesa) 		increased susceptibility to autoimmune diabetes J:108768
Tg(TcraY1,TcrbY1)416Tev/0
(involves: C57BL/6J * DBA/2J) 		abnormal immune tolerance J:84288
Tg(Tcrb)93Vbo/0
(involves: C57BL/6 * C57BL/LiA * CBA/BrA) 		abnormal T cell clonal deletion J:66565
Tg(TcrbBL17)1Lmor/0
(involves: DBA/1J * SWR/J) 		increased susceptibility to induced arthritis J:134111
Tg(TcrbBL17)1Lmor/Tg(TcrbBL17)1Lmor
(involves: DBA/1J * SWR/J) 		increased susceptibility to induced arthritis J:134111
Tg(TcrLCMV)327Sdz/Tg(TcrLCMV)327Sdz
(NOD.Cg-Tg(TcrLCMV)327Sdz/Dvs) 		autoimmune response J:71050
Tg(tetO-MAP2K1)#Ahsa/?
Tg(CD2-rtTA)CRza/?
(involves: C57BL/6 * C57BL/10 * CBA * SJL) 		increased anti-double stranded DNA antibody level J:174339
Tg(Tlr7)1Boll/0
(involves: C57BL/6) 		autoimmune response J:127600
increased anti-nuclear antigen antibody level J:127600
X/Tg(Tlr7)6Boll
(involves: C57BL/6) 		autoimmune response J:127600
increased anti-nuclear antigen antibody level J:127600
Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J) 		increased anti-double stranded DNA antibody level J:58798
increased anti-single stranded DNA antibody level J:58798
increased autoantibody level J:58798
Tg(Tnfsf13b)1Fma/0
(B6.Cg-Tg(Tnfsf13b)1Fma) 		increased autoantibody level J:114782
Tg(Tnfsf13b)1Fma/?
(B6.Cg-Tg(Tnfsf13b)1Fma) 		increased anti-double stranded DNA antibody level J:113556
Tg(UBC-scFv)2Nemz/0
(involves: C57BL/6 * DBA/2) 		abnormal immune tolerance J:96759
Tgfb1tm3.1Flv/Tgfb1tm3.1Flv
Tg(Cd4-cre)1Cwi/0
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: 129 * C57BL/6 * DBA/2 * NOD * SJL) 		increased susceptibility to autoimmune diabetes J:196160
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		autoimmune response J:148747
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Tg(Cd4-cre)1Cwi/0
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: 129 * C57BL/6 * DBA/2 * NOD * SJL) 		increased susceptibility to autoimmune diabetes J:196160
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(involves: 129 * C57BL/6 * NOD * SJL) 		increased susceptibility to autoimmune diabetes J:196160
TgTn(pb-CAG-Gm614)#Cya/0
(involves: C57BL/6) 		increased susceptibility to systemic lupus erythematosus J:307345
Thbs1tm1Hyn/Thbs1tm1Hyn
(involves: 129S2/SvPas * C57BL/6) 		increased anti-single stranded DNA antibody level J:153126
Thop1Gt(CSG163)Byg/Thop1Gt(CSG163)Byg
(B6.129P2-Thop1Gt(CSG163)Byg) 		increased susceptibility to experimental autoimmune encephalomyelitis J:290567
Tigittm1Sdl/Tigittm1Sdl
(involves: C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:168902
Tigittm1Sdl/Tigittm1Sdl
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:168902
Timd4tm1Kuch/Timd4tm1Kuch
(C57BL/6-Timd4tm1Kuch) 		increased anti-double stranded DNA antibody level J:160747
Timd4tm1Kuch/Timd4tm1Kuch
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:235399
increased susceptibility to systemic lupus erythematosus J:235399
Tlr4Lps-d/Tlr4Lps-d
(involves: C3H/HeJ) 		increased susceptibility to induced arthritis J:96356
Tlr4tm1Aki/Tlr4tm1Aki
(C.129P2-Tlr4tm1Aki) 		decreased susceptibility to induced arthritis J:178054
Tlr5tm1Flv/Tlr5tm1Flv
(involves: 129S1/Sv * C57BL/6) 		increased susceptibility to autoimmune diabetes J:158055
Tlr7em2Anu/Y
(C57BL/6NCrl-Tlr7em2Anu) 		increased anti-double stranded DNA antibody level J:324448
increased anti-nuclear antigen antibody level J:324448
increased anti-single stranded DNA antibody level J:324448
increased autoantibody level J:324448
increased susceptibility to systemic lupus erythematosus J:324448
Tlr7em2Anu/Tlr7+
(C57BL/6NCrl-Tlr7em2Anu) 		increased anti-double stranded DNA antibody level J:324448
increased anti-nuclear antigen antibody level J:324448
increased anti-single stranded DNA antibody level J:324448
increased autoantibody level J:324448
Tlr7em2Anu/Tlr7em2Anu
(C57BL/6NCrl-Tlr7em2Anu) 		increased anti-nuclear antigen antibody level J:324448
increased anti-single stranded DNA antibody level J:324448
increased susceptibility to systemic lupus erythematosus J:324448
Tlr7tm1Flv/Tlr7tm1Flv
(B6.129S1-Tlr7tm1Flv) 		decreased anti-insulin autoantibody level J:165267
Tlr8/Tlr7tm1Vlcg/Tlr8/Tlr7tm1Vlcg
(B6.Cg-Tlr8/Tlr7tm1Vlcg) 		decreased anti-insulin autoantibody level J:165267
Tlr8/Tlr7tm1Vlcg/Tlr7+
Tlr8/Tlr7tm1Vlcg/Tlr8tm1Vlcg
(B6.Cg-Tlr8/Tlr7tm1Vlcg Tlr8tm1Vlcg) 		decreased anti-insulin autoantibody level J:165267
Tlr8/Tlr7tm1Vlcg/Tlr8/Tlr7tm1Vlcg
(B6.Cg-Tlr8/Tlr7tm1Vlcg Tlr8tm1Vlcg) 		decreased anti-insulin autoantibody level J:165267
Tlr8tm1Vlcg/Tlr8tm1Vlcg
(B6.129S1-Tlr8tm1Vlcg) 		increased anti-double stranded DNA antibody level J:165267
increased anti-nuclear antigen antibody level J:165267
Tlr9tm1Aki/Tlr9tm1Aki
(B6.129P2-Tlr9tm1Aki) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:105435
Tmem178tm1Lex/Tmem178tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		increased susceptibility to induced arthritis J:228311
TnfBpsm1/Tnf+
(involves: C57BL/6) 		rheumatoid arthritis J:226052
TnfBpsm1/TnfBpsm1
(involves: C57BL/6) 		rheumatoid arthritis J:226052
Tnftm1.1Sned/Tnftm1.1Sned
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to autoimmune disorder J:95684
Tnftm1.1Sned/Tnftm1.1Sned
Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2) 		decreased susceptibility to autoimmune disorder J:95684
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:114740
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv) 		decreased susceptibility to autoimmune disorder J:95684
Tnftm1Gkl/Tnftm2Gkl
(involves: 129S/SvEv * C57BL/6) 		rheumatoid arthritis J:54056
Tnftm1Jods/Tnftm1Jods
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:44545, J:98591
Tnftm1Jods/Tnftm1Jods
(C57BL/6-Tnftm1Jods) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:118417
Tnftm1Jods/Tnftm1Jods
(C57BL/6-Ltatm1Jods) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:47428
Tnftm1Ljo/Tnftm1Ljo
(involves: 129S1/Sv) 		decreased susceptibility to autoimmune disorder J:95684
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6) 		rheumatoid arthritis J:54056
Tnftm2Gkl/Tnf+
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		rheumatoid arthritis J:54056
Tnftm2Gkl/Tnftm2Gkl
(involves: 129S/SvEv * C57BL/6) 		rheumatoid arthritis J:54056
Tnftm2Jods/Tnftm2Jods
(C57BL/6-Tnftm2Jods) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:98591
Tnftm3Gkl/Tnftm3Gkl
(involves: 129S/SvEv * C57BL/6) 		autoimmune response J:114740
decreased susceptibility to experimental autoimmune encephalomyelitis J:114740
Tnfaip3tm2Ama/Tnfaip3tm2Ama
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6) 		increased autoantibody level J:163917
increased susceptibility to autoimmune disorder J:163917
Tnfrsf1atm1.1Gkl/Tnfrsf1atm1.1Gkl
(involves: 129/Sv * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:92470
Tnfrsf1atm1Blt/Tnfrsf1atm1Blt
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:115225
Tnfrsf1atm1Blt/Tnfrsf1atm1Blt
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:115225
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased susceptibility to experimental autoimmune uveoretinitis J:115094
decreased susceptibility to induced arthritis J:120707
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
(involves: 129S2/SvPas * C57BL/6J * NOD) 		decreased susceptibility to autoimmune diabetes J:64051
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
Tnip1Gt(E059E05)Wrst/Tnip1Gt(E059E05)Wrst
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased susceptibility to systemic lupus erythematosus J:180054
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129S2/SvPas * C57BL/6J * NOD) 		decreased susceptibility to autoimmune diabetes J:64051
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129S2/SvPas * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:115225
Tnfrsf13btm1Vmd/Tnfrsf13btm1Vmd
(involves: C57BL/6) 		increased anti-double stranded DNA antibody level J:82331
increased anti-nuclear antigen antibody level J:82331
Tnfsf4tm1Shr/Tnfsf4tm1Shr
(NOD.129S4-Tnfsf4tm1Shr) 		decreased susceptibility to autoimmune diabetes J:86926
Tnfsf10tm1Mjs/Tnfsf10tm1Mjs
(B6.129-Tnfsf10tm1Mjs) 		increased susceptibility to autoimmune diabetes J:82145
increased susceptibility to experimental autoimmune encephalomyelitis J:101672
increased susceptibility to induced arthritis J:82145
Tnfsf13tm1Pod/Tnfsf13tm1Pod
(B6.Cg-Tnfsf13tm1Pod) 		decreased susceptibility to induced arthritis J:141374
Tnfsf15tm1Cdon/Tnfsf15tm1Cdon
(B6.129-Tnfsf15tm1Cdon) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:136280
Tnfsf15tm1Hluo/Tnfsf15tm1Hluo
(D1LacJ.129(B6)-Tnfsf15tm1Hluo) 		decreased susceptibility to induced arthritis J:207029
Tnip1Gt(E059E05)Wrst/Tnip1Gt(E059E05)Wrst
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-double stranded DNA antibody level J:180054
increased anti-nuclear antigen antibody level J:180054
increased susceptibility to systemic lupus erythematosus J:180054
Tnip1m1Btlr/Tnip1m1Btlr
(C57BL/6J-Tnip1m1Btlr) 		increased anti-double stranded DNA antibody level J:265175
Tnip1tm1.1Pcoh/Tnip1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-double stranded DNA antibody level J:176826
Tnip1tm1.1Pcoh/Tnip1tm1.1Pcoh
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-double stranded DNA antibody level J:176826
increased anti-nuclear antigen antibody level J:176826
Tpp2tm1.1Gnie/Tpp2tm1.1Gnie
(involves: 129S6/SvEvTac) 		increased anti-nuclear antigen antibody level J:221205
increased autoantibody level J:221205
Tpsab1m1/Tpsab1m1
Tpsb2tm1(cre)Adch/Tpsb2tm1(cre)Adch
(B6.Cg-Tpsb2tm1(cre)Adch Tpsab1m1) 		decreased susceptibility to induced arthritis J:142880
Tpsb2tm1.1Mfg/Tpsb2tm1.1Mfg
(B6.129-Tpsb2tm1.1Mfg) 		decreased susceptibility to induced arthritis J:142880
Traf3tm1Bshp/Traf3tm1Bshp
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL) 		autoimmune response J:124329
increased anti-double stranded DNA antibody level J:124329
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(involves: 129/Sv * BALB/c) 		increased anti-double stranded DNA antibody level J:93923
increased anti-histone antibody level J:93923
increased anti-single stranded DNA antibody level J:93923
increased autoantibody level J:93923
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(C.129-Traf3ip2tm1.1Lix) 		increased autoantibody level J:138560
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(B6.129-Traf3ip2tm1.1Lix) 		increased anti-chromatin antibody level J:187766
increased anti-double stranded DNA antibody level J:187766
increased anti-histone antibody level J:187766
increased anti-nuclear antigen antibody level J:187766
increased autoantibody level J:187766
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
Tnfsf13btm1Msc/Tnfsf13btm1Msc
(involves: 129 * 129S2/SvPas * BALB/c) 		increased autoantibody level J:138560
Traf3ip2tm1Sbn/Traf3ip2tm1Sbn
(either: B6.129-Traf3ip2tm1Sbn or (involves: 129) or (involves: 129 * BALB/c)) 		decreased susceptibility to autoimmune disorder J:144320
Traf6tm2Ywc/Traf6tm2Ywc
Tg(Cd4-cre)1Cwi/?
(involves: C57BL/6 * DBA/2) 		abnormal lymphocyte anergy J:130882
Trem1tm1(KOMP)Vlcg/Trem1tm1(KOMP)Vlcg
(C57BL/6N-Trem1tm1(KOMP)Vlcg/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
Trex1em3Gpt/Trex1em3Gpt
(C57BL/6JGpt-Trex1em3Gpt) 		increased susceptibility to autoimmune disorder J:330879
Trex1tm1.1Fwpe/Trex1tm1.1Fwpe
(involves: 129S1/SvImJ * 129S4/SvJae * 129S6/SvEvTac) 		increased anti-double stranded DNA antibody level J:220965
increased susceptibility to systemic lupus erythematosus J:220965
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd) 		increased autoantibody level J:202757
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-nuclear antigen antibody level J:181257
increased susceptibility to systemic lupus erythematosus J:181257
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N) 		increased autoantibody level J:234263
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * C57BL/6J) 		increased susceptibility to autoimmune disorder J:243357
Trim21tm1Mwah/Trim21tm1Mwah
(C57BL/6-Trim21tm1Mwah) 		autoimmune response J:151775
increased autoantibody level J:151775
Trim25tm1Mura/Trim25+
Usp15L749R/Usp15+
(involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:259382
Tsc22d3tm1.2Efmd/Y
(Not Specified) 		abnormal susceptibility to autoimmune disorder J:201728
Tusc2tm1Avi/Tusc2+
(involves: 129S1/Sv * C57BL/6J) 		increased anti-nuclear antigen antibody level J:119985
increased susceptibility to autoimmune disorder J:119985
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv * C57BL/6J) 		increased anti-nuclear antigen antibody level J:119985
increased susceptibility to autoimmune disorder J:119985
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv) 		increased susceptibility to autoimmune disorder J:309768
Tyk2E775K/Tyk2E775K
(B10.D1-H2q/SgJ) 		decreased susceptibility to induced arthritis J:69051
Tyrobptm1Lll/Tyrobptm1Lll
(involves: 129P2/OlaHsd * C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:64763
Tyrobptm1Lll/Tyrobptm1Lll
(involves: 129P2/OlaHsd) 		decreased susceptibility to induced arthritis J:158811
Tyrobptm1Ttk/Tyrobptm1Ttk
(B6.129P2-Tyrobptm1Ttk) 		increased anti-double stranded DNA antibody level J:177613
increased autoantibody level J:177613
Ubash3btm1Jni/Ubash3btm1Jni
Ubash3atm1Jni/Ubash3atm1Jni
(Not Specified) 		increased susceptibility to experimental autoimmune encephalomyelitis J:89761
Unc93b1tm1.1Kmiy/Unc93b1tm1.1Kmiy
(involves: 129P2/OlaHsd * C57BL/6) 		increased anti-nuclear antigen antibody level J:174308
increased autoantibody level J:174308
Usp15L749R/Usp15+
(involves: 129S1/SvImJ * C57BL/6J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:259382
Usp15L749R/Usp15L749R
(involves: 129S1/SvImJ * C57BL/6J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:259382
Usp15L749R/Usp15tm1Pgrs
(involves: 129S1/SvImJ * C57BL/6J) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:259382
Usp15tm1Pgrs/Usp15tm1Pgrs
(Not Specified) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:259382
Usp25Gt(RRS805)Byg/Usp25Gt(RRS805)Byg
(involves: 129P2/OlaHsd) 		increased susceptibility to experimental autoimmune encephalomyelitis J:188557
Vdrtm1Ska/Vdrtm1Ska
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		decreased susceptibility to autoimmune diabetes J:112519
Vdrtm1Ska/Vdrtm1Ska
(NOD.Cg-Vdrtm1Ska/CmatJ) 		increased susceptibility to autoimmune diabetes J:127787
Vsig4tm1Gne/Vsig4tm1Gne
(C57BL/6-Vsig4tm1Gne) 		increased susceptibility to experimental autoimmune encephalomyelitis J:281762
Vsirtm1Lex/Vsirtm1Lex
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S5/SvEvBrd * C57BL/6) 		increased susceptibility to experimental autoimmune encephalomyelitis J:222944
Vtcn1tm1Xxz/Vtcn1tm1Xxz
(involves: 129S4/SvJae * BALB/c * C57BL/6) 		increased susceptibility to autoimmune diabetes J:177612
increased susceptibility to experimental autoimmune encephalomyelitis J:177612
Vwftm1Wgr/Vwftm1Wgr
(B6.129S2-Vwftm1Wgr) 		increased susceptibility to experimental autoimmune encephalomyelitis J:140334
Wastm1Itl/Y
(Not Specified) 		increased anti-double stranded DNA antibody level J:153247
Wastm1Itl/Wastm1Itl
(Not Specified) 		increased anti-double stranded DNA antibody level J:153247
Wastm1Sbs/Y
(involves: 129S6/SvEvTac) 		increased anti-double stranded DNA antibody level J:153247
Wastm1Sbs/Y
(involves: 129S6/SvEvTac * C57BL/6) 		increased anti-chromatin antibody level J:182528
increased anti-double stranded DNA antibody level J:182528
increased anti-single stranded DNA antibody level J:182528
increased autoantibody level J:182528
Wastm1Sbs/Wastm1Sbs
(involves: 129S6/SvEvTac) 		increased anti-double stranded DNA antibody level J:153247
Wastm1Sbs/Wastm1Sbs
(involves: 129S6/SvEvTac * C57BL/6) 		increased anti-chromatin antibody level J:182528
increased anti-double stranded DNA antibody level J:182528
increased anti-single stranded DNA antibody level J:182528
increased autoantibody level J:182528
Wastm2Itl/Y
(Not Specified) 		increased anti-double stranded DNA antibody level J:153247
Wastm2Itl/Wastm2Itl
(Not Specified) 		increased anti-double stranded DNA antibody level J:153247
Wipf1tm1Geha/Wipf1tm1Geha
(involves: 129S6/SvEvTac * C57BL/6) 		increased autoantibody level J:116168
Xcl1tm1.1Dnax/Xcl1tm1.1Dnax
(either: (involves: 129/Sv * BALB/c) or (involves: 129/Sv * C57BL/6)) 		autoimmune response J:176844
Xkrxtm1b(EUCOMM)Wtsi/Xkrxtm1b(EUCOMM)Wtsi
(C57BL/6N-Xkrxtm1b(EUCOMM)Wtsi/Wtsi) 		increased anti-nuclear antigen antibody level J:211773
X/Yaa
((NZB x BXSB)F1) 		increased anti-erythrocyte antigen antibody level J:6235
increased anti-nuclear antigen antibody level J:6235
increased autoantibody level J:6235
increased susceptibility to autoimmune disorder J:6235
X/Yaa
((SJL/J x BXSB)F1) 		increased susceptibility to autoimmune disorder J:6235
X/Yaa
((C57BL/6J x BXSB)F1) 		increased susceptibility to autoimmune disorder J:6235
X/Yaa
(involves: BXSB * NZB) 		increased susceptibility to autoimmune disorder J:6235
X/Yaa
(BXSB/MpJ) 		increased anti-erythrocyte antigen antibody level J:6235
increased anti-nuclear antigen antibody level J:179430
increased susceptibility to autoimmune disorder J:108760, J:6235
X/Yaa
((NZW x SB)F1) 		increased susceptibility to autoimmune disorder J:7276
X/Yaa
((NZW x BXSB)F1) 		increased susceptibility to autoimmune disorder J:7276
X/Yaa
(BXSB/MpJScr) 		increased anti-nuclear antigen antibody level J:10973
increased susceptibility to autoimmune disorder J:10973
YaailNZW/Ola/?
(involves: C57BL/6Ola * NZW/Ola) 		increased anti-double stranded DNA antibody level J:52110
Zap70m1Saka/Zap70m1Saka
(involves: BALB/c) 		abnormal T cell clonal deletion J:154166
increased autoantibody level J:86607
increased susceptibility to induced arthritis J:154166
rheumatoid arthritis J:86607
Zap70m1Saka/Zap70tm2.1Weis
(involves: 129S4/SvJae * BALB/c) 		abnormal T cell clonal deletion J:154166
decreased susceptibility to induced arthritis J:154166
Zap70tm2.1Weis/Zap70tm2.1Weis
(C.129S4-Zap70tm2.1Weis) 		abnormal T cell clonal deletion J:154166
Zap70tm2.1Weis/Zap70tm2.1Weis
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S4/SvJae * C57BL/6J * DBA/2J) 		abnormal T cell clonal deletion J:154166
Zc3h12atm1Aki/Zc3h12atm1Aki
(involves: 129X1/SvJ * C57BL/6) 		increased anti-double stranded DNA antibody level J:147868
increased anti-nuclear antigen antibody level J:147868
Zc3h12atm1c(EUCOMM)Hmgu/Zc3h12atm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA) 		increased anti-nuclear antigen antibody level J:304105
increased autoantibody level J:304105
Zc3h12dtm1Tom/Zc3h12dtm1Tom
(B6.Cg-Zc3h12dtm1Tom) 		increased susceptibility to experimental autoimmune encephalomyelitis J:209383
Zfp36tm2.1Pjb/Zfp36tm2.1Pjb
(involves: C57BL/6) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:229078
decreased susceptibility to induced arthritis J:229078
Zranb1tm1c(EUCOMM)Hmgu/Zranb1tm1c(EUCOMM)Hmgu
Tg(Itgax-cre)1-1Reiz/0
(involves: 129S4/SvJaeSor * C57BL/6N * CBA) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:235701
Zranb1tm1d(EUCOMM)Hmgu/Zranb1tm1d(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6N) 		decreased susceptibility to experimental autoimmune encephalomyelitis J:235701
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/19/2024
MGI 6.24 		The Jackson Laboratory